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Abstract 
Bone is one of the most common tissues to be transplanted, with over 2.2 million 
grafting procedures performed worldwide every year (Van der Stok et al., 2011). 
Autologous bone grafts, while considered the current gold standard, have 
inherent risks including limited donor tissue availability, donor site morbidity, 
surgical complications, and pain of procedure. Alternative approaches to treating 
bone tissue defects are required based on clinically effective bone graft 
substitutes that can be manufactured at a commercially relevant scale. Tissue 
engineering is an alternative strategy that uses biocompatible scaffolds in 
combination with cells as a bioactive implant to induce bone repair. In this thesis, 
microspherical bioactive glasses have been studied as a platform for scalable 
bone tissue engineering that has flexibility to address diverse geometric 
requirements with the aim of becoming a commercially available tool. Specifically, 
titanium-doped phosphate glass microspheres have been studied for their ability 
to support bone progenitor cells. Here, the microspheres (5 and 7 mol% TiO2) 
were assessed in their ability to support proliferation of osteoblast-like cell 
(MG63) and proliferation and osteogenic differentiation of human bone-marrow 
derived mesenchymal stem cells (hBM-MSCs) under static and dynamic agitation 
culture. Scalability was assessed using scalable dimensionless Froude number 
to scale microwell plate cultures to 125ml Erlenmeyer flask cultures using Froude 
as a tool to map mixing systems at both scales. MG63 and hBM-MSC proliferation 
was observed on the microspheres under all conditions studied as well as 
extracellular matrix protein secretion, confirming the biocompatibility of the 
materials tested. Similar growth kinetics was observed at both scales, where 
moderate agitation stimulated cell proliferation, but higher agitation was 
damaging to cells. Upregulation of key bone expression markers (COL1A1 and 
SPP1) was observed also at moderate orbital agitations, while on at high agitation 
rates this was largely absent, except for upregulation of SPP1 on the control 
microsphere, Synthemax. Furthermore, biomaterial resorption was observed 
upon differentiating mouse-derived monocytes into osteoclasts on the titanium-
phosphate glass discs. In conclusion, large-scale culture using titanium-doped 
phosphate glass microspheres was achieved with hBM-MSCs, with the substrate 
effectively supporting cell proliferation and osteogenic differentiation. This 
research provides a stepping stone in understanding how biomaterials processed 
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into microcarrier format can be utilised in a commercial environment to create 
clinically relevant quantities of tissue engineering bone.  
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Figure 4.13 hBM-MSCs cultured on Corning® Synthemax at day 21 of 
culture when cultured under static conditions. Confocal laser scanning 
microscopy images were acquired and converted into Z-stack images which 
were rendered to produce a maximum intensity projection of cross-sections 
up to 150µm.  Staining pattern highlights fibronectin (green) and type-1 
collagen (red) expressed in the extracellular matrix. Nuclear staining was 
carried out using Hoechst 33342. Images taken at 20x magnification. 154 
 
Figure 4.14  hBM-MSCs cultured on (A) TI-PGMS and (B) Corning® 
Synthemax at day 21 of static culture. Confocal laser scanning 
microscopy Z-stack images were rendered to produce a maximum intensity 
projection of cross-sections up to 150µm.  Staining pattern highlights 
fibronectin (green) and type-1 collagen (red) expressed in the extracellular 
matrix. Bright field images (far-right) show the distribution of microcarriers in 
the cluster. Nuclear staining was carried out using Hoechst 33342. Images 
were taken at 5x magnification. 155 
 
Figure 4.15 hBM-MSCs cultured to Ti-PGMs at day 21 of static culture. 
Confocal laser scanning microscopy Z-stack images were rendered to 
produce maximum intensity projection of cross-sections up to 150µm.  
Staining pattern highlights osteopontin (green) and osteocalcin (red) found 
in the extracellular matrix.  Images taken at 10x magnification where scale 
bar is 100µm. 156 
 
Figure 4.16  hBM-MSCs cultured on Synthemax at day 21 of static 
culture. Confocal laser scanning microscopy Z-stack images were rendered 
to produce maximum intensity projection of cross-sections up to 150µm.  
Staining pattern highlights osteopontin (green) and osteocalcin (red) found 
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in the extracellular matrix.  Images taken at 10x magnification where scale 
bar is 100µm. 157 
 
Figure 4.17 Relative quantification of gene expression of (A) COL1A1 
(B) RUNX2 and (C) SPP1 in hBM-MSCs seeded on Ti-PGMs and 
Synthemax after 21 days in culture. Significance values denoted by * = 
p<0.05, ** =p <0.01 and *** = p< 0.001 indicate highly significant gene 
expression compared to Synthemax. Error bars represent the mean value 
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magnifications. 179 
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Chapter 1 .   Introduction and review of the 
literature 
 
 
1.1 Introduction 
There has been a surge in innovative ideas used to exploit the problem of 
regenerating diseased and damaged tissues, resulting in the emergence of a new 
healthcare sector. Described as an interdisciplinary field that applies principles 
and methods of engineering, life sciences, material sciences, cellular and 
molecular biology, and surgery towards the development of biological substitutes 
that restore damaged tissue (Langer and Vacanti, 1993), tissue engineering has 
travelled a long way from its early use in diabetic patients (Chick et al., 1975). 
Currently, procedures involve a biopsy taken to attain an appropriate cell source, 
which is then expanded until enough cells have been generated for the intended 
purpose, and consequently transplanted back into the patient either using 
materials of natural sources or synthetic materials for cellular delivery.  
 
At present, tissue can be used in either an implantation or transplantation. The 
latter involves harvesting cells from either the host or a donor, after which the 
cultured tissue sample is transplanted to the host site using surgical procedures. 
The former, is the development or modification of man-made materials to 
combine with living host tissues. The significance of tissue-engineered implants 
is that they provide benefits over transplantation, such as ease of availability, 
reliability, and reproducibility. Furthermore, stringent guidelines have been set, 
such as good manufacturing practise and international standards, which minimize 
the failure rate of such techniques. Another advantage of using tissue engineered 
constructs is that structures can be created to produce a product of a desired 
shape and size, complimentary to the defect in a three dimensional format 
(Lahann et al., 2003). There are concerns associated with the use of implants 
such as interfacial stability with host tissue, biomechanical mismatch of elastic 
moduli and maintaining a stable blood supply. Additionally, implants generally 
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don’t have the ability to self-repair or modify their structure in response to 
environmental changes (Hench, 1998). 
 
While progress exists in this area, no one solution has arrived to solve all issues 
and henceforth large bone defects remain a continuing challenge for research. 
The established field of tissue engineering provided the basis to develop 
materials around the advancing regenerative medicine, with the roles of 
biomaterials becoming paramount in developing bone tissue-engineered 
constructs. These constructs consist of any combination of bone marrow tissue, 
synthetic scaffolds, and various biological factors (Barrere et al., 2008). 
 
To this date millions of individuals who have had their quality of life improved 
substantially with the use of the man-made implants, however the efficacy of 
these biomaterials has been poor due to the response illustrated not being 
comparable to the qualities seen of natural tissue such as their bone loading 
properties. Despite the conduction of many studies in tissue engineering, the field 
is still considered to be in its infancy, with skin grafts and cartilage repair products 
being the main contributors of its success. With many disciplines slowly merging 
together including the likes of gene therapy, stem cell research and even the 
nanotechnology industry, the potential for developing new effective therapies 
keeps increasing (Moroni and van Blitterswijk, 2006). 
 
Stem cells provide an ideal candidate to be used in forming bone tissue 
engineered constructs, as they can be sourced in large amounts and 
differentiated under the right conditions into bone progenitor cells. To ensure that 
stem cell technologies are used in an efficient manner, large numbers of cells 
with defined characteristics need to be produced, and hence a careful systematic 
approach with controlled monitoring is required. Depending on the intended use 
of the stem cells, a suitable culture system should be used which incorporates 
methods to increase yields of viable cells and limit differentiation towards 
unwanted lineages. Owing to bioprocess engineering, successful large-scale 
cultures can be established and operated at the standards required for clinical 
application. 
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1.2 Research Motivation 
Biomaterials have been widely studied since the development of the novel 45S5® 
BioGlass, reported by Larry Hench in 1969. While various iterations of this 
silicate-based glass have been developed and extensively studied, work with 
phosphate glasses is limited (Hench, 1991, Hench, 1998). Studies of phosphate 
glasses and their use in applications such as orthopaedic, dental and 
maxillofacial implants, clearly suggest that this family of glasses illustrate a new 
generation of biomaterials with a host of associated benefits such as their ability 
to be tailored and physiochemical properties (Knowles, 2003). From the range of 
studies focusing on the suitability and applicability of the various stoichiometric 
variations of phosphate glasses, limited studies have looked at the effect of 
scaling these exploratory studies to a clinically relevant scale. While it is important 
to establish the biocompatibility of these materials, a better understanding is 
needed of whether these novel compounds can elicit the same beneficial 
responses both structurally and biologically, when used in large scale culture 
systems. 
 
This research focuses on understanding how commonly used bioprocessing 
tools, such as microcarriers and shaken culture can be used at their fullest to 
optimize cell yields and to gain an improved understanding of how to minimize 
cell variability in terms of identity and maturity. The project aims to bring together 
three distinct aspects of tissue engineering (cell culture, biomaterials, 
bioprocessing). Substantial research has been carried out in all the respective 
areas; however there remains a knowledge gap associated with the synergism 
between each of these studied areas 
 
Therefore, it is hypothesized that spheroidized phosphate glass microspheres 
can support critical cell responses that enable scalable production of bone-like 
tissue microunits. The aim of this research was to demonstrate the potential of 
Titanium-doped phosphate glass to provide bone-like tissue in a manner that is 
transferable to scalable bioreactor-based cell culture. To establish the efficacy, 
the following aims were initially set out: 
 
 34 
 
1) Assess the biocompatibility of the material with the following differentiated 
and primary cell types: 
a) Osteosarcoma cell line (MG63) 
b) Human bone marrow-derived mesenchymal stem cells (hBM-
MSCs) 
2) Determine the effects of fluid flow forces induced by dynamic culture on    
cell/engineered tissue quality. 
3) Establish whether scale-up of cell culture can be achieved to create 
increased quantities of engineered bone-like material. 
 
 
1.3 Organisation of review 
This chapter aims to provide an in-depth analysis of the principles the research 
focuses on i.e. bone defects, the osteogenic potential of the biomaterials used in 
the research, focusing on phosphate glasses containing TiO2 as a metallic oxide 
doping agent, the role of bioprocess forces and their influences on bioreactor 
development. This review aims to consolidate previously carried out studies 
applying similar principles to the ones of this project highlighting their relevance 
and main contributions to the research area. 
 
 
1.4 Bone 
1.4.1 Constituents of bone 
Bone is responsible for protection, support and motion of the body and its vital 
organs. Flexibility and elasticity are key characteristic of ribs which protect the 
heart, lungs, and other organs whose function involves mobility. The stiffness 
quality of bone also allows it to provide structural support to soft tissues, such as 
muscle or even the lungs during expansion (Buckwalter et al., 1996a). At a 
cellular level, it surrounds bone marrow storage having a protective aspect in its 
nature. Additionally, it also plays a role in the endocrine system in regulating 
calcium and phosphate levels via homeostasis (Barrere et al., 2008). 
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The entity bone belongs to a family of tissues with varying structural motifs, each 
consisting of the same basic unit of collagen fibril. This structural family comprises 
of other materials such as dentin and cementum, the inner layer of teeth and the 
substance that binds teeth to the gum respectively, along with mineralized 
tendons (Weiner and Wagner, 1998). Collagen fibrils are composed of the protein 
collagen in a structural manner that is present in a variety of soft tissues. The 
collagen acts as the main component of a structural 3D matrix into which the 
mineral forms, adding strength and hardness. The primary mineral formed is 
known as carbonate apatite (Ca5 (PO4, CO3)3( (Weiner and Wagner, 1998), one 
of the few minerals in bone. The final constituent of this structure is water. There 
is a need to distinguish that bone is a structure rather than a material, in that its 
nature is not fixed, as each of the constituents can vary in quantity present and 
be organized in various manners depending on the function of the bone (Weiner 
and Wagner, 1998). 
 
 
1.4.2 Bone remodelling 
Bone remodelling involves the resorption of mineralized bone by osteoclasts, 
followed by the formation of bone matrix through osteoblasts, and its subsequent 
mineralization. Adult bones are fascinating in that they constantly remodel based 
on the mechanical stresses exerted upon them, such as fluid flow from blood 
supply, which subsequently maintains bone health and its regeneration as a 
consequence of small injuries. Remodelling of bone occurs without any change 
in properties such as density or shape (Buckwalter et al., 1996b). The overall 
remodelling process is affected by age and can be illustrated by certain diseases 
which impact bone mass, hence promoting fragility of the bone, and leaving it 
prone to fracture. One of the key causes is the imbalance of resorption and 
formation of bone due to oestrogen deprivation  (Vaananen and Harkonen, 1996, 
Marie, 2005). Further examples of altered bone formation can be seen in 
astronauts, who experience zero-gravity on a regular a basis, which results in 
their modified bone shape and density (Tavassoli, 1986). 
 
The formation of bones is promoted by two specific processes, intramembranous 
and endochondral ossification (Marolt et al., 2010).  The former involves the 
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differentiation of condensed mesenchymal tissue into osteoblasts and 
subsequently form bone. On the other hand, endochondral ossification results in 
the formation of cartilaginous anlage, which consequently becomes calcified 
following the invasion of blood vessels, resulting in new bone formation 
(Bhumiratana and Vunjak-Novakovic, 2012). During intramembranous 
ossification, mesenchymal stem cells (MSCs) give rise to bone forming cells 
osteoblasts and osteocytes in the process known as osteogenesis (Wei et al., 
2013). Spindle-shaped osteoblast precursors arise from MSCs and shift into large 
cuboidal osteoblasts during the osteogenesis process in bone (Davies, 1996, 
Clarke, 2008). During this process, osteoblasts secrete osteoid (Tenenbaum and 
Heersche, 1982) which contains type-I collagen and non-collagenous proteins 
such as osteopontin (Pinero et al., 1995) toward the bone formation surface 
(Clarke, 2008). Osteoid acts as the basic matrix for mineralization and bone 
formation. Alkaline phosphatase (ALP), also produced by osteoblasts, helps 
extracellular matrix (ECM) calcification (Pinero et al., 1995, Takeyama et al., 
2001, Clarke, 2008). The precise function of osteoblasts in bone apatite formation 
remains unknown, however a crystallization role has been proposed 
(Boonrungsiman et al., 2012).  
 
Osteoclasts, developed from mononucleated precursor cells both in bone marrow 
and  the circulatory system (Quinn et al., 1998), are stimulation responsible for 
bone resorption during the bone remodelling process (Orriss and Arnett, 2012). 
Their differentiation direction is comparable to macrophages and dendritic cells 
(Alvarez et al., 1992) with coming from receptor activator of nuclear factor kappa-
B ligand (RANKL) and macrophage colony-stimulating factor (M-CSF) (Shirai et 
al., 1999, Vaananen et al., 2000, Heinemann et al., 2011).  M-CSF and RANKL, 
expressed by MSCs and osteoblastic cells, are presented to osteoclasts and its 
progenitors by cell-cell contact (Heinemann et al., 2011). This has been proved 
essential in inducing expression of enzymes specific to bone resorption, such as 
tartrate-resistant acid phosphatase (TRAP) (Bune et al., 2001), cathepsin K (Xia 
et al., 1999, Nakayama et al., 2011), matrix metalloproteinase (Visse and 
Nagase, 2003) and vacuolar type H+-ATPase (V-ATPase) (Blair et al., 1989).  
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1.4.3 Bone defects 
Bone is unique in that, unlike a majority of other connective tissues, it does not 
form scars upon reconstitution of an injury due to molecular and cellular 
processes involved in the repair being sequential (Arvidson et al., 2011). This 
repair process is carried out by a regulation mechanism controlled by specific 
factors, although the full extent to the molecular and cellular processes that 
contribute to these phases is still not fully understood. Large bone defect repairs 
occur primarily via endochondral ossification and include a cascade of events 
known to be haematoma, inflammation, angiogenesis, chondrogenesis, 
osteogenesis, and finally bone remodelling (Figure 1.1) (Phillips, 2005).  Each of 
the phases mentioned involve various levels of cell migration and differentiation 
coupled with processes linked with calcification (Arvidson et al., 2011). When 
looking at the process in more detail a familiar pattern can be identified whereby 
the inflammatory response that occurs coordinated with the haematoma 
formation, contributes to the initiation of the bone healing cascade through the 
action of specific cytokines, and promotes endochondral bone formation and 
remodelling (Gerstenfeld et al., 2003a). Sequentially, osteogenic events such as 
mesenchymal and osteoprogenitor cell proliferation and differentiation occur, via 
the activity of biological factors including members of the transforming growth 
factors (TGF) family such as bone morphogenetic protein (BMPs) and insulin-like 
growth factors (IGF) (Tsiridis et al., 2007).   
 
 
Figure 1.1 Stages involved in bone repair cascade. Copyrights of images owned by 
Benjamin Cummings (2004) Pearson Education. Inc 
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The cascade is concluded with the process of angiogenesis regulated by the 
angiopoietin pathway (Gerstenfeld et al., 2003b) and vascular endothelial growth 
factor (VEGF)-dependent pathway, where osteoblasts and osteoblast-like cells 
induce VEGF expression in relation to endochondral bone formation (Deckers et 
al., 2002). A full understanding of the cascade that takes place is not complete 
and links are still being made between several molecules and processes in the 
bone repair mechanism. 
 
After fully healing, bone shape and mechanical properties are restored (Barrere 
et al., 2008). The main physiological bottleneck rectifying such injuries is that 
there is a size limit to which bone can self-repair. This limit is defined as the critical 
size defect, and states that defects of this size and larger will not naturally heal 
during the lifetime of an animal (Schmitz and Hollinger, 1986, Trounce et al., 
2000). This creates an opportunity for tissue engineering and it is currently wide 
open. The full level to which the osteogenesis process can be optimized is still 
not fully understood. There are many strategies widely being studied but one 
major limitation of the tissue produced in these studies is that it does not exhibit 
the same load bearing qualities especially when concerning large bone defects.  
 
The most common methods of treatment for bone defects favoured by surgeons 
are autografts, involving the transplantation of bone from another part of the 
patient, originating usually from the pelvis, to the defective site (Kucera et al., 
2012). One of the setbacks is that its supply is limited and associated with 
inherent pain from isolation for the grafts. Synthetic options are required to treat 
the one million plus patients who require treatment for bone defects every year. 
Interventions are used to satisfy this insufficient availability of bone, through the 
mixing of bone graft extender material with the autograft, generally in the form of 
calcium phosphate. These granules form a putty-like substance when mixed with 
the host’s blood, which is pressed into the defect. The benefits of this are that the 
blood improves the handling on the material, with the added advantage of 
providing natural growth factors to aid bone repair (Jones, 2013). With 
demographics showing that a majority of bone related injuries and diseases 
associated with the elderly, and form of cell therapy replacement will need to aid 
the healing process due to the reducing regeneration potential with age. 
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1.5 Biomaterials and filling the gap 
1.5.1 Biomaterial properties 
The product profile of a potential implantable bone regeneration scaffold is that it 
should be able to act as a three-dimensional (3D) structure to aid bone repair. 
The structure should be temporary in nature while being able to enable natural 
human regeneration, by bringing together bone marrow stem cells and blood 
vessels to regenerate new bone and vascularise the newly formed tissue 
respectively. 
 
During the last few decades, attention has been put upon the use of bioactive 
materials and their fixation to connective tissues, by bonds formed with strengths 
up to six-fold of those seen commonly within a collagen structure. This quality 
can be attributed to the in vivo growth of a dense layer of hydroxyl-carbonate 
apatite layer which binds to the collagen fibrils (Hench, 1998). Metals and non-
degradable ceramics have been used predominantly for connective tissue 
reparation, due to the qualities they possess such as high tensile strength 
(Barrere et al., 2008).  
 
One useful tool of certain biomaterials is their ability to induce an osteogenic 
response. This osteoinductive characteristic has been studied in animal models 
such as goats (Kruyt et al., 2004, Habibovic et al., 2006) and has shown that bone 
production can occur in areas not akin to bone formation. This property can be 
helpful in regenerating areas in which the bone defects tend to be large by nature. 
Prior examples of osteoinductivity extend back to 1969, where poly-
hydroxyethylmetyl-methacrylate (poly-HEMA) sponges were reported to induce 
bone formation in soft tissues (Winter and Simpson, 1969). Calcium phosphate 
is a common example, where dissolution-precipitation processes incur surface 
transformations, which promote bone bonding (Habibovic et al., 2006). It is the 
calcium phosphate that promotes the ionic exchange that affects the surrounding 
milieu and has been identified as a key promoter amongst others of 
osteoinduction. The full nature of osteoinductive influence is not clearly 
understood, however some factors thought to play a role in the process include 
porosity of the biomaterial along with the surface physio-chemistry (Habibovic et 
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al., 2006). These porous structures exist either when initially formed (Winter and 
Simpson, 1969, Fujibayashi et al., 2004, Habibovic et al., 2006) or due to the 
degradation of the structure (Gosain et al., 2002). This attribute of porosity was 
illustrated in earlier studies with titanium implants inducing greater osseo-
integration where the implant had a rough nature (Wall et al., 2009). The surface 
roughness exhibited by the titanium implant, while reducing cellular proliferation 
increased the induction into an osteogenic phenotype, which was evident from 
the early mineralization of the matrix. When considering titanium macroporous 
structures, 3D structures show osteoconductive tendencies when compared to 
regular fibrous meshes, which did not induce a bone formation response 
(Fujibayashi et al., 2004) implying only specific pore geometries promote bone 
formation (Magan and Ripamonti, 1996). 
 
A variety of different bioactive materials undergo degradation by nature in that 
they exhibit physical, chemical structure and appearance variations. The degree 
of degradation is dependent on the nature of the biomaterials. There are a range 
of factors which initiate material degradation and vary from material to material. 
It is essential to understand how the fluid and cells used influence the rate of 
biomaterial degradation. Controlling the rate of degradation and allowing it to 
synchronize effectively with the rate of tissue growth to ensure full regeneration 
of tissue is achieved, is a great challenge that is still faced in the biomaterial field. 
Efforts are being focused on trying to improve degradation kinetics, with 
techniques such as multiphase calcium phosphate mixing, using different ratios 
of soluble and highly soluble materials to adjust the kinetics of the bioactive 
material to that of the bone formation kinetics (Arinzeh et al., 2005). 
 
 
1.5.2 Commercial bioactive glasses 
The current biomaterial market is improving vastly, with a plethora of bioactive 
substances being tested; however, discrepancies lie between what engineers 
deem key factors for a commercially successful scaffold, and the qualities 
surgeons require. Bioactive glasses are a class of biomaterial which have shown 
to induce specific biological responses. Deciding which composition to use when 
generating a bioactive glass can be a tedious task; however, there are essential 
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qualities which all types must hold. Bio-functionality and biocompatibility cover 
these properties, with the bio-functionality aspects including properties such as 
tensile strength, mechanical properties, Young’s Modulus, surface chemistry and 
degradation to name a few  (Barrere et al., 2008). Biocompatibility, on the other 
hand, looks at the ability for the material to perform with an appropriate host 
response (D.F.Williams, 1999). Historically, bioactive glasses have been defined 
as a material which when implanted into a host, leads to the formation of an 
apatite-like layer that is responsible for the materials bone with hard and soft 
tissues. There are many commercially available glass-based products for bone 
defect regeneration including BioGlass, Biogran® (BIOMET 3i, Palm Beach 
Gardens, FL) and BonAlive® (S53P4) (BonAlive Biomaterials, Turku, Finland) all 
derived from the same silicate structure. Since the development of BioGlass in 
1969, it has been used to treat over a million patients with bone defects. 
Considering the age of the product, it has gained limited commercial success. To 
date, the most marketable iteration of it has come in the form of NovaMin® 
(GlaxoSmithKline, UK), the active ingredient in Sensodyne®, responsible for the 
mineralization of the tiny pores in dentine, reducing overall tooth sensitivity. 
Further modified versions of BioGlass have also been used to treat deafness, 
where a patient received treatment for the degradation of two bones within the 
eardrum (Rust et al., 1996, Stanley et al., 1997). Another product BonAlive when 
used with autologous bone allowed the integration of titanium roots into the 
porous maxilla, with significantly improved bone repair and a thicker trabeculae 
when compared to autograft alone (Turunen et al., 2004). Furthermore, trials with 
S53P4, the key ingredient of BonAlive, showed improved bone quantity and 
quality when compared to synthetic hydroxyapatite (HA) (Peltola et al., 2006). 
While fusion rates are comparably higher from autografts than the commercially 
available substitutes, the results from most studies and trials indicate promising 
results. An associated issue with S53P4 is the lack of full resorption, which could 
be related to the silicate content, with observed glass granules remaining even 
after 11 years (Heikkila et al., 2011, Pernaa et al., 2011). More clinical data is 
readily available for BonAlive than for BioGlass, with greater clinical results 
associated with BonAlive, however illustrate less than ideal degradation rates.  
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The first particulate based therapy to enter the market was PerioGlas®, now sold 
by NovaBone (NovaBone Products LLC, Alachua, FL), used in periodontal 
disease. With a particle size of 90-710 µm, it is used to regenerate bone around 
the damaged root of a tooth, and to provide support for damaged bones in the 
jaw for anchoring titanium implants. Studies carried out in vivo and in clinical trials 
indicated that PerioGlas generated significantly higher amounts of bone 
compared to controls (Schepers and Ducheyne, 1997, Froum et al., 1998). The 
successes of the periodontal treatments using these particulates lead to the 
development of NovaBone, a treatment for orthopaedic bone grafting on non-
load-bearing sites. It showed great advantages over autografts in treating 
adolescent idiopathic scoliosis, with fewer infections and mechanical failures, and 
the added benefit that a donor site is not required (Jones, 2013). 
 
 
1.5.3 Phosphate glasses and metallic oxides 
The initial use of phosphate glasses were for their applications as achromatic 
optical elements based on their low dispersion and relatively high refractive 
indices (Kreidl and Weyl, 1941), however they have been conceptualized to a 
range of purposes from securing nuclear waste to semiconductors (Marasinghe 
et al., 1997, Brow, 2000).  
 
The unique properties of a biomaterial candidate relevant to the purpose of tissue 
engineering research are its ability to degrade and its chemical components. The 
degradation of phosphate glasses can be controlled, and this becomes important 
when used in different solubilising media types. These materials when 
manufactured properly can remain stable in situ for periods ranging from as little 
as a couple of hours to 1 year or longer. This is simply done by the modification 
of the phosphate glasses ternary structure (P2O5 - Na2O – CaO), through the 
addition of suitable metal oxides which form quaternary structures, therefore 
reducing the solubility level of these glasses. These components of the ternary 
structure have a vital role to play in the interactions between the phosphate glass 
and the osteogenic environment in vitro and in vivo. The key elements within the 
glass (e.g. P, Na, and Ca) are common inorganic minerals found within the bone 
and therefore their interactions in a physiological similar bone based environment 
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need to be understood (Anselme, 2000).  The vast majority of glasses tend to 
comprise of a high quantity of pure P2O5 by composition, however its hygroscopic 
nature negates its potential use as a biomaterial (Hudgens et al., 1998). The initial 
studies carried out on phosphate glasses looked at methods to stabilize the 
structure, making them more suitable as candidates for biological applications. 
This was done through the addition of stabilizing oxides such as Na2O and CaO 
(Burnie et al., 1981), generating the aforementioned ternary structure which 
allowed the first iteration of phosphate glasses flexibility in their degradation rates. 
This is illustrated in the opposite effects noticed with the calcium and sodium ions, 
with the former having a stabilizing effect on the phosphate glass dissolution rate, 
while the sodium ions have a depolymerising effect, consequently increasing the 
glass solubility in aqueous solutions (Pickup et al., 2007, Vitale-Brovarone et al., 
2011). While the first generation of these ternary glasses showed potential in their 
flexibility and ability to be tailored, their rates of dissolution were relatively high 
which caused abnormally high fluctuations in pH therefore reducing their 
biocompatibility. More recent studies have looked to improve this issue of 
degradation closely by the addition of metallic oxides relevant to the purpose of 
eliciting an improved cellular response. The metal oxides studied to date include 
Fe2O3, CuO, Al2O3, TiO2, MgO, ZnO, Ag2O, Ga2O3 and SrO (Lakhkar et al., 
2015b). The metallic oxides not only serve a purpose in their stability role, but 
also their ions released induce biological responses such as antimicrobial effects 
and cell proliferation/differentiation qualities (Knowles, 2003, Abou Neel et al., 
2009b).  
 
 
1.5.3.1 Titanium dioxide 
Titanium dioxide’s toxicity to human tissue can be potentially chronic and this is 
dependent on factors such as concentration and the physical and chemical 
properties of the compound. Systematic in vitro and in vivo methods are required 
to validate the toxicity when the compound is used in biomaterials (Chellappa et 
al., 2015). Studies such as those using Titanium dioxide in nanoparticle form, 
have identified that Titanium dioxide is not cytotoxic at specific concentrations 
(Jin et al., 2008). Phosphate glasses doped with titanium dioxide have been 
studied thoroughly, in terms of their structural and mechanical properties (Brow 
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et al., 1997, Brow, 2000, Abou Neel et al., 2008). TiO2 acts as a nucleating agent, 
and while it is miscible at the high temperatures during glass formation, it induces 
phase separation during the cooling period post melt (Monem et al., 2008). The 
introduction of TiO2 improves the stability of the phosphate glass due to the high 
field strength observed with its oxide. This stability induces an overall reduction 
in the dissolution and hence ion release is kept to a minimum. The subsequent 
effect is that the biocompatibility of the phosphate glass is improved (Zhang and 
Santos, 2001, Abou Neel et al., 2008, Monem et al., 2008). The rapid degradation 
of an unstable structure could lead to extreme fluctuations in pH and ionic 
concentrations. This stability becomes very important when culturing cells, as a 
stable substrate is required for cell attachment and proliferation. Due to the nature 
of the oxide being small in structure and having such high ionic charge, upon its 
entry into the vitreous structure, a stabilizing effect is witnessed because of the 
cross linking between the phosphate chains and rings (Navarro et al., 2003). This 
observation has been studied with various TiO2 concentrations, and results 
indicate that increased TiO2 concentrations induce an observed reduction in 
solubility. The way in which TiO2 improves this is through the formation of ionic 
cross links with phosphate chains and the generation of Ti-O-P covalent bonds 
that reinforce the phosphate glass, consequently minimizing the water diffusion 
at the glass/solution interface and hence limiting the dissolution rate. The reduced 
degradation associated by this, also limits the pH decrease observed caused by 
acidic degradation products (Vitale-Brovarone et al., 2011). Results from X-ray 
diffraction analysis of crystallized TiO2 doped phosphate glass indicated that the 
main phases in a range of TiO2 glasses studied were TiP2O7 and NaCa(PO3)3 
(Abou Neel et al., 2008). 
 
Some studies have accomplished to understand the limits to which TiO2 can be 
incorporated into the phosphate glass. Abou Neel et al determined that the upper 
limit to which the ternary phosphate glasses nature remains amorphous was at a 
TiO2 content of 15%. This was validated by this upper limit value capable of 
supporting cellular growth when used to grow an osteoblast-like cell line (MG63) 
(Abou Neel et al., 2008). However, physical properties were altered such as 
density and the temperature required to fabricate the material, factors which when 
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generating clinically relevant quantities of tissue engineered bone are key 
variables when trying to understand bioprocessing parameters. 
 
Studies have been carried out to establish the effect of phosphate based glass 
doped with titanium upon a range of various cell types including fibroblasts 
(Guedes et al., 2012) and osteosarcoma cell lines (Abou Neel et al., 2007). The 
use of titanium dioxide in phosphate glasses has been studied within both in vivo 
and in vitro studies. TiO2 doped phosphate glasses showed that increased 
biocompatibility was achieved by the addition of 5 mol% TiO2 in vitro, however 
during early cell culture (D1-D3) lower levels of alkaline phosphatase (ALP), a by-
product of osteoblast activity, were witnessed. These patterns were not 
concurrent with genetic expression on D14, where ALP and collagen type I alpha 
subunit I (COL1A1) showed significant increases, when compared to the 
commercially available control. There were also significant differences in 
composition of TiO2 used, with 5 mol% showing higher levels of osteogenic gene 
expression than 3 mol% (Abou Neel et al., 2007). 
 
Titanium dioxide has shown to enhance cell proliferation and gene expression of 
MG63 with 3 and 5 mol% illustrating the greatest effects. It was suggested that 
the improved cell properties were down to the reduced level of degradation of the 
compositions, henceforth maintaining conditions favourable to osteoblast 
formation due to the improved structural support. It was also put forward that the 
ideal TiO2 content was 5 mol% in that it induced the higher cellular response. The 
content of TiO2 also plays a significant role in the osseo-integration of these 
particles upon implantation, indicated by 1 and 3 mol% showing limited hard 
tissue formation in comparison to the 5 mol% (Abou Neel et al., 2007). 
 
 
1.5.3.1.1 Material characterization 
As previously mentioned, altering the glass composition and chemistry can 
control the degradation rates over several magnitudes (Abou Neel et al., 2008). 
A common trend observed with many of the glasses studied is the uniform 
linearity between weight loss and ion release of phosphate glasses, as a function 
of immersion time within a suitable solubilising agent (Ahmed et al., 2008, Khor 
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et al., 2011). Different species of phosphate glass ions in different amounts, from 
cyclic phosphates to orthophosphates (Ahmed et al., 2005a). This glass 
degradation process occurs with solubilising media in three distinct stages. The 
initial stage of slow degradation sees H2O molecules diffuse into the structure of 
the glass covering the entire surface in the process. This occurs due to the 
saturation of the surface by H+ and OH- ions released through acid/base reactions 
(Bunker et al., 1984, Gao et al., 2004) The second stage involves the uniform 
degradation of the phosphate glass, by the hydrated layer separating from the 
underlying partially hydrated section, causing dissolution, and leaching of ions 
into the surrounding medium. The concluding stage is a hydrolysis reaction, 
which causes the polymeric phosphate chains to disintegrate, rather than 
individual P-O bonds, due to hydrolytic attack (Bunker et al., 1984). The key 
factors responsible for the degradation include internal factors such as 
composition of phosphate glass and thermal preparation, and external factors 
such as pH, temperature of solution and surface area to volume ratio. 
 
Establishing the effect that the release of phosphate ions, as well as the glasses 
additional components, has upon contact with physiological fluid is paramount; 
hence a considerable amount of work has been carried out in this area. The use 
of ion exchange chromatography and high-performance liquid chromatography 
(HPLC) are approaches used in identifying the distinct levels of varying 
phosphate ions released. Ion exchange chromatography is more common than 
most due to the process simplicity for smaller molecular weight phosphates 
(Baluyot and Hartford, 1996).  
 
The addition of TiO2 reduces the overall phosphate ion release due to its metal 
ion valency and atomic radius, hence creating a slower rate of degradation of 
these doped phosphate glasses (Abou Neel et al., 2008, Gayathri Devi et al., 
2010). Raman spectrometry carried out by Navarro et al. on phosphate glasses 
(44.5P2O5.44.5CaO.11Na2O where Na2O is replaced with TiO2) containing 0, 3 
and 5 mol% of TiO2, showed that an increase in TiO2 content increased levels of 
TiO5 and TiO6 units, where an increase in these units was witnessed in the higher 
TiO2 composition glasses. Furthermore, increasing the TiO2 content increased 
the chemical durability and elastic modulus of the glasses (Navarro et al., 2003). 
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Thorough characterization studies have been previously carried out on the 
phosphate glasses doped with TiO2 at 3, 5 and 7 mol% by Lakhkar et al. Thermal 
analysis validated initial density measurements using Archimedes’ principle, 
showing as glass compositions increased in Ti content from 3 to 7 mol% an 
increase in the glass transition temperature from 489oC to 529oC is witnessed. 
The increased densification owes to the formation of TiO5 and TiO6 units formed 
creating P-O-Ti bonds (Abou Neel et al., 2009a). Degradation studies followed a 
similar trend, where Ti3 had a percentage cumulative weight loss per unit surface 
area of 0.0092% µm-2 after 80 hours in comparison to Ti7, whose degradation 
was approximately four times lower at 0.0024% µm-2. When looking at pH 
measurements, all the different composition increased the levels of acidity when 
immersed in deionized water over a 21-day period, with the greatest release of 
phosphate ions observed between day 0 to day 1. The composition that 
generated the highest acidic environment was Ti3 with Ti7 generating an overall 
less acidic environment over the same period. The reason behind the reduction 
in pH is attributed to the released phosphate ions forming phosphoric acid under 
aqueous conditions. This release of phosphate ions was concurrent with the 
release of its cationic neighbours (Ca2+ and Na+), again with the same trend 
witnessed with the other characterization studies. X-ray diffraction (XRD), nuclear 
magnetic resonance (NMR) and Ti K-edge X-ray near edge absorption data 
suggested there were no structural differences between the three compositions 
with coherent spectra across the three different concentrations (Lakhkar et al., 
2012b). Regarding the other ions present in the structure of ternary phosphate 
glass (Ca2+ and Na+) the release of these ions is at a rate inversely proportional 
to the CaO content of the glass. This is witnessed in glasses containing 45 to 55 
mol% P2O5, where this activity occurs due to CaO serving to densify the glass 
structure. This trend is also witnessed with phosphate glass when increasing 
amounts of high covalent metallic dopants are added to the structure (Ahmed et 
al., 2004b, Ahmed et al., 2004a, Ahmed et al., 2005b, Abou Neel et al., 2008). 
 
 
1.5.3.1.2 Biocompatibility of TiO2 doped phosphate glasses 
Biocompatibility research of phosphate glass doped with Ti has been carried out 
through approaches including in vitro analysis of the material after immersion into 
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physiological similar solutions such as Tris-HCL, Tris buffer or simulated 
biological fluid (SBF) (Kasuga et al., 1999). The latter is very common in 
understanding how the material behaves when in direct interaction with 
physiologically relevant solutions containing ions such as Na+, K+, Mg2+, Ca2+ and 
HCO3- to name a few, at concentrations approximately equal to human plasma. 
These studies provide an easy alternative to cellular based techniques to 
evaluate bioactivity through apatite formation upon the material surface in contact 
with the defined solution. Studies have revealed that phosphate glasses doped 
with TiO2 formed apatite on the surface as opposed to phosphate glass doped 
with MgO (Kasuga et al., 1999). Other studies have contradicted such findings 
suggesting that no apatite formation was observed with TiO2-doped phosphate 
glass when immersed in SBF for 14 days at 37oC (Abou Neel et al., 2007, ElBatal 
et al., 2009, Gayathri Devi et al., 2010, Lucacel et al., 2010). While there isn’t a 
clear understanding of the effect that the immersion of TiO2-doped phosphate 
glass in SBF has upon apatite formation, it should be made clear that apatite 
formation on the surface of such materials is not a pre-requisite for the material 
to be considered biocompatible (Kokubo and Takadama, 2006, Lee et al., 2006). 
Hence, in vitro analysis in SBF immersion alone can’t provide a conclusive 
understanding of the bioactivity of phosphate glass. Further studies in the form of 
cell culture can provide better insight into the level to which TiO2 phosphate glass 
can support the growth and maintenance of tissue.  
 
Early studies using titanium phosphate glasses used MC3T3-E1 murine pre-
osteoblast cells, identifying growth and differentiation characteristics at the cell-
material interface over a 37-day period. Protein and genetic analysis indicated 
that normal proliferation and differentiation rates were supported (del Valle et al., 
2003). Further studies indicated that glasses containing higher quantities of TiO2 
promoted better cell adhesion, growth, and proliferation (Dias et al., 2005, Brauer 
et al., 2006). Brauer et al. also considered the effect of porosity on MC3T3-E1 
cells proliferation and adhesion using an MTT assay. The investigation showed 
that cell culture was initially inhibited by the porous surface, with proliferation 
rates and extensive cellular growth towards latter periods of culture (Brauer et al., 
2006). 
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There have been minimal studies carried out using in vivo techniques when 
compared to the aforementioned in vitro studies. The existing studies focus on 
using rat and rabbit models by filling in defective areas with glass particulates of 
a specific size range and understanding how well the material can interact with 
the hosts tissue via light and polarized microscopy. Monem et al. implanted 
phosphate glass containing TiO2 into rabbit femurs, where it was concluded that 
glasses containing TiO2 concentrations above 0.5 mol% were associated with 
reduced bioactivity, with the stated concentration promoting improved bone cell 
growth (Monem et al., 2008). Other studies using different animal models showed 
that the required concentration for an effective bioactive response were 
magnitudes higher than those established by Monem et al. In calvarium defects 
of male rats it was found that a TiO2 content of 5 mol% significantly increased the 
amount of bone tissue formation (Abou Neel et al., 2007). The combination of 
both in vitro and in vivo studies accentuates the link between the material 
composition and its biocompatibility. These promising results have provided an 
incentive for researchers to conduct research to gain a better understanding of 
the opportunities available using TiO2 containing phosphate glasses. 
 
 
1.6 Microcarriers for bone tissue engineering 
When growing cells on conventional tissue culture plastic, contact-inhibition 
gradually decelerates the proliferation rate, hence requiring constant passaging 
of the cells into new and bigger flasks. Dynamic culture avoids such issues by 
allowing to culture large quantities of cells owing to the increased surface area to 
volume ratios, consequently maintaining high cell densities (Majd et al., 2011). 
When 3D scaffolds are used in static conditions, nutrient gradients are common, 
leading to inconsistent cell growth and differentiation (Volkmer et al., 2008). 
Recently, the tissue engineering approach to address bone defects has been 
‘bottom-up’, where focus has looked at the development of smaller entities 
forming the building blocks of the required structures that mimic the morphology 
and composition of natural tissues, consequently binding these structures to treat 
macroscopic defects. Many methods have been tested including using cell 
saturated microgels (Du et al., 2008), cell aggregates (Kelm et al., 2006) and cell 
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based microsphere clusters (Martin et al., 2011), the latter being the method of 
application in the present research. 
 
Microcarriers are an ideal entity for stem cell therapies as they have very high 
surface area to volume rations, and hence already show advantages over the 
growth of stem cells in static T-flask culture. Furthermore, unlike scaffolds, 
microcarriers possess the ability to be motile and can be adjusted if necessary 
(Park et al., 2013). Studies have indicated that the optimization of cellular yield 
revolves around parameters such as cell seeding density, microcarrier density 
and microcarrier type (Fok and Zandstra, 2005, Abranches et al., 2007). Several 
types of microcarriers exist, with varying affinity and suitability to cell type. This is 
due to the ease at which cells can grow in/around the structure and is determined 
by factors such as surface topography, porosity, chemical composition, and 
diameter of carrier. Carriers can either come in porous or non-porous form, where 
the latter enables a monolayer surface to be grown to ensure homogenous mass 
transfer while the more common, porous, allows cell growth into the carrier, hence 
increasing the surface for growth (Park et al., 2013). 
 
In order to recover the cells from the structure, enzymes such as trypsin or 
collagenase are used in a similar fashion to their use in T-Flask culture. Studies 
carried out provide a good basis for further expansion on the use of microcarriers 
as an adherent surface, with some studies producing positive results. Such 
studies include one carried out by Eibes et al., who used microcarriers coated 
with 2% fetal bovine serum (FBS) to increase the cell seeding efficiency 
producing a strategy to maximize cell proliferation. The experiment generated a 
maximum cell density of 4.2x10 5 cell/ml, which was an 8-fold increase in the total 
cell number. Furthermore, the potency of the cells was maintained after the 
culture, allowing differentiation of the MSCs into adipogenic or osteogenic 
lineages, while also maintaining their ability to clone further. This indicates that a 
microcarrier based culture system can provide the correct arrangement and 
condition to generate substantial amounts of cells (Eibes et al., 2010). 
 
A diverse range of commercial microcarriers exist for bone tissue engineering. 
The extensive list includes microcarriers based on collagen (CellagenTM  by MP 
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Biomedicals) (Overstreet et al., 2003) ; polystyrene (HyQSphereTM by Solohill) 
(Ontiveros and McCabe, 2003, Zayzafoon et al., 2004) and dextran (CytodexTM 
1 (Howard et al., 1983, Sautier et al., 1992, Tang et al., 1994) and CytodexTM 3 
(Fok and Zandstra, 2005). Microcarriers have also been developed for specific 
applications using materials such as ceramics (Qiu et al., 1999, Hong et al., 
2009), polycaprolactone (PCL) (Hong et al., 2009) and poly (lactic-co-glycolic 
acid) (PLAGA) (Botchwey et al., 2001). Studies with microcarriers have not only 
aided the development of culture systems but have also provided insight into the 
in vitro behaviour of the cells used (Malda and Frondoza, 2006). The use of 
microcarriers has helped to study the phenomena of bone loss within microgravity 
conditions such as space-flight. A rotating wall bioreactor was used to culture 
osteoblasts on gelatin-coated microcarriers (Solohill), allowing to generate a 
model depicting how microgravity resulted in the reduced expression of key bone 
formation regulators (Ontiveros and McCabe, 2003). Furthermore, evidence 
shows that progenitor cells and blasts of the osteogenic lineage proliferate on 
different types of microcarriers, having been used in both in vivo and in vitro 
studies (Howard et al., 1983, Sautier et al., 1992, Barrias et al., 2005) 
 
The use of glass microspheres in bone tissue engineering for in vitro cell 
proliferation and bone tissue engineering provides unique benefits over 
commercially available platforms including microcarriers. When compared to 
tissue culture plastic, the magnitude of surface area for expansion in a given 
volume increases considerably, nonetheless this is an advantage common to all 
types of microcarriers. Many of the microcarriers available require cells to be 
harvested before implantation with a suitable scaffold material, however the 
biocompatible nature of phosphate glass eradicates these cell processing steps 
creating a more streamlined and resource efficient process.  
 
 
1.7 Scale-up of microcarrier cultures for bone tissue engineering  
A key aspect of bone tissue engineering is the use of scaling up and bioreactors. 
These vessels can be used to efficiently control oxygen and nutrient supply to 
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cells and generate specific environments to provide a desired lineage of stem cell 
differentiation (Chao et al., 2007). These controls can be used to manipulate the 
development of the bone and the characteristics associated with cartilage and 
bone regions, by stimulating and hence enhancing the load bearing aspect of the 
bones through the use biophysical stimulation (Marolt et al., 2010). 
 
Critical quality parameters need to be considered when determining the 
bioreactor choice for cell culture. Uniform properties and high purity are essential 
for therapeutic medicines, and hence the importance surrounding bioprocess 
control is highly necessary if a full understanding is to be gained from stem cell 
culturing. Developments in differentiation and expansion of adult stem cells have 
gathered some pace, from the initial culturing of haematopoietic stem and 
progenitor cells (HSPC) in bioreactors. While such cell types grow extensively in 
stirred or suspended cultures, others such as mesenchymal stem cells thrive in 
perfusion reactors with the aid of 3D scaffolds (King and Miller, 2007). Limited 
work has been carried out on the scalability of biomaterials, and how well they 
can be incorporated into industrially relevant platforms, therefore parallel efforts 
need to be made to translate the plethora of biomaterials developed into 
commercially viable applications. 
 
The most common methods for the expansion of MSCs in laboratories are tissue 
culture flasks which are easy to operate and provide good oxygen transfer with 
the external environment, however, due to limitations in surface area, large 
numbers of flasks are needed to generate cell yield at clinically relevant scales. 
This increases the overall manual handling, flask to flask variability and the 
chances of contamination. While current bioreactor culture techniques share 
common advantages such as the promotion of homogenous environments and 
controllability of crucial process parameters (e.g., temperature, dissolved oxygen, 
pH) when compared to static cultures, many contrasts still exist between the 
culture types (Table 1.1). The choice regarding culture system is complex as 
many challenges currently exist, including compromises needed due to 
hydrodynamic shear experienced at high mixing rates. Bioreactor properties are 
specific to each type, and hence it is important to carefully analyse each potential 
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candidate carefully, selecting the best one for the large-scale expansion and 
differentiation of MSCs for bone tissue engineering.  
 
 
Table 1.1 Bioreactor comparison 
Bioreactor 
type 
Advantages Disadvantages 
Stirred 
suspension  
• Homogenous conditions 
and can be used with 
microcarriers 
• Easily monitored and 
controlled 
• Prone to subject cells to 
hydrodynamic stress due to 
agitation 
• Cell agglomeration 
Roller 
bottles 
• Simple operation protocol 
• Low cost 
• Monitoring and control complex 
• Technology suited for anchorage 
cell cultures 
• Tend to produce concentration 
gradients 
Wave  • Disposable technology 
hence minimized need for 
cleaning. More suitable for 
GMP and easier validation. 
• Relative difficulty in monitoring and 
sampling 
Hollow-fibre  • Subject cells to low levels 
of shear 
• Monitoring and control not simple 
• Difficult to scale up technology 
• Concentration gradients formed, 
heterogeneous environment 
Rotating 
Wall 
• Efficient gas transfer 
• Subject cells to low levels 
of shear 
• Complex system which is not easily 
scaled 
Parallel 
Plate 
• Continuous removal of 
toxic metabolites. 
• High productivities 
• Effect of removal of secreted factors 
not fully understood as well as 
hydrodynamic effects of vessel  
Fixed & 
Fluidized 
Bed 
• Compatible with 3D 
scaffolding 
• Cellular interaction mimic 
in vivo structure 
• Scaling-up difficulties 
• Concentration gradients (Fixed bed) 
• Shear stress prone (Fluidized bed) 
 
Modified from RODRIGUES, C.A.V., FERNANDES, T.G., DIOGO, M.M., DA SILVA, C.L. and 
CABRAL, J.M.S., 2011. Stem cell cultivation in bioreactors. Biotechnology Advances 
 
 
The most commonly used platforms are stirred and shaken bioreactors. 
Continuous stirred-tank reactors are commonly used in bioprocessing, with the 
tissue engineering iteration developed from those used for fermentation of yeast 
(Martin and Vermette, 2005). A considerable proportion of work focusing on the 
use of MSCs in spinner flasks and stirred tank reactors utilises microcarriers with 
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the Mobius® 3L Bioreactor one of the first bioreactors reported to succeed in the 
expansion of hMSCs on microcarriers. A yield of 6x108 cells was obtained in a 
2.4L working volume whilst retaining their basic cell characteristics and 
differentiation potential (Jing et al., 2013). Phenotypic properties have also been 
maintained in other studies carried out using the Biostat® B 1L and 5L after post-
harvest analysis from microcarriers (Goh et al., 2013, Rafiq et al., 2013). Bone 
marrow derived MSCs (BM-MSCs) have also been successfully expanded in 
other stirred vessels, including the 1.3L Bioflo® reactor generating cell yields of 
approximately 1.4x105 cells/ml (Dos Santos et al., 2014). The added benefit of 
operating these vessels with different feeding strategies (batch, fed-batch, 
perfusion), adds flexibility in the supply of nutrients and reduces the level of 
undesired waste products (Rodrigues et al., 2011). 
 
Establishing the correct impeller/stirrer speeds is critical when optimizing 
microcarrier based processes in stirred vessels, to determine the fluid dynamic 
conditions. Furthermore, the correct conditions are also needed to help promote 
efficient attachment of cells across the entire population of microcarriers. While 
agitation will ensure homogeneity of cell growth, the sensitivity of cell growth to 
hydrodynamic shear forces can result in cell lysis and altered cellular phenotypes 
(Cherry and Papoutsakis, 1988, Chen et al., 2013). However, with careful control 
and its associated benefits such as the affordable cost of equipment and the ease 
of process translation to a larger scale, allows spinner flasks to carry significant 
appeal in hMSC expansion. 
 
The alternatives to spinner flasks are culture vessels agitated by an orbital 
motion. An estimated 90% of all mammalian cell culture experiments in 
biotechnology are carried out via this platform, with current trends looking at 
disposable versions of these shaken vessels for animal cell culture (Büchs, 
2001). Studies have validated the efficacy of these systems up to scales of 
1000L, showing efficient mixing and oxygen transfer (Zhang et al., 2009, Tissot 
et al., 2010). An additional advantage with shaken flasks when compared to other 
stirred bioreactor systems is the reduced formation of damaging bubble bursts 
due to air sparging (Olmos et al., 2015). The operating parameters that impact 
the bioprocessing factors (such as oxygen transfer, cell growth and cell viability) 
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include the flask’s shape and size, the orbital agitation speed and diameter, and 
properties of liquid and particles within the flask (Büchs, 2001, Weheliye et al., 
2013). The phenomenon of particle suspension is due to a combination of 
turbulent eddies, forces acting upon the particles (drag, buoyancy, gravity) along 
with particle interaction with the vessel and other particles. While stirred 
bioreactors have been studied thoroughly to understand the required agitation to 
suspend microcarriers, work is still being carried out on understanding the fluid 
dynamics within a shaken flask required to suspend particles. Studies have 
shown that the critical conditions that impact the suspension of microcarriers in a 
shaken vessel are the particle to liquid density rations, geometrical ratios, the 
flask filling ratio and, to lesser extent, the particle to flask diameter ratio (Olmos 
et al., 2015).  
 
Limited work has been carried out on understanding the expansion efficiency of 
microcarriers in an orbitally shaken system, and hence there is a great need to 
establish whether the simplest of vessel forms, could potentially provide the 
answer to culturing large quantities of shear sensitive mammalian cells.  
 
 
1.7.1 Scaling orbitally shaken platforms 
Immense importance has been placed on understanding the operating ranges 
required for effective cell culture using microcarriers, hence aiding translation to 
larger scales. Currently less than 2% of relevant publications having focused on 
the use of shaken bioreactors (flasks or microwells) limitations exist when trying 
to scale up shaken platforms to larger volumes and even to alternative reactor 
types such as stirred vessels (Büchs, 2001). Recently, progress has been made 
in understanding how fluid dynamics in orbitally shaken vessels are responsible 
for the suspension of microparticles, allowing the development of models 
establishing the minimal shaken speeds required to provide microcarrier 
suspension. The emergence of large shaken bioreactors at pilot and industrial 
scale has prompted greater clarification of mixing patterns and the awareness of 
spatial gradients. Previous work looked at using dimensionless analysis to 
establish macro-parameters such power consumption and the volumetric mass 
transfer coefficient kLa, which provide an overall assessment of the bioreactor 
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rather than looking at flow dynamics at varying operating conditions (Zhang et al., 
2005, Zhang et al., 2008). 
 
The relationship between flow velocity in a cylindrical vessel, the orbital diameter 
of the shaker and the inner diameter of the well, allows for scaling between the 
various reactor sizes using a dimensionless scalable parameter, Froude number 
(Eq.1.1). The Froude number is the ratio between the characteristic flow velocity 
and the wave propagation velocity, where g is the gravitational acceleration, and 
V and l are the flow characteristic velocity and length scale respectively (Buchs 
et al., 2000). 
 
In more recent studies, a further derivation of the fundamental equation has been 
developed which focuses on the ratios between inertial and gravitational forces 
to which Eq.1.2 is suggested. This equation is widely used in work carried out by 
Weheliye et al. and Ducci and Weheliye and for consistency will provide the basis 
of the work carried out in the project 
  
                                           𝐹𝑟 =
𝑣
√𝑔𝑙
                                                           (1.1)                                                         
 
                                     𝐹𝑟 = (
2𝑑𝑜(𝜋𝑁)2 
𝑔
)                                                  (1.2) 
 
The Froude component provides a scaling parameter which provides better 
control over the process by determining an optimum window of operation. 
Ensuring effective mixing is essential, as the presence of spatial gradients in 
culture parameters produces heterogeneous cultures. To achieve such 
conditions, it was important to understand what types of mixing systems emerge 
within a well. According to Weheliye et al, during agitation, counter rotating 
toroidal vortices form (Figure 1.2). These vortices are present only in the upper 
part of the fluid in the well, which can be stated as Zone A. In the area below 
these vortices, Zone B, there is a relatively stagnant region of mixing due to lack 
of exposure to these vortices. Upon an increase in agitation speed, the vortices 
begin to extend to the bottom of the vessel with their intensity increasing in 
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magnitude, hence incorporating both zones within the mixing system. This 
distribution of different zones within the vessel were validated from previous 
experiments carried out at low shaker frequencies, producing what was stated as 
a convection zone (Zone A) and a diffusion zone (Zone B) (Tissot et al., 2010).  
 
At higher agitation rates, a shift is seen towards a phenomenon known as out-of-
phase flow, where the movement of the fluid is not in sync with that of the shaking 
platform. Such conditions are witnessed for vessels demonstrating Fr>0.4, 
indicating most of the fluid is spread across the vessel wall (Weheliye et al., 
2013).  
 
 
 
 
 
  
 
 
 
 
 
 
Using the Froude number, studies then focused on the mixing and fluid dynamic 
in shaken bioreactors providing a detailed understanding of the single-phase flow 
created at different operating conditions including a range of orbital shaking 
speeds, internal diameters, orbital diameters, and filling volumes. A scaling law 
was derived to estimate the agitation rate at which this flow transition occurs, 
which is dependent upon the Froude number (Fr), the non-dimensional fluid 
height (h/di) and the non-dimensional orbital diameter (do/di). From these ratios 
two associated regimes are created whereby if h/di ≤ √ do/di the Froude number 
can be obtained from Eq. 1.3, indicating that the active toroidal vortices reach the 
base of the cylindrical vessel before phase transition occurs, while if h/di ≥ √do/di, 
Increased 
Agitation 
Zone A 
Zone B 
Figure 1.2 Mixing zones in a cylindrical vessel. The image highlights the change in 
height of mixing zone (Zone A) when fluid in a cylindrical vessel is subjected to increased 
agitation 
 
Figure 1.3 Mixing zones in a cylindrical vessel. The image highlights the change 
i  height of mixing zone (Zone A) when fluid in a cylindrical vessel is subjected to 
increased agitatio  
 
Figure 1.4 Mixing zones in a cylindrical vessel. The image highlights the change 
in height of mixing zone (Zone A) when fluid in a cylindrical vessel is subjected to 
increased agitation 
 
Figure 1.5 Mixing zones in a cylindrical vessel. The image highlights the change 
in height of mixing zone (Zone A) when fluid in a cylindrical vessel is subjected to 
increased agitation 
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transition occurs without the toroidal vortex extending to the reactor base, hence  
Eq. 1.5 can be applied where h is the fluid height within the vessel, 𝑎𝑜 is the 
constant of proportionality (𝑎𝑜 =1.4 for fluid with water like characteristics) which 
is directly related to the fluid type and takes into consideration extra inertial forces, 
and di and do are the vessel inner diameter and the orbital diameter of the shaker, 
respectively. If Eq. 1.3 is satisfied, the transitional speed can be derived by using 
the critical wave amplitude from Eq. 1.4  (Weheliye et al., 2013).  
 
 
                              𝐹𝑟 =
1
𝑎𝑜
ℎ
𝑑𝑖
(
𝑑𝑜
𝑑𝑖
)
0.5
                                             (1.3) 
 
                             (
𝑑𝑜
𝑑𝑖
)
0.5
=  (
∆ℎ
ℎ 𝑐
)                                     (1.4) 
 
                                  𝐹𝑟𝑑𝑖 =  
1
𝑎𝑜
                                          (1.5)                             
 
 
The flow transition is dependent on the increase in size of the toroidal vortex with 
increasing agitation, N (i.e. Fr) and occurs when this vortex extends across the 
length of the cylindrical bioreactor. It was concluded that this phase transition is 
associated with more complete mixing of the fluid within the cylindrical vessel and 
is signalled upon reach Froude critical (Frc), corresponding to a critical agitation 
speed. Having established what Froude number is required to achieve complete 
mixing of the well, it can be assumed that particles of a specific size and density 
would be mixed in a similar manner within the cylindrical vessel, hence it is logical 
to assume that a homogenous suspension of microcarriers can be developed, 
controlled by specific orbital speeds. 
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1.7.2 Bioprocess forces 
Static culture is a mode of material transport with many limitations due to the 
heterogeneous environment generated therefore supporting lower cell densities 
and cell numbers. To overcome mass transport issues associated with static 
culture, dynamic culture conditions are used (Panoskaltsis et al., 2005). 
 
Hydrodynamic forces are ever present in bioprocesses, and influence cells 
particularly in stirred bioreactors. The diameter of a cell becomes an important 
factor when understanding these forces, because if the cell size is of similar 
magnitude to that of the turbulent Kolmogorov eddy size, damage will be induced, 
and this can be attributed to microcarriers as well as cell aggregates 
(Papoutsakis, 1991). When comparing either single cells, aggregates or cell 
supports, these known eddy sizes decrease with increased agitation, and hence 
at these agitation levels affect the large structures more. Furthermore, shear 
stress is also caused by the geometry, position and speed of the impeller used 
and further instruments such as probes, spargers and baffles also disturb the flow 
patterns exhibited (Gilbertson et al., 2006). 
 
While this shear force can be monitored and controlled, there is a high possibility 
that exposure varies between different regions of a 3D structure (Yeatts et al., 
2012). This effect is also true for nutrient and oxygen transport; however, unlike 
shear stress whose effects are known to effect osteoblastic differentiation, the 
role of oxygen is still not fully understood. Whilst commonly known that declining 
nutrient and oxygen level promote cell death some studies have shown that 
oxygen levels of 2% promoted cell proliferation and differentiation when 
compared to the exact same cell type in 20% oxygen (Grayson et al., 2007). 
 
Enhancing biophysical signals in a developmental manner can improve the 
overall osteogenic process. Using perfusion systems (Sikavitsas et al., 2003, 
Grayson et al., 2008, Frohlich et al., 2010), and cyclic loading (Sittichockechaiwut 
et al., 2009) has been shown to improve osteogenesis by increasing mass 
transport and fluid shear to generate a homogenous bone construct. Mechanical 
stimulation has also shown to be influential on bone differentiation and the 
mineralization of the cells, due to fluid shear stresses (Bilodeau and Mantovani, 
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2006). It is stated that in vivo mechanical stresses instigate the remodelling of the 
bone, and hence this can be the basis for the hypothesis of fluid shear being 
responsible (Sikavitsas et al., 2001). It is the communication between terminally 
differentiated osteoblasts, known as osteocytes, and their link to osteo-progenitor 
cells that allow them to respond to shear stress. They tend to respond to shear 
stresses in the range of 8 to 30 dyn/cm2 (Rubin et al., 2006). Just as the stated 
cells respond to shear in vivo, we can extrapolate that in vitro shear conditions 
should also affect bone cells. This can be seen from multiple studies which 
examined cells such as osteoblasts and MSCs alike and showed direct response 
to shear stresses (Grellier et al., 2009). 
 
Studies have been carried out to indicate whether agitation can have an 
advantageous effect on proliferation and differentiation upon cells seeded on a 
3D construct. This was done by the comparison of two methods for culture, 
spinner flask and static culture, whereby a stir bar and stir plate are used while 
scaffolds are suspended in culture. Spinner flasks are often used for culture of 
bone tissue as they promote the expression of alkaline phosphate and 
osteocalcin, osteoblastic markers which are present in lower values when in static 
culture and rotating-wall bioreactor. With static cultures, a gradient is established 
whereby nutrients are not sufficiently introduced into the centre of the scaffold. 
This is also evident in spinner flasks as studies have shown that osteoblastic 
lineage induced cells predominantly exist on the surface of the scaffolds 
(Sikavitsas et al., 2002). This is evidence that osteogenic differentiation occurs 
when exposed to shear, as the surface of the scaffold construct is exposed to a 
considerable amount of hydrodynamic stress  (Wang et al., 2009). Results from 
such experiments also suggested that increasing agitation had an effect on 
osteoblastic differentiation due to higher expression of ALP (Yeatts and Fisher, 
2011). 
 
It is difficult to understand what parameters regarding shear stress have a direct 
effect on the proliferation of MSCs as shear frequency and magnitude are found 
to vary in many studies. Where some shear rates of high magnitude induce cell 
proliferation, the danger of cell death is possible, however limiting the levels could 
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potentially reduce levels of cell growth (Brindley et al., 2011). With all the efforts 
regarding the identification of the role of shear stress on the whole process of 
differentiation and proliferation of stem cells down a specific lineage, efforts were 
made to identify which stages of development showed the greatest response to 
shear forces. Hydrodynamic shear has also shown to be selective in proliferation, 
with MSCs showing decline in numbers where osteoblast proliferation flourished 
at a specific shear stress. This notion is known as osteogenic selection. This 
evidence shows that specific magnitudes of shear can be used to selectively 
promote the required lineage. Shear stress has a major effect on the transition 
through the osteogenic lineage effecting cellular/gene expression which can 
regulate the differentiation away from matrix production, to calcification and 
mineralization (Grellier et al., 2009). A study carried out by Kreke et al., aimed to 
identify which stages of osteoblastic differentiation are affected by the level and 
duration of shear stress. The first stages of differentiation are identified by 
proliferative effects (Lian and Stein, 1992), however surprisingly unlike prior 
studies carried out with rat bone mesenchymal stem cells (Nauman et al., 2001, 
Kreke and Goldstein, 2004) and neonatal calvarial osteoblasts (Klein-Nulend et 
al., 1996, Hillsley and Frangos, 1997) which showed the expected result, this 
study did not show proliferative signs (Kreke et al., 2005). Further studies show 
increase in proliferative levels such as the study carried out by Li et al., where 
bMSCs increased in cell number when stimulated by oscillatory flow (Li et al., 
2004). From the contrast in results, shear-induced cell proliferation is dependent 
on multiple factors such as type of species used, mode of shear stress, 
magnitude of shear applied, as well as the stage of development of the cell. 
 
After the early proliferative effects cease to exist, the latter stages of osteoblastic 
differentiation involve the expression of non-collagenous matrix proteins 
osteopontin, osteocalcin and bone sialoprotein (OPN, OCN, and BSP) (Lian and 
Stein, 1992). Expression of these late osteoblastic differentiation markers 
increased with prolonged exposure to shear stress, OPN and BSP in particular. 
Durations of 5, 30 and 120 minutes were used as periods of shear administration. 
While 30 and 120 minutes showed increased level of gene expression for the 
stated genes, 5 minutes did not seem a long enough period to enhance the levels 
of gene expression. The study carried out by Li et al., concurred with this data in 
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longer durations used generated higher levels of OPN and OCN genes when 
oscillatory flow was used (Li et al., 2004).  
 
Shear stress can aid and control the osteogenic events that occur with MSCs by 
the activation of several regulating proteins known as metalloproteases (MMP’s) 
and their respective inhibitors, tissue inhibitors of metalloproteases (TIMP). Main 
activity that occurs is associated with MMP2, MMP9, MMP13 and TIMP2, which 
all showed increased levels after mechanical stimulation in MSCs 
(Charoonpatrapong-Panyayong et al., 2007). The MMP13 is known to be highly 
involved in osteogenic differentiation of MSCs (Kasper et al., 2007). The exact 
extent of the effect MMPs have on osteogenesis is not fully understood, however 
hypothesis exist to suggest that mechanisms such as cryptic binding domains by 
cleavage of ECM components, release of matrix-bound bioactive molecules and 
alterations in matrix architecture and assembly aid cytoskeleton modifications 
(Mott and Werb, 2004).  
 
Studies carried out in vitro suggest that the most sensitive cells to mechanical 
forces, such as shear stress, are the mature osteocytes which have a higher 
expression of prostaglandin E2 when mechanically stimulated, hence it was 
hypothesized that in vivo, a similar outcome is possible (Klein-Nulend et al., 
1995).  This could allow strategic shear manipulation to aid differentiation and 
proliferation when the more differentiated state is reached. However, other 
studies show that osteoblasts are affected by interstitial fluid flow as it promotes 
the release of nitric oxide (NO), an osteoblast mitogen. These studies used rat 
calvarial cells to identify whether fluid flow was the cause of this NO expression. 
Stationary culture produced negligible levels of NO; hence generating evidence 
to show fluid flow had an effect on proliferation and differentiation (Johnson et al., 
1996). Although the level to which shear is needed was not identified, the 
magnitude was like other studies carried out using osteoblasts, with the varying 
results being down to the different organisms used. Further analysis indicates 
that there are two mechanisms related to mechano-sensation, based on nitric 
oxide levels. The first involves a response mechanism to steady shear, while the 
other involves calcium signalling and G-protein activation, which are sensitive to 
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transients in mechanical stress (Kreke et al., 2005). This potentially explains why 
certain cell types respond differently to different flow types (Jiang et al., 2002).  
 
The correlation between the forces subjected upon stem cells and their resultant 
differentiation patterns, provides backing to the hypothesis that under controlled 
dynamic conditions and stimulation periods, cells can be proliferated and 
differentiated within one closed system. 
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Chapter 2 .   Preliminary studies using human 
osteosarcoma cell line MG63 to determine 
efficacy of Ti-PGMs as a culture platform under 
static and dynamic conditions 
 
 
 
 
2.1. Introduction 
Human osteoblasts can be cultured on biomaterial substrates such as 45S5 
BioGlass® and sol-gel derived 58S, produce collagenous ECM and ultimately 
bone nodules without the use of supplements or growth factors (Effah Kaufmann 
et al., 2000, Gough et al., 2004). When cultured on silicate-based glass materials, 
they can also upregulate the production of insulin growth factor II (IGF-II), 
resulting in a >3-fold increase in osteoblast proliferation  (Xynos et al., 2001). 
Previous work has also demonstrated that human MG63 osteoblast-like cells can 
be cultured on phosphate glass discs (Abou Neel et al., 2008, Abou Neel and 
Knowles, 2008). The phosphate glass composition (50P2O5.30CaO.20Na2O) 
makes it possible to dope ions into the glass by replacing Na2O with, for example, 
TiO2. Upon testing several concentrations of TiO2 (0, 1, 3 and 5 mol%), 3 and 5 
mol% were found to optimally support cell functions such as adhesion and 
proliferation, due to increased stability and reduced degradation. When 
compared to the control glass, the compositions containing TiO2 at a 
concentration higher than 3 mol%, induced greater biological activity. However, 
concentrations beyond 5 mol% have not been studied in detail and so the full 
extent to which TiO2 concentration exerts a dose-dependent response has not 
been determined. In addition to adhesion and proliferation, phosphate glasses 
containing 3 and 5 mol% quantities of TiO2 upregulated the genes COL1A1, ALP, 
SPARC and CBFA1 (RUNX2), which are all associated with osteoblastic function 
(Abou Neel et al., 2007). 
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The efficacy of titanium phosphate glass microspheres (Ti-PGMs) to provide a 
platform for growth of MG63 cells is understood at a static level (Guedes et al., 
2012). However, as suggested before, the application of this material should not 
be limited to static cell culture if it is to be used in tissue engineering at a 
commercially and clinically relevant scale.  
 
The aim of this chapter was to undertake a preliminary study of whether Ti-PGMs 
can be used as a substrate for cell culture under dynamic culture conditions. The 
experiments were carried out using an MG63 cell line because these cells are a 
well-established tool for biocompatibility studies and their robustness enables 
bioprocess boundaries to be established (Abou Neel et al., 2009b, Guedes et al., 
2012, Kiani et al., 2012, Lakhkar et al., 2012b). This inherent robustness and 
ability to rapidly proliferate on a majority of cell culture surfaces prevents a 
complete understanding from being established of the biomaterials ability to 
support clinically relevant cell types. Despite these limitations, human 
osteosarcoma cell lines allow to better understand osteoblast function because 
they initially represent clonal populations derived from the osteoblast lineage. 
However, in order that these cell lines produce data of physiological relevance, it 
is important that relevant cell lines are chosen for further investigation (Clover 
and Gowen, 1994) 
 
Based on previous observations of the positive effect of fluid flow shear stress 
under laminar flow conditions (Kapur et al., 2003), it was hypothesized that 
dynamic agitation conditions would stimulate MG63 cell proliferation due to the 
associated fluid flow shear stress. As these cells are osteoblastic, it was expected 
that their tolerance to shear stress would be greater than that of immature 
mesenchymal stem cells, and the dynamic conditions induced further 
osteoblastic maturation. Furthermore, this chapter sought to examine whether the 
dose-dependent improvement in cell responses to TiO2 would continue beyond 5 
mol% and so an additional concentration of 7 mol% was tested. No higher 
concentrations were assessed due to significant increases in both density and 
stability reported with glasses containing TiO2 above 10 mol%, limiting further 
their ability to be suspended (Abou Neel et al., 2008). 
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2.2 Materials & Methods 
2.2.1 Formulation of glass 
The phosphate glass compositions were manufactured according to techniques 
described in Abou Neel et al. (Abou Neel and Knowles, 2008), where 
stoichiometric quantities of the following precursor were mixed in a Seward 
Stomacher®400 Circulator (Wolf Laboratories, York, UK) at 200 rpm for 1 minute 
(unmodified purities of >99%, obtained from VWR-BDH, Poole, UK): phosphorus 
pentoxide, (P2O5), calcium carbonate (CaCO3), sodium dihydrogen 
orthophosphate (NaH2PO4) and titanium dioxide (TiO2). The precursor mix was 
consequently poured into a Pt/10% Rh type 71040 crucible (Johnson Matthey, 
Royston, UK). The process initiates with the removal of CO2 and H2O by 
preheating the composition at 700°C and then melting the resulting mixture at a 
composition specific temperature listed below (Table 2.1). After melting at the 
conditions indicated, the glass is left to quench by pouring onto a steel plate at 
room temperature and allowing to cool overnight. 
Table 2.1 Glass Compositions 
Glass 
Composition 
Composition Breakdown (mol.%) Processing 
Temperature 
Calcium 
oxide 
Sodium 
oxide 
Phosphorous 
Pentoxide 
Titanium 
Dioxide 
Melting 
Temperature 
(°C)/Time(h) 
P50Ca30Na20
Ti0 (0 mol%) 
30 20 50 0 1100/1 
P50Ca30Na15
Ti5 (5 mol%) 
30 15 50 5 1300/3 
P50Ca30Na13
Ti7 (7 mol%) 
30 13 50 7 1350/5.5 
 
Modified from ABOU NEEL, E. A., CHRZANOWSKI, W. & KNOWLES, J. C. 2008. Effect of 
increasing titanium dioxide content on bulk and surface properties of phosphate-based 
glasses. 
 
The quantities used in each of these compositions were calculated as follows 
with Ti5 as the basis of the example. 
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1)  Sodium dihydrogen orthophosphate (NaH2PO4) 
 
 2NaH2PO4  →  Na2O  +  P2O5  +  2H2O  
Mol. wt. (g/mol) 240   62   142  36 
Relative mol. wt. 
(g/mol) 
1  0.26  0.59  0.15 
 
 
Amount of NaH2PO4 required to produce 15 mol% Na2O 
 
= [(Mol. fraction of Na2O) × (Mol. wt. of Na2O)] 
                 (Relative mol. wt. of Na2O) 
 
=  (0.15 x 62) 
         0.26 
 
=  35.77g 
 
2) Phosphorus pentoxide (P2O5) 
 
Amount of P2O5 produced in the reaction above 
 
= (amount of NaH2PO4 required) × (relative mol. wt. of P2O5)  
 
= 35.77 × 0.59 = 21.10g  
 
Amount of P2O5 required to produce 50 mol% P2O5  
 
= 0.50 × 142 = 71.00 g  
 
Additional amount of P2O5 
 
= 71.00 – 21.10  
= 49.9 g 
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3) Calcium carbonate (CaCO3) 
 
 CaCO3  →  CaO  +  CO2  
Mol. wt. (g/mol)  100   56   44 
Relative mol. wt. (g/mol)  1  0.56  0.44  
 
 
Amount of CaCO3 needed in order to obtain 30 mol% CaO  
 
= (0.3 × 56)/0.56  
= 30.00 g 
 
4) Titanium (IV) dioxide (TiO2) 
 
Mol. wt. of TiO2 = 47.90 + (2 × 16)  
 
= 79.9 
 
Amount of TiO2 to be added in order to obtain 5 mol% TiO2  
 
= 0.05 × 79.9  
= 3.995 g 
 
 
2.2.2 Preparation of Ti-PGMs 
After a solid structure is formed, the quenched glass is then fragmented into 
microparticles with the use of manual methods using a mortar and pestle, and 
ball milling using a Retsch MM301 milling machine (Haan, Germany) operating 
at a frequency between 10-15 Hz. To separate the required fraction of 
microspheres for use during tissue culture, the particles were sieved (Endecotts 
Ltd, UK) down to 63µm-106µm using a sieve shaker (Fritsch GmbH, Germany). 
Studies have indicated that this range of microsphere as the optimal particle size 
for preparation due to fractions smaller than this range indicating ineffective 
particle spheroidization after fragmentation, while larger fractions having a 
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shorter residence time during the spheroidization step, generating irregular 
structure unsuitable for cell attachment and culture (Lakhkar et al., 2012b). 
 
The glass microspheres generated after the sieving stage do not automatically 
possess a spherical structure required for ideal tissue adherence, therefore 
simplistic spheroidization apparatus were used to generate the required three-
dimensional spherical structure. The spheroidization set up used was obtained 
from Lakhkar et al. and includes the following components: (1) blow torch, (2) 
feed and (3) collectors. The blow torch assembly is comprised of a Rothenberger 
Superfire 2 gas torch (Rothenberger Werkzeuge GmbH, Kelkheim, Germany), 
fitted to a 453g MAP-PLUS gas canister (Todays Tools, UK), a substitute for the 
standard MAPP gas (methylacetylene-propadiene propane) which generates a 
high flame temperature of 2925°C in the presence of oxygen. The feed consists 
of an aluminium trough (200 x 20 x 30 mm) with the outlet edge located ~10mm 
above the torch at an angle to the horizontal. A DC motor (15800 rpm, 4.5-15V, 
35.8 mm diameter; RS Components, Corby, UK) is attached to the other end of 
the trough and is connected to a programmable power supply (RS Components, 
Corby, UK). A metal screw attached to the axle of the motor provides an offset, 
generating the vibrations required to propagate the microspheres through the 
trough, before entering the flame. The process occurs at its optimum when a 
programmable power supply of 4-6W is applied in a constant manner. The 
collecting section is comprised of 4 glass trays (275 x 150 x 60 mm) in an 
arrangement which sees the longer edges of each tray in contact with each other. 
The first tray is placed directly under the flame as to collect the particles that do 
not fall into the flame. Each consequent tray is placed in the axis of the flame as 
to collect any beads that enter its path. As the microparticles pass through the 
flame they undergo a spheroidization due to the surface tension forces and fall in 
to the 4 trays placed below (Lakhkar et al., 2012b). 
 
After spheroidization, the microparticles in each tray are analysed using light 
microscopy to establish the proportion of spherical microparticles. Particles 
deposited in the first tray were discarded due to the mixture of non-spherical and 
 70 
 
spherical particles exhibited. In the remaining trays, the proportion of non-
spherical glass was minimal and therefore collected and stored for use in studies.  
 
 
2.2.3 Preparation of MG63 cells 
An MG63 cell line was used to assess the biological response to titanium doped 
biomaterials. These cells were obtained from in-house stocks (P3-P9) from the 
Biochemical Engineering Department, University College London which were 
stored in cryovials in liquid nitrogen. These cells were resuscitated by rapid 
thawing in a water bath at 37oC. Cells were first cultured in a 75cm2 T-Flask at a 
seeding density of 1x104 cells/cm2 using Dulbecco’s Modified Eagle Medium 
(DMEM) (1g/l glucose), supplemented with Fetal Bovine Serum (FBS) (10%) and 
antibiotic-antimycotic solution (1%) (all reagents acquired from Gibco®, Life 
Technologies Ltd., Paisley, UK unless specified otherwise) at 37oC and 5% CO2. 
Cell passages were carried out when ~90% confluency was reached, established 
by visual observation through phase contrast microscopy. At this point, all existing 
media was removed, and the surface of the cells was washed with Phosphate 
Buffer Saline (PBS) (Sigma-Aldrich, UK) to remove any residual media; the cells 
were then incubated with 4ml 0.25% trypsin-ethylenediaminetetraacetic acid 
(Trypsin-EDTA) solution for 5 minutes at 37oC. Upon the conclusion of this step, 
the trypsin was inhibited by adding 8ml of fresh DMEM media; the resultant cell 
suspension was then transferred to an appropriate falcon tube and centrifuged at 
300g for 3 minutes. The supernatant was carefully removed and discarded 
ensuring that the cell pellet formed wasn’t disturbed. Based on the number of 
flasks harvested, an appropriate volume of fresh media was used to re-suspend 
the cell pellet prior to cell counting. Cell number quantification was carried out 
using a Neubauer haemocytometer and viability determined using Trypan blue 
dye exclusion method (Strober, 2001). 
 
 
2.2.4 Cell culture on Ti-PGMs under static conditions in ultra-low 
attachment 96-well microplates 
The static culture of MG63 cells was carried out in ultra-low attachment 96-well 
microplates (Corning® Costar®, Sigma-Aldrich, UK) to ensure that undesired cell 
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attachment didn’t occur. A pre-calculated quantity of microspheres for each 
titanium concentration was inserted into wells of a 96-well microplate. The 
amount calculated was enough to cover the surface area of the well (5mg/well 
(±0.1mg)) in a monolayer. The calculation took into consideration the average 
cross-sectional area of the Ti-PGMs and the density of each material studied (0, 
5 and 7 mol%). The beads were then UV sterilized for 1 hr and 40 minutes using 
a high intensity Blak-Ray B-100SP lamp (UVP, Cambridge, UK). The beads were 
then removed and equilibrated with 135µL of pre-warmed media to avoid direct 
contact of the cells with the dry surface of the microspheres. MG63 cells were 
trypsinized from the flasks to be used and cells were counted to ensure a 
sufficient amount was present for studies and controls. A cell density of 1x106 
cells/ml was generated by either diluting or concentrating the cell solution 
accordingly, after which the MG63 cells were seeded on the microspheres 
(1.5x104 cells in 150µL of medium per well), upon which the plates were then 
incubated at 37°C in an atmosphere of 5% CO2. A fed-batch system was applied, 
with spent medium replaced every 48 hours. Positive controls of 2D monolayer 
cultures of MG63s in Nunclon™ flat bottomed tissue culture 96-well microplates 
(Thermo Fisher Scientific, UK) were used to establish the relative cell attachment 
and growth on the microspheres. Static cultures were run with slow agitation 
(50rpm) for 5 minutes, prior to incubation, to ensure that there was even 
distribution of beads and cells in each well. Cells were cultured for 13 days with 
readings taken on days 1, 3, 5, 7, 9 and 13. with spent medium fully replaced 
every 48 hours. Media was extracted by tilting the microwell plate at an angle and 
aspirating media from the empty region of the well.  
 
2.2.5 Cell culture on Ti-PGMs under dynamic conditions in ultra-low 
attachment 96-well microplates 
Dynamic studies were carried out using ultra-low attachment plates placed on a 
KS260 control orbital shaker (IKA, Germany) with an orbital diameter of 10mm. 
Each well contained 5mg (±0.1mg) of beads and were seeded with 1.5x104 MG63 
cells, comparable to the setup in the static studies. Plates were incubated at 37°C 
and 5% CO2 for 24 hours overnight, to allow cells to adhere to the microspheres 
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before agitation. After 24 hours, the plates were transferred and secured to the 
orbital shaker. The plates were agitated for up to 13 days with readings taken on 
day 1, 3, 5, 7, 9 and 13 with spent medium fully replaced every 48 hours.  
The agitation speeds used were selected based on relevant dimensionless 
numbers such as the Froude number (Fr). For this study, the Frc range calculated 
was 0.66 and 0.70, which took into consideration any changes in volume of media 
due to evaporation. These calculations were based on the directly and inversely 
proportional relationships between the non-dimensional fluid height h (min or max) 
and the non-dimensional wave amplitude (Eq.1.3).  
 
                                        
ℎ
𝑑𝑖
= 𝑎𝑜 (
ℎ
∆ℎ
)
𝑐
𝐹𝑟𝑐                                              (2.1)     
 
Using the constant of proportionality αo, a Froude number was generated (Eq. 
2.1.) which was then used to calculate N, agitation speed from Equation 1.2 
(Weheliye et al., 2013). A critical agitation rate was calculated to be 340-350rpm 
(Appendix A.1), with the range accommodating any evaporation affecting fluid 
height. Agitation speeds higher than the critical values would correspond to the 
single processing vortex flow pattern, explained in Chapter 1, and would 
correspond to higher turbulence levels. It can be therefore postulated that this 
flow pattern would correspond to a better microsphere suspension, albeit with 
more damage caused to the growing cells. Whilst a multitude of commercially 
available microcarriers are available with densities like water (1030kg/m3 
(Cytodex-1) – 1242 kg/m3 (Sephadex G10)) (Olmos et al., 2015), the Ti-PGMs 
are characterised by density of 2.6-2.7 times the density of water. This property 
could potentially cause attached cells to be subjected to extremely high levels of 
shear at speeds of 340rpm, at which point the toroidal vortices would reach a 
relatively stagnant layer of microspheres, due to their densities limiting their ability 
to be suspended. To understand whether the benefits of agitated conditions could 
be exploited when used with this material, two different speeds were studied, 150 
and 300 rpm, based upon the hypothesis that at a lower agitation speed than that 
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calculated at NC, partial vessel mixing could result in increased vessel 
homogeneity, improved metabolism, and overall increased proliferation.  
Upon cell seeding, agitation was administered for 5 minutes to ensure a 
homogenous distribution of cells and microspheres were present in each well. To 
allow for cells to adhere effectively the plates were left in static conditions for 24 
hours, after which each agitation speed to be studied was applied. Limitations 
arose when carrying out the dynamic studies due to only one orbital shaker 
available with the same orbital diameter. This required carrying out each speed 
with different batches of MG63 cells, therefore calibration curves were required 
for each individual run carried. Furthermore, for each run a static control was 
always present to further increase the reliability of the study. By including a static 
control when carrying out the 150rpm and 300rpm study, three static runs were 
available to illustrate the comparability of each run and to also provide the basis 
to carry out statistics analysis on the three conditions; static, 150rpm and 300rpm. 
 
2.2.6 Cell proliferation assay 
The cell proliferation on each type of the microspheres in both static and dynamic 
conditions was measured using the Cell Counting Kit-8 (CCK-8) cell proliferation 
assay (Dojindo EU, Germany). Each CCK-8 test required 10µL of CCK assay for 
100µL of media (10% v.v-1) which would contain the Ti-PGMs and MG63 cells. 
After incubation with the assay, the resulting solution was aspirated into 
Nunclon™ flat bottomed tissue culture 96-well microplates leaving behind the 
microspheres and cells due to their interference with the spectrophotometer 
laser. All time points were assayed in triplicate with a mean and standard 
deviation calculated. At different points up to day 13, optical densities were 
measured at a wavelength of 450-490nm in a Safire2 plate reader (Tecan, UK). 
Cells cultured in the tissue culture grade plates were used as a positive control 
due to their ability to enhance cell proliferation. The absorbance reading provided 
would correlate to the number of cells; therefore, a calibration curve would be 
plotted prior to any cell viability calculations to establish the correlation of 
absorbance to cell number. The standard calibration curve allowed correlation 
between cell population in multiples of 1 x103 (1 x103, 5 x103, 1 x104, 1.5 x104, 
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2x104, 3 x104, 4 x104, 5 x104 and 6 x104) and absorbance. To produce an 
accurate calibration curve, cells would be seeded in a tissue culture grade 96-
well microplate in the aforementioned quantities, allowing them to fully attach 
(approx. 3 hours), before carrying out the CCK-8 protocol. The period used was 
to ensure that cell proliferation was kept to a minimum and the seeding densities 
were accurate representations of the absorbance provided. The attachment of 
cells was qualitatively estimated using a phase contrast microscope. 
 
 
2.2.7 Metabolite analysis 
Offline glucose and lactate analysis was carried out using a YSI bioanalyser (YSI 
Life Sciences, Yellow Springs, Ohio, USA) at days 1, 3, 5, 7, 9, and 13. Samples 
of various volumes depending on the overall volume of media present were taken 
and kept in 1ml Eppendorf tubes. This was to ensure that 100µL of media was 
available for the cell proliferation assay procedure (mentioned above), and to 
compensate for any evaporation of media that occurred during incubation. Each 
aliquot was kept in ice to ensure that the media did not reach a temperature below 
4oC, preventing further metabolic activity or degradation. All samples were 
assayed in triplicate for consistency with a mean and standard deviation 
calculated. 
 
 
2.2.8 Phase contrast microscopy imaging 
Imaging of the well was carried out using an EVOS™ XL Cell Imaging System 
with images taken on the same days as the cell proliferation assay and metabolite 
readings. The samples were imaged prior to the addition of the assay, due to the 
colorimetric nature of the CCK-8 reducing agent. The lid of each of the plates to 
be imaged would be changed to a sterile version to reduce interference of any 
condensation present on the lid. Images were taken at 2x and 20x magnification 
to aid understanding of the complete well distribution and microsphere-cell cluster 
structure respectively. Properties of the image such as the level of lighting and 
focus were maintained at the same level for ease of comparison. Effort was made 
to ensure that the images used would represent the wells clearly and that no bias 
existed in selecting wells. 
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2.2.9 Confocal laser scanning microscopy imaging 
Cell staining procedures were carried out to label the actin filaments of the 
cytoskeleton and the cell nucleus. Cells were first washed in situ in PBS, fixed 
with 4% paraformaldehyde (PFA) for 10 minutes at room temperature, once again 
washed twice with PBS, and consequently permeabilized with 0.5% Triton X-100 
in PBS for 5 min at room temperature. The resulting cultures having had the Triton 
X removed, were then stained with Acti-StainTM 488 phalloidin (2.5 vol% 
phalloidin methanolic stock solution in PBS) (Invitrogen, UK) for 20 minutes at 
room temperature in a dark chamber to reduce photobleaching and evaporation. 
Counter-staining with propidium iodide (PI) was carried out by staining the cells 
with a 1µg/ml PI solution for 10 minutes also in dark conditions. Phalloidin and PI 
labelling were visualized under a Radiance 2100 confocal microscope (BioRad, 
Loughborough, UK). 
 
2.2.10 Statistical analysis 
All statistical analysis was carried out using IBM SPSS Statistics version 22. First 
and foremost, the data sets were analysed using a normality test (Shapiro-Wilks 
test) revealing that specific data sets did not have a normal distribution. The 
normally distributed data would then be examined for equal variance using the 
Levene’s Statistics Test, at which point a one-way ANOVA would be carried out 
if the assumption of equal variance had not been violated. If the assumption of 
equal variance had been rejected, a Robust Tests of Equality of Means would be 
carried out using the powerful Brown-Forsythe test. Depending on the Levene’s 
test and Brown-Forsythe test, a suitable post-hoc analysis was carried out to 
establish the significance; tests used were the Tukey Honest Significant 
Difference (HSD) and Games-Howell test depending on whether the data showed 
equal variance or unequal variance respectively. If the Shapiro-Wilks test 
indicated that the data wasn’t normally distributed (p≤0.05) non-parametric tests 
were used, specifically the Kruskal-Wallis H test and Mann-Whitney U test 
depending on the number of variables. Consequently, multiple pairwise 
comparisons were made with corrections using the Bonferroni correction method. 
The level of significance assumed for statistical tests was 0.05, with the 
Bonferroni correction implemented by multiplying the calculated p-value 
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significance by the number of pairwise comparisons. The relevant statistical 
significance is illustrated on the graphical representations of the data which was 
produced in bar chart form. The repeats indicated with each figure identify the 
number of technical repeats rather than biological repeats, unless otherwise 
stated. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.3 Results 
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2.3.1 Cell proliferation of MG63 cells cultured on Ti-PGMs under static and 
dynamic conditions 
In the first experiment, cell proliferation was assessed on two different Ti-PGMs 
compositions (5 and 7 mol %) and compared to control tissue culture plastic 
(TCP) 96-well microplates. Prior to calculating the viable cell number an 
appropriate standard calibration curve was produced as shown in Figure 2.1 for 
each experiment run to account for batch variation.  
 
Using the standard curve equations produced in Figure 2.1, allowed the data 
obtained from the CCK-8 proliferation assay over the 13-day period to be 
converted to a viable cell count from their respective absorbance values. Figure 
2.2 shows the results of the CCK-8 cell proliferation assay carried out over the 13 
days on the three different materials (Ti5, Ti7 and TCP) under the three different 
conditions; 0, 150 and 300rpm. Phosphate glass with 0 mol% TiO2 doping has 
not been included due to the excessive degradation of the material within 24 
hours of in vitro studies. The remaining compositions of phosphate glass 
promoted significant cellular growth from day 1 onwards. Glasses containing 5 
mol% of TiO2 cultured with MG63 cells showed increases in viable cell numbers 
between day 1 and day 9 under static and 150 rpm conditions while with 300rpm 
these increases were delayed until day 13. Viable cell number declined under 
static conditions on Ti5 after day 9 with a 25% decrease in cell number on day 
13, whereas dynamic conditions resulted in significantly higher cell numbers 
when compared to static conditions (*p<0.05). Viable cell number under 300rpm 
agitation was significantly less on day 9 when compared to 150rpm (*p<0.05). 
Cell proliferation on Ti7 was similar to Ti5 over the course of the experiment. 
Significant differences were not documented between the different conditions 
when cells were cultured on Ti7. In comparison, cells cultured on TCP showed 
that under all agitation conditions, cells thrive early on with significant increases 
in cell numbers after only one day, however cell cultured in 300rpm conditions 
showed lower increases in cell numbers within the first 72 hours (*p<0.05).  
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Figure 2.1 Standard curve of MG63 cell growth on tissue culture grade 96-well microplates. 
Line graph plotted as Absorbance (nm) versus Number of viable cells after using a CCK-8 
proliferation assay upon complete attachment of the cells for the experiments involving the 
following conditions: (A) Static (B) 150rpm and (C) 300rpm. Absorbance based on a wavelength 
of 450nm. Values represent mean ± SD (n=6) 
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Figure 2.2 MG63 proliferation on (A) Ti5 (B) Ti7 microspheres in ultra-low attachment 
culture plates and (C) TCP (control). Bar charts comparing CCK-8 assay readings were at days 
0, 1, 3, 5, 7, 9 and 13 under static and dynamic conditions. Values represent mean ± SD (n=3).  
* indicates p<0.05. 
* 
* 
* 
(Ti7) 
(Ti5) 
(TCP) 
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The overall best condition for supporting and proliferating MG63 cells on 
phosphate glass microspheres and on TCP is at 150rpm agitation (Table 2.2). 
The cell yields achieved under this speed are at least 5% higher than the other 
respective conditions for each material. While the two different phosphate glass 
materials produced similar values of fold increase in cell number, the cell yields 
achieved by TCP are significantly higher with a 42% difference to the next highest 
candidate within the agitation speed (*p<0.05). 
 
Table 2.2 Fold increase values indicating the maximum cells yield achieved 
over the course of the experiment under the different conditions and 
materials used. Values within brackets indicate the time point maximum 
yield was achieved. 
 
Material Condition (Day) 
 
0rpm 
 
150rpm 300rpm 
Ti5 2.64 (9) 2.92 (9) 2.77 (13) 
Ti7 2.65 (9) 3.10 (7) 2.63 (9) 
TCP 4.59 (13) 4.80 (9) 4.29 (13) 
 
When assessing the same data based on material composition, there were 
limited differences between Ti5 and Ti7 with no significant differences at all three 
speeds studied (Figure 2.3). When compared to the TCP surface, there is a stark 
difference with cell proliferation on Ti-PGM. The cell numbers cultured on TCP 
were significantly higher across each day assessed when compared to the 
phosphate glass compositions on both static and 150rpm (*p<0.05) with 300rpm 
showing the same trend (*p<0.05) except on day 5 where there were no 
significant differences between Ti7 and TCP. 
 
The maximum cell yield achieved under static conditions was expectedly highest 
with TCP across all the materials studied where 150rpm provided the highest 
overall cell yield at a 4.79-fold increase in cell numbers at day 9. When analysing 
the maximum yields produced by the two different phosphate glasses Ti7 
produced its highest cell yield on day 7 with a 3.10-fold increase in cell number 
while Ti5 achieved a 2.9-fold increase on day 9 both occurring under 150rpm 
conditions. 
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Figure 2.3 MG63 proliferation under (A) 0rpm (B) 150rpm and (C) 300rpm conditions at days 
0,1, 3, 5, 7, 9 and 13 cultured on the two TiO2 compositions and TCP represented via a bar 
chart. Error bars represents ± SD (n=3). For represenation purposes the significance between 
TCP and the phosphate glasses have not been indicated on the graph, however have been 
discussed further in the results. 
(150rpm) 
(300rpm) 
(0rpm) 
( r ) 
( r ) 
(0rpm) 
(150rpm) 
(300rpm) 
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As these experiments were undertaken in batches, the consistency across 
experiments was determined (Figure 2.4). Static cultures using Ti-PGMs were 
used as controls during each of the separately run 150rpm and 300rpm studies, 
therefore by showing that there are no significant differences amongst the three 
static cell proliferation profiles, it is possible to make comparisons across the 
different experiments.   
 
 
 
Figure 2.4 Comparison of different MG63 proliferation profiles under static conditions over 
13 days on Ti5. Bar charts Exp 1, 2 and 3 denote three different static runs which were used as 
controls carried out in parallel with the dynamic studies (150rpm, 300rpm). Exp 1- Static only Exp 
2- Static control for 150rpm study and Exp-3 Static control for 300rpm study. Values represent 
mean ± SD (n=3).  
 
 
2.3.2 Impact of agitation rates on MG63 cell metabolism  
Next, the metabolic activity of cells in culture was profiled (Figure 2.5). The 
profiles show the different level of glucose consumption and consequent lactate 
production under each condition investigated. The glucose profile for MG63 cells 
grown on Ti5 shows that more glucose was consumed by the cells in 96-well 
plates agitated under 150rpm conditions compared to static conditions at day 7 
(*p<0.05). This trend continued through day 9 (*p<0.05) and by day 13 both 
dynamic conditions led to significantly higher levels of glucose consumption 
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compared to static conditions (**p<0.05). The profiles for lactate production 
followed a similar trend in that cells cultured at 150rpm produced significantly 
higher amounts of lactate through the course of 13 days compared to static 
conditions (*p<0.05). By day 13 the MG63 cells agitated at 150rpm produced 
more lactate than both static (***p<0.001) and 300rpm (*p<0.05), with both 
dynamic conditions producing higher amounts of lactate than the MG63 cells in 
static culture. Surprisingly, cells cultured on phosphate glass doped with 7 mol% 
of TiO2 showed different trends in glucose consumption. The differences seen 
between conditions for cells cultured on Ti7 occurred earlier than with Ti5, where 
static and 150rpm conditions led to greater glucose consumption compared to 
the 300rpm condition up to day 5 (*p<0.05). By day 13 cells cultured under static 
conditions did not have as high glucose consumption compared to the dynamic 
conditions (*p<0.05). There were no significant differences in metabolite 
concentration between the different agitation speeds when cells were cultured on 
the TCP control. The lactate profile of cells cultured on TCP also showed minimal 
differences during the first nine days of culture. However, on day 5 the level of 
lactate production began to decrease and at day 13 an extremely significant 
difference could be seen between 300rpm and the other two conditions (*p<0.05). 
 
When comparing this data across materials at a given agitation rate, Ti5 resulted 
in significantly lower levels of glucose consumption when compared to Ti7 and 
TCP surfaces between days 3 to 5 (**p<0.01), in both static and 150rpm 
conditions. Under static conditions TCP reached minimal glucose levels towards 
day 13 of culture, whereas Ti7 showed reduced consumption of glucose when 
compared to day 9 with glucose concentration changing from 0.052 g/l to 0.13 
g/l. Overall glucose consumption was higher under 150rpm agitation when 
compared to the other conditions across all the different culture surfaces. The 
change in level of glucose consumptions across 0 and 150 rpm, were mimicked 
by the opposing change in lactate concentrations. This trend however was not 
visible at 300rpm for TCP and Ti7, as lactate levels decreased at a point where 
glucose levels reached their limit.  
 
 
 Glucose Lactate 
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Figure 2.5 MG63 metabolic profiles for glucose consumption and lactate production based 
on agitation rate. Line graph represent glucose consumption (A, C, E) and lactate production (B, 
D, E) when cultured on Ti5 (A & B), Ti7 (C&D), and TCP (E & F) at days 0, 1, 3, 5, 7, 9 and 13 
under ●- 0rpm ■- 150rpm and ▲-300rpm condition. Values represent mean ± SD (n=3).  
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Glucose Lactate 
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Figure 2.6 MG63 metabolic profiles for glucose consumption and lactate production based 
on culture material. Line graph represents glucose consumption (A, C, E) and lactate production 
(B, D, E) under 0rpm (A & B), 150rpm (C&D), and 300rpm (E & F) conditions at days 0, 1, 3, 5, 
7, 9 and 13 when cells are culture on ●- Ti5 ■- Ti7 and ▲TCP. Values represent mean ± SD 
(n=3).  
 
Ti7 
TCP 
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2.3.3 Macroscopic evaluation of MG63 cell-Ti-PGMs clustering 
Cells were imaged over the course of the experiment. Figure 2.7 shows cell 
distribution throughout the well, including presence of spaces between adjacent 
microspheres in the monolayer. As the ultra-low attachment plates were 
maintained in static conditions for the first 24 hours to allow settling of cells, there 
is no distinguishable difference between the day 1 images for any of the 
conditions, with the images showing cells scattered evenly amongst the 
microspheres on both Ti5 and Ti7 materials. By day 13, cells have formed 
networks bridging between microspheres, consequently bringing them together 
and forming densely packed clusters. The darker areas seen in each of the 
images show densely populated clusters of microspheres and cellular material. 
The opaque nature of the images indicates a multi-layered structure consisting of 
at least two layers of microspheres. There is no system or regularity in which 
these structures are formed, and their formations in even static conditions 
indicate that fluid flow created by orbital agitation isn’t a prerequisite for allowing 
cells to bridge and form networks between the materials. 
 
Macroscopic images were taken to show the extent of clustering of cell-
microcarrier material across the whole well (Figure 2.8). As stated above there 
were no differences at day 1, but at day 3 it can be observed there are clear 
differences in the impact orbital agitation has upon the formation of microsphere 
clusters. The darker areas visible inside each of the wells corresponds to the 
denser structures that were noted in Figure 2.7. Under static conditions there are 
a large amount of small microunits already formed. When you compare these 
structures to the clusters formed under 150rpm and 300rpm, the sizes of these 
units are on average smaller in size and larger in quantity. When comparing the 
two orbitally agitated plates, while there doesn’t seem to be a difference in cluster 
size between the two speeds, the numbers of clusters formed seem to be higher 
in 150rpm, based upon the visible empty areas within the well. As can be seen 
from Figure 2.8, by day 9 the clusters formed in static and 150rpm have 
developed into macrostructures and incorporate a vast quantity of microcarriers 
initially seeded in the well. The structure in the static plate is less uniform than 
that visible in 150rpm with large parts of the structure seeming to be in the initial 
stages of integration into the main structure. 
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The microunits formed in 300rpm are comparably smaller than those produced 
under static and 150rpm conditions. Furthermore, the quantity of clusters formed 
and number of microcarriers remaining suggests that increasing the rate of 
agitation is limiting the ability of the clusters incorporating the microspheres 
adjacent, illustrated by a large proportion of microspheres remaining unused by 
day 13.  
 
However, the image in Figure 2.8 for day 13 under 300rpm conditions shows a 
large quantity of microspheres remaining, while the cell proliferation assay 
(Figure2.2 (A)) indicates that 300rpm has the highest viable cell count. There are 
two potential reasons for this lack of agreement between the cell proliferation 
assay on Figure 2.2 (A) and the phase contrast images of Figure 2.8: firstly, the 
aggregates may contain an apoptotic core, where only cells that form the 
periphery of the clusters represent the cell numbers in Figure 2.2 (A), or that the 
CCK-8 assay was unable to effectively penetrate through the thick collagenous 
matrix produced by the MG63 cells evident from Figure 2.7. It is important that 
multiple analytical techniques are used to generate a conclusive picture of what 
occurs within each of the wells.  
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Figure 2.7 Formation of networks between MG63 cells and Ti-PGMs under different 
agitation rates. Phase contrast images illustrating MG63 cultured on Ti-PGMs over a 13-day 
period. Images of phosphate glasses doped with 5 mol% (a-d) and 7 mol% (e-h) were taken on 
day 1 (a, c, e, and g) and day 13 (b, d, f, and h) cultured under static (a, b, e, and f) and 150rpm 
(c, d, g, and h) conditions. Images were taken under 20x magnifications where scale bars 
represent 200µm 
Ti7 
Ti5 
Day 1 Day 13 
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Figure 2.8 Formation of Ti-PGM-cell clusters under different agitation rates. Phase contrast 
microscopy images of individual wells illustrating MG63 cells cultured on Ti5 over a 13-day period 
using the same well from day 3 onwards. Red markings highlight areas of clustering. Images were 
taken under 2x magnification. 
 
 
2.3.4 Matrix deposition by MG63 cells on Ti-PGMs 
To further characterise the nature of MG63 cell interactions with TiO2 
microspheres, imaging was undertaken using confocal laser scanning 
microscopy. Representative images in Figure 2.9 show cells attached to Ti5 
microspheres at day 13 post culture. The cells actin filaments are clearly stained 
with phalloidin, illustrating good alignment along the curved surface evenly 
covering the entire microsphere (Figure 2.9b). Processes developed from the 
edges of the cells, aided the bridging between multiple microspheres forming 
clusters of cell-microsphere aggregates. The spaces between microspheres are 
densely populated with MG63 cells (Figure 2.9a).  
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Figure 2.9  MG63 cells attached to Ti5 glass microspheres on day 13 under 150rpm 
conditions using confocal laser scanning microscopy. Phalloidin stain was used to identify 
the actin filaments of the cytoskeleton (green) while the propidium iodide (PI) stain was used for 
the nuclear staining (red). Image a) provides a sliced cross-section through a cluster of 
microspheres cultured with MG63 cells, while image b) illustrates a 3D rendered image of an 
individual microsphere. Scale bar is a) 50µm and b) 25 µm respectively.  
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2.4 Discussion 
The present study examined the interaction between Ti-PGMs and MG63 
osteosarcoma cells under two types of conditions: (1) static and (2) dynamic 
culture on ultra-low attachment cell culture plates. The dynamic culture speeds 
studied were predetermined using the scalable mixing dimensionless Froude 
number, which provided the critical agitation speed, 340rpm. The aim was to 
understand whether Ti-PGMs could be used in a dynamic bioprocess 
environment to support the growth of osteoblastic cells that will underpin the 
creation of tissue engineered bone. Within this study, we wanted to know whether 
increasing the quantity of TiO2 within the microsphere would promote further 
proliferation of MG63 cells based on improved structural stability and surface 
properties. The results obtained from the study provide a preliminary insight into 
the biocompatibility of the Ti-PGMs and provide a basis for the subsequent results 
chapters. 
 
Firstly, the microspheres produced were cultured with MG63 cells under static 
and dynamic conditions. From the three microsphere materials produced (Ti0, 
Ti5 and Ti7), the composition with no TiO2 doping, Ti0, was deemed unsuitable 
for applications relating to cell culture due to rapid degradation within 24 hours 
resulting in an inability to provide the structural integrity required to support cell 
attachment and growth. These effects are in agreement with the previous 
observations made by Abou Neel et al. who showed that both 0 or 1 mol% TiO2 
underwent rapid degradation and limited MG63 cell growth (Abou Neel and 
Knowles, 2008). The remainder of the microsphere types were assessed for their 
suitability as culture substrates for MG63 cells using the quantitative cell 
proliferation assay CCK-8. A positive control of MG63 cells on TCP was used. 
The quantity of Ti-PGMs used was calculated based on their cross-sectional area 
rather than total surface area. While this increases the surface area available for 
cell growth compared to the surface of a 96-well microplate well, the spherical 
surface of the Ti-PGMs limits the efficiency of cell attachment. To establish a 
better understanding of how cells grow on the material when compared to TCP, 
disc forms of the biomaterial could be created of the same surface area as the 
well. 
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The formation of formazan dye in the assay is directly proportional to the number 
of living cells. This assay provides advantages compared to other commonly used 
assays such as the MTT assay, which relies primarily on metabolic activity as 
opposed to the number on living cells. The results indicate that Ti5 and Ti7 
provided support for cell attachment and growth, albeit to a lesser degree than 
the chemically enhanced TCP, which provides an optimal substrate for 
attachment and proliferation (Figure 2.3). These findings are consistent with 
those found previously in the lab, using fibroblast cells, where TCP exceeded the 
cell growth on the Ti-PGMs by approximately 50% (Guedes et al., 2012). This is 
an expected outcome since the surface of TCP is optimized for cell attachment 
being hydrophilic and its flat surface providing improved conditions for cell 
proliferation. While the MG63 cells showed decreased proliferative capacity on 
Ti-PGMs compared to TCP, the substrates ability to induce an osteogenic 
response has not been matched by commercially available substrates, therefore 
the trade-off to culture fewer cells with enhanced osteogenic properties could be 
deemed more than acceptable. The ultra-low attachment plates used are coated 
with a covalently bound hydrogel layer that inhibits the attachment of cells to the 
surface, allowing the true affinity of the microspheres to be understood. Both Ti5 
and Ti7 compositions showed significant increases in cell number over the 13-
day culture period. There were no significant differences between the Ti5 and Ti7 
microspheres in terms of overall cell proliferation, except for the days upon which 
maximum cellular yield was achieved, with Ti7 yielding higher cell numbers when 
subjected to 150rpm conditions on day 7 as opposed to day 9 at which Ti5 
reached its maximum yield. The limited differences in cell proliferation indicate 
the suitability of both materials as potential candidates for MG63 cell attachment 
and growth and further quality markers of cell identity and function would need to 
be assessed to determine optimal substrate.  
 
Confocal laser microscopy images illustrated the ability of the cells to wrap 
around and cover the curved surface of the microspheres (Figure2.9b). It has 
been established in previous work carried out by Abou Neel et al., that phosphate 
glasses doped with 5 mol% TiO2 showed partial release of PO43- ions after 13 
days when in a solubilising solution, however the local environment created by 
the release of these ions from Ti5 microspheres, the more soluble of the two Ti-
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PGMs studied, provided no detrimental effect upon cell viability after 13 days 
illustrated by the densely packed areas in the confocal images (Figure 2.9a) 
(Abou Neel and Knowles, 2008).  
 
Studying the effect dynamic culture conditions have upon cell proliferation 
provides crucial insight into the applicability of the material as a substrate for use 
in dynamic bioreactors, and the effect the mechanical processes have upon cell 
proliferation. The use of the Froude scaling law (Weheliye et al., 2013) provided 
a foundation for identifying which orbital agitation speeds should be studied to 
understand the impact mixing patterns have upon cell proliferation. This was done 
because applying a model that defines critical orbital agitation speed (at which 
the contents of a cylindrical vessel are thoroughly mixed and the microspheres 
contained within are theoretically in suspension), should lead to effective cell 
expansion due to reduced nutrient and oxygen gradients. The effect the dynamic 
culture conditions had upon cell numbers were evident from Table 2.1, which 
indicated that the highest cell yields could be achieved by 150rpm agitation, with 
values of 2.9 and 3.1-fold increases when cells are cultured on Ti-PGMs 
compared to values for 0 and 300rpm ranging from 2.64 to 2.77-fold increase. 
   
The data obtained from the YSI Bioanalyser in Figures 2.5 and 2.6 provide an 
insight to the consumption of the feed substrates and their conversion to waste 
products within the whole well. The glucose and lactate concentrations were 
monitored to indirectly evaluate cell viability. Glucose acts as a primary source 
for mammalian cells to produce ATP through oxidative phosphorylation or via 
anaerobic glycolysis (Schop et al., 2009). The values produced by the YSI 
Bioanalyser provide an overall average of the metabolite concentration in the 
well, therefore to fully grasp how well each condition and material can support 
cell metabolism, it is important to normalize these values to viable cell number. 
As media changes were made every 48 hours, which were carried out after each 
cell proliferation assay time point, calculating the respective glucose 
consumptions for the current time point was possible and subsequently these 
values were normalized to viable cell number. The ratio of lactate production to 
glucose consumption per cell (YLac/Glc) indicates the metabolic pathway the cells 
prefer to use as a mode of energy production (Ljunggren and Haggstrom, 1994, 
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Schop et al., 2009). Schop et al. stated that a YLac/Glc value of 2 indicates that the 
cells inefficiently convert glucose using the glycolytic pathway as opposed to 
oxidative phosphorylation to produce energy. The ratio indicates that the 2 moles 
of lactate, the maximum yield possible, are created per mol of glucose. A lower 
ratio indicates that glucose consumption generates fewer units of lactate in a 
more energy efficient process (Schop et al., 2009). Cells cultured under 300rpm 
(YLac/Glc= 1.33) showed higher conversion ratios than both 0rpm (YLac/Glc= 0.96) 
and 150rpm (YLac/Glc= 0.97), values that are found to be consistent with studies 
carried out by Schop et al., who analysed metabolic activity of MSCs on 
microcarriers (Schop et al., 2008). The values show that 300rpm produced the 
least favourable conditions amongst those studied, correlating with the lower cell 
yields. It is concluded that the cells are not finding the higher agitated conditions 
ideal as they are unable to efficiently metabolise glucose. Shear stress from fluid 
flow can contribute to metabolic quiescence in some cell lines via the action of 
transcription factors (Doddaballapur et al., 2015), a potential explanation to why 
higher YLac/Glc ratio are produced with 300rpm. It has been well documented that 
there are significantly lower oxygen transfer rates in 96-well microplates inducing 
potential anaerobic conditions, however this factor would not influence the results 
as each condition carried the same volume of media with limited variations in both 
ultra-low attachment and surface treated TCP (Running and Bansal, 2016). A 
potential explanation lies in the size of the construct formed at 150rpm potentially 
limiting the dynamic benefit of oxygen and nutrient transport. It is hard to conclude 
whether the unfavourable shift in metabolic pathway is attributed to the shear 
stress caused by fluid flow, or potentially down to limited oxygen and nutrient 
transfer into the core of the structure.  
 
The differences witnessed between the conditions studied do not corroborate 
with the initial hypothesis that complete mixing of the fluid within the cylindrical 
vessel would induce greater cell proliferation caused by the complete suspension 
of microspheres allowing effective seeding and expansion of the MG63 cells. The 
agitation rate correlating to Frc, 300rpm, on average produced the lowest yield 
increase across all three different materials studied, which would bring into 
question the ease of implementing the model developed by Weheliye et al. 
(Weheliye et al., 2013) to identify the ideal speed needed for effective cell seeding 
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and expansion. The model has a limitation in that it fails to incorporate the density 
of any particulates higher in density than the fluid within the vessel. The densities 
of the materials used in the study are 2.65 and 2.71 g/cm3 for Ti5 and Ti7 
respectively, which are magnitudes higher than commercially available 
microcarriers with many them lying in a similar range to the density of water (1 
g/cm3). The high densities of the Ti-PGMs limited their movement to the base of 
the cylindrical wells of the microplate; therefore, the mixing that occurred at 
150rpm would be above the microspheres in the two toroidal vortices, while at 
300rpm the vortices are closer to the surface. From the results, it can’t be 
deduced that NC provides optimal agitation for culturing MG63 cells on the 
microspheres in question; however, there is foundation to assume that agitation 
rates below NC could provide better fluid mixing systems for culturing cells on 
dense microspheres. 
 
The MG63 cells are very robust in nature and have a tendency to show high 
proliferation rates (Mohseny et al., 2011). Therefore, while the cells have given 
an early indication to the ability of the material to support cell growth under both 
static and dynamic conditions on both types of phosphate glass studied, the cells’ 
ability to withstand comparatively higher shear and their documented growth 
kinetics can’t be directly translated to clinically relevant cell types. Their lack of 
reliability necessitates further studies to be carried out with more immature cells 
such as MSCs, to establish the full extent that fluid dynamics impacts on cell 
proliferation and differentiation when cells are cultured on these doped phosphate 
microspheres. The next chapter looks to use the preliminary data obtained in this 
chapter, more specifically the impact of cluster formation and cell growth and 
translate the experimental environment to cell types more clinically relevant such 
as MSCs. 
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Chapter 3 .   Critical functional responses of 
human bone marrow derived mesenchymal stem 
cells and Ti-PGMs  
 
 
3.1 Introduction 
Reconstructive medicine often involves designing a biocompatible scaffold, 
where its clinical use elicits limited side-effects or immunological responses 
(O'Brien, 2011) which when coupled with stem cells produces a high capacity to 
repair damaged tissue. The multi-lineage differentiation potential and high 
expansion capacity of MSCs, along with their prominent immunomodulatory role, 
makes these cells an ideal candidate for bone tissue engineering. Furthermore, 
as these cells can be sourced in large quantities from patients themselves, the 
limitation of obtaining osteoprogenitors from a compromised source, is overcome 
by MSC therapy. 
The work in this chapter explores the interactions between hBM-MSCs and Ti-
PGMs under static and dynamic conditions. BM-MSCs have greater osteogenic 
differentiation potential when compared to MSCs originating from other sources 
such as adipose-derived MSCs (Im et al., 2005). The different compositions of 
Ti-PGMs produced were compared to commercially available Corning Low 
Concentration Synthemax II Microcarriers (Corning® Costar®, Sigma-Aldrich, UK) 
assessing both cell proliferation and differentiation. The chapter develops on the 
work carried out on MG63 osteosarcoma cells in Chapter 2 by considering the 
effect dissolution ions of Ti-PGMs have upon osteogenic differentiation. Having 
demonstrated that controlled agitation at speeds lower than Nc induced better 
cellular responses the aim of this chapter was to determine the effects of dynamic 
culture on growth and differentiation of hBM-MSCs. While osteogenic 
differentiation of MSCs cultured in the presence of dexamethasone, β-
glycerophosphate and l-ascorbic acid-2-phosphate is well known (Pittenger et al., 
1999), some studies have demonstrated that mechanical stress, particularly in 
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the form of fluid flow, can stimulate multiple intracellular signalling pathways 
associated with osteogenic differentiation (Reich et al., 1990, Bancroft et al., 
2002, Kreke and Goldstein, 2004, Li et al., 2004, Kreke et al., 2005). In addition, 
hMSCs are highly responsive to their immediate environment such as 
topographical features which the cells respond to by reorganising cytoskeleton 
and cell adhesion apparatus (McBeath et al., 2004, Engler et al., 2006). The 
sensitivity of MSCs under culture in vitro highlights the need for stringent process 
controls that are required to limit variability in the cell differentiation process. This 
sensitivity of MSCs when compared to progenitor cells, more specifically 
osteoblasts, would indicate that higher agitation speeds would impact cell 
behaviour of MSCs more than mature cell types. Evidence exists to show that 
MSC with a flatter morphology tend to mature towards an osteoblastic fate 
compared to round cells which promote adipogenesis, therefore it is important 
that MSCs bind effectively to the surface of the microspheres (Lavenus et al., 
2010). It has also been observed in other studies that MSCs which had higher 
numbers of focal adhesions were associated with a greater commitment to an 
osteogenic lineage (Lavenus et al., 2011). Tailoring a process to take advantage 
of the mechano-sensitivity of hMSCs allows control of its fate in vitro to optimize 
osteogenic differentiation. The effect of fluid flow has a limiting effect on cell 
proliferation when used excessively (Kreke and Goldstein, 2004) and therefore a 
careful balance is needed to ensure that cell growth occurs to its highest 
efficiency with cues that can be used to promote a specific phenotype. Taking the 
above into consideration, the pre-determined speeds calculated for the studies in 
the Chapter 2 were deemed potentially excessive and therefore a lower range of 
speeds were used for this study. The rationale behind changing the orbital speed 
range for this study was down to the immaturity of the hBM-MSCs when 
compared to the osteoblastic cell line previously used, coupled with improved 
cluster formation at speeds lower than that at NC.  
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3.2 Materials & Methods 
3.2.1 Preparation of human bone marrow derived mesenchymal stem cells 
Human bone marrow MSCs (Lonza, Belgium) were sourced from in-house stocks 
(P3-P6) at the Biochemical Engineering Department, University College London 
which were stored in cryovials in liquid nitrogen expanded from an individual P0 
vial. These cells were restored by rapid thawing within a water bath at 37oC. The 
hBM-MSCs were cultured using the same protocol as described previously in 
section 2.2.3, however a different seeding density (2x103-4 x103 cells/cm2) was 
used to ensure the cell line grew in optimal conditions. Cell passages were carried 
out when cells reached 80-90% confluency, confirmed by visual observations 
through phase contrast microscopy. 
 
3.2.2 Cell characterization 
3.2.2.1 Multilineage differentiation 
Mesenchymal stem cell functionality was determined using an identification 
assay. The human mesenchymal stem cell functional kit (R&D Systems, Bio-
Techne Ltd, UK) was used to differentiate the cells into different mesenchymal 
lineages. Media preparation for osteogenic and adipogenic differentiation started 
with the combination of aMEM basal media with 10% FBS and 1% Penicillin-
Streptomycin-Glutamine. Chondrogenic media consisted of DMEM/F-12 basal 
media supplemented with 1% Insulin-Transferrin-Selenium (ITS) supplement and 
1% Penicillin-Streptomycin-Glutamine, which was consequently stored in dark 
conditions for prolonged stability. Each differentiation procedure was carried out 
in Nunclon™ flat bottomed tissue culture 24-well microplates (Thermo Fisher 
Scientific, UK) according to the supplier’s protocol.  
 
Adipogenic and osteogenic differentiation started with harvested hBM-MSCs 
seeded at a density of 2.1x104 cells/cm2 in adipogenic basal media and 4.2x103 
cells/cm2 seeded in osteogenic basal media cultured up until 100% and 50-70% 
confluency respectively, at which point the basal media was replaced with the 
respective differentiation media. The media was changed every 3-4 days for a 
period of up to 21 days, and consequently fixed for detection of adipogenic 
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marker FABP4 and osteogenic marker osteocalcin using immunocytochemistry 
techniques. The osteogenic and adipogenic differentiation of both samples were 
also assessed by Alizarin Red S (Sigma, UK) and Oil Red O staining (Sigma, 
UK), respectively. Alizarin Red staining was carried out by leaving the solution 
with the cells incubated at room temperature for 10 minutes and rinsed with dH2O 
thrice to avoid any non-specific staining, with cells imaged using a Nikon 
microscope. Oil Red O solution was used to stain the cells by incubating 500µl of 
the solution with cells at room temperature for 10 minutes. Cells were gently 
rinsed with dH2O twice and incubated for 1 hour with 2% isopropanol to visualize 
lipid droplets 
 
The procedure for assessing the hBM-MSCs chondrogenic differentiation 
capacity differed from the supplier’s protocol. The harvested cells were 
resuspended in basal chondrogenic media at a concentration 1.6x107 cells/ml. 
This concentrated suspension of cells was used to then form a micromass culture 
by seeding a 5 µL droplet of cell solution in the centre of the microwell. The 
resultant pellet was maintained in high humidity conditions for 2 hours without 
any supplemented media, after which chondrogenic media is added. The media 
was changed every 2-3 days for up to 14 days, after which immunocytochemistry 
and Alcian Blue staining were carried out. All fluorescent images were 
counterstained with Hoechst 33342. 
 
 
3.2.2.2 Flow cytometry of hBM-MSCs 
Human BM-MSCs of the highest passage used during the research (P6) were 
examined for expression of mesenchymal markers (CD73, CD90 and CD105), 
together with a lack of expression of monocyte and macrophage markers 
(CD11b), a haematopoietic progenitor and endothelial cell marker (CD34) and 
leukocyte marker (CD45) by flow cytometry. Dual staining was carried out with 
the following conjugated antibodies: Mouse-anti human CD73 (IgG1, APC), CD90 
(IgG1, FITC), CD105 (IgG1, PerCPTM5.5), CD11b (IgG1, PE), CD34 (IgG1, PE) 
and CD45 (IgG1, FITC) (All from BDBiosciences, UK). The combinations of two 
stains used per sample were of antibodies with different fluorochromes to prevent 
signal overlap. Three tubes of cells (5x105) were stained with 100µL of the 
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combined conjugated antibody solution using the manufactures specified 
concentrations for 30 minutes at 4oC. Tube 1 was stained with CD45 and CD73, 
Tube 2 with CD11b and CD106, and Tube 3 with CD34 and CD90. The cells were 
consequently washed in PBS with 2% FBS for 5 minutes at 1200rpm under room 
temperature conditions. Cell were analysed in a BD AccuriTM C6 Flow Cytometer 
using isotype controls for each of the fluorochromes to compensate for non-
specific background signal caused by the conjugated antibody. 
 
 
3.2.3 Interaction of hBM-MSCs on Ti-PGMs cultured under static and 
dynamic conditions 
3.2.3.1 Cell culture on Ti-PGMs and Corning Synthemax II-SC microcarriers 
under static condition in ultra-low attachment 96-well microplates 
The cultured hBM-MSCs were harvested and trypsinized by the same method 
described in section 2.2.3. Static culture of the hBM-MSCs was carried out in the 
similar manner as described previously in section 2.2.4, where the sterilization 
protocol and the amount of Ti-PGMs used per well were the same. The control 
microcarriers (Corning Synthemax II-SC) were added in quantities of 3.5mg to 
each well providing the equivalent cross-sectional area as the Ti-PGMs. These 
microcarriers were weighed and sterilized in the same manner as the Ti-PGMs, 
after which all microspheres were equilibrated with 135µL of pre-warmed media 
and seeded with 5x103 cells/well. As per the method in section 2.2.4, static 
cultures were initially mixed under slow agitation to ensure even cellular and 
microsphere distribution. Cell culture was carried out for 13 days with reading 
taken on days 1, 3, 5, 7, 9 and 13 with media changes occurring every 48 hours. 
 
 
3.2.3.2 Cell culture on Ti-PGMs and Corning Synthemax II-SC microcarriers 
under dynamic conditions in ultra-low attachment 96-well microplates 
The dynamic studies were carried out in parallel to the static cultures in ultra-low 
attachments plates using the method described in section 2.2.5. The differences 
between the two protocols lie in the changes in orbital agitation speeds the cells 
were subjected to and the seeding density in each well. The orbital agitation 
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speeds used for this study were, 0, 70, 100 and 150rpm, with the rationale behind 
these choices explained further in the discussion. The seeding density was in 
accordance with the static studies; therefore, a cell seeding density of 5x103 
cells/well was used. Agitation was used for a brief period to ensure a 
homogenous distribution of cells and microspheres. To allow for effective cell 
attachment, the dynamic plates were left in static conditions for 24 hours after 
which they were kept at the selected speeds. Furthermore, for each dynamic 
experiment run, a static control plate was used using the method described in 
section 2.2.5. 
 
 
3.2.3.3 Cell proliferation assay 
Cell proliferation on both the Ti-PGMs and the Synthemax II-SC under static and 
dynamic conditions were quantified using the CCK-8 assay, as per the method 
provided in section 2.2.6. Standard calibration curves were produced for each 
condition studied to correlate absorbance to absolute cell values. 
 
 
3.2.3.4 Phase contrast microscopy imaging 
Phase contract imaging of the ultra-low attachment plate was carried out using 
the same method described in section 2.2.8.  
 
 
3.2.3.5 Confocal laser scanning microscopy 
Samples were prepared for confocal microscopy by fixing them in situ with 20% 
PFA for 20 minutes at room temperature. The fixed samples were then washed 
and preserved in PBS until immunostaining was carried out. Cell staining was 
carried out to label the extracellular matrix proteins fibronectin (Mouse 
monoclonal, ab6328, Abcam, Cambridge, UK) and type-1 collagen (Rabbit 
polyclonal, ab34710, Abcam, Cambridge, UK), and bone specific extracellular 
matrix proteins osteopontin (Mouse monoclonal, ab69498, Abcam, Cambridge, 
UK) and osteocalcin (Rabbit polyclonal, ab10911, Millipore, UK). Both fibronectin 
and type-1 collagen were used in a 1:200 dilution while, osteopontin and 
osteocalcin were used in 1:100 dilutions, both diluted in PBS. The fixed samples 
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were incubated overnight in the primary antibody staining solution and kept at 
4oC. Counterstaining was carried out with each antibody’s respective secondary 
antibody accompanied with their suitable fluorochromes. During the 
counterstaining process, the samples were kept in the dark at room temperature 
for 1 hour, consequently washed and kept in PBS until imaged. Confocal light 
microscopy was carried out using a Zeiss LSM 700 microscope, ensuring that the 
capture properties of each image are the same for accurate comparison. 
  
 
3.2.4 The effect of conditioned-media on cell/microsphere interaction 
3.2.4.1 Cell culture using conditioned-media 
This part of the study focuses on understanding the effect different media types 
have upon the proliferation and differentiation of hBM-MSCs. The media types 
studied can be categorised into 3 main groups of media type: 1) TiO2- 
Conditioned media 2) osteogenic differentiation media 3) DMEM (control). The 
production of TiO2-conditioned media involved DMEM being mixed with powders 
of 5 mol% Ti-PGMs. These particulates had diameters within the range of 0-62µm 
and were used as powders which could be dissolved within low-glucose DMEM. 
Different concentrations of TiO2-conditioned media were formed by addition of 
pre-defined quantities of powders to a 125ml Corning Erlenmeyer flask (VWR, 
UK) containing 50ml of media. The flasks were kept in an incubator on a KS260 
control orbital shaker (IKA, Germany) and left to agitate for 72 hours. After this 
period, the media was then filtered using a Millex-GP Syringe filter with a 22µm 
(Millipore, UK) to reduce and undesired residuals remaining in solution. The 
osteogenic differentiation media was made using a hMSC Osteogenic BulletKit 
(Lonza, UK) following the suppliers protocol. The basal media was supplemented 
with dexamethasone, L-glutamine, ascorbate, penicillin/streptomycin, 
mesenchymal cell growth supplement and β-glycerophosphate. All media types 
were stored at 4oC in suitable media bottles for use in cell culture. Cells were 
cultured in Nunclon™ flat bottomed tissue culture 96-well microplates (Thermo 
Fisher Scientific, UK) using a seeding density of 3x103 cells/well. Cell proliferation 
was determined on days 1, 3, 5 and 7 with media changes carried out every 48 
hours. 
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3.2.4.2 Cell proliferation assay 
Cell proliferations of the hBM-MSCs were quantified using the CCK-8 assay, 
using the method provided in section 2.2.6.  
 
 
3.2.4.3 Immunofluorescence imaging 
Immunocytochemistry was established using immunofluorescent techniques 
described in section 3.2.3.5. Samples were fixed on day 7 and were fixed using 
PFA and were stained for Type-I collagen, osteocalcin and osteopontin. Samples 
were stored at 4˚C to minimize degradation and allow for images to be acquired 
post-staining.  
 
 
3.2.5 Statistical analysis 
All statistical analysis was carried out using IBM SPSS Statistics version 22. 
Analysis was carried out using the techniques described in 2.2.10. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 105 
 
3.3 Results 
3.3.1 Characterization of human bone marrow mesenchymal stem cells 
The cells were analysed in terms of their ability to undergo tri-lineage 
differentiation along adipogenic, osteogenic and chondrogenic lineages. 
Additionally, the hBM-MSCs were characterized by their ability to adhere to 
plastic surfaces and by the expression of hBM-MSC’s surface markers through 
flow cytometry. 
 
The capacity for hBM-MSCs to differentiate along multiple lineages in response 
to specific induction media is shown in Figure 3.1. Adipogenic differentiation of 
P6 hBM-MSCs was induced by culturing them with adipogenic media for 21 days, 
after which the formation of lipid droplets, a key indication of adipogenic 
differentiation, was observed (Figure 3.1a). Osteogenic differentiation was 
evaluated by the calcium deposition observed via Alizarin Red S staining using 
light microscopy, which is an orange red colouring as seen in Figure 3.1c. 
Chondrogenic differentiation was observed by immunofluorescent staining of the 
micromass formed in Figure 3.1e using Aggrecan. Differentiation was also 
observed by performing immunofluorescent labelling of protein markers specific 
to osteoblasts (osteocalcin) and adipocytes (FABP4). It is evident from Figure 
3.1 that after 21 days of selective differentiation each of the surface markers 
selected were positively expressed by the hBM-MSCs. Results from the flow 
cytometry experiments are displayed in Figure 3.2. The data confirms that the P6 
hBM-MSC population tested was CD73+ CD90+ CD105+ CD34- CD45- CD11b-. 
Gates respective to each of the surface markers were set using isotype controls.  
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Figure 3.1 Tri-lineage differentiation of hBM-MSC. Light microscopy (A, C, E) and 
immunofluorescent (B, D, F) images indicating the differentiation potential of the cells to 
differentiate towards adipogenic (A, B), osteogenic (C, D) and chondrogenic (E, F) lineages. hBM-
MSCs cultured in adipogenic media were positively stained with Oil Red O after 21 days (A) and 
were positive for FABP4 (B; green signal). After 21 days in osteogenic culture media, hBM-MSCs 
were positively stained with Alizarin Red S (C) and were positive for osteocalcin expression (D; 
green signal). Chondrogenic differentiation in a cell pellet was characterised using Alcian Blue 
stain (e) and Aggrecan (F; green channel) after 21 days. Immunofluorescent images were 
counter-stained with Hoechst 33342 (blue). Images were captured at 4x (Fig 3.1 - E) and 10x 
magnification (Fig 3.1 – A, B, C, D and F) 
c) 
A 
B 
D 
F E 
C 
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Figure 3.2  Phenotypic analysis of hBM-MSCs and expression of pluripotency markers. A 
single cell suspension of hBM-MSCs was examined for the expression of mesenchymal markers 
A) CD90, B) CD105, C) CD73) and hematopoietic markers D) CD45, E) CD34 and F) CD11b. 
Matching isotype controls were used to ensure observed staining is due to specific antibody 
binding. 
 
 
 
3.3.2 Interaction of hBM-MSCs on Ti-PGMs cultured under static and 
dynamic conditions 
3.3.2.1 Cell proliferation of hBM-MSCs on Ti-PGMs under orbital agitation 
Cell proliferation levels of hBM-MSCs cultured on the different Ti-PGMs and 
Synthemax microcarriers were determined by referencing against a standard 
curve that was generated (Figure 3.3). The high R-squared values highlights the 
linearity between the absorbance and the viable cell count numbers indicating a 
strong positive relationship and validates the use of the assay with the cell type 
used. As mentioned in the previous chapter, three separate standard curves were 
produced due to each condition being run as batches. 
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Growth profiles of hBM-MSCs cultured on the three different culture materials 
(Ti5, Ti7, and Synthemax) under static and agitated conditions are shown in 
Figure 3.4. Limited differences are observed from seeding on day 0 to 
proliferation of hBM-MSCs on day 5 between the 4 conditions studied on each 
material. However, after day 5 significant differences can be observed between 
the different conditions, with cells cultured under 70 rpm conditions showing 
significantly higher viable cell counts on all three surfaces (*p<0.01). For hBM-
MSCs cultured on Ti5 microspheres under 70 rpm conditions, significantly higher 
cell numbers can be observed on day 7 when compared to 0rpm (*p<0.05) and 
150rpm (***p<0.001), where 0rpm viable cell counts were also significantly higher 
than 150rpm (*p<0.05). The difference noted between 70rpm and 150rpm 
remains constant from day 7 until day 13 with significant differences on both day 
9 (**p<0.01) and on day 13 (***p<0.001). Furthermore, on day 13, 150rpm 
conditions showed significantly lower cell count values compared to 100rpm 
(*p<0.05). The trends noticed on Figure 3.4A are also mimicked by cells cultured 
on Ti7 (Fig 3.4B) microspheres, with clear differences illustrated from day 7 
onwards. The same result is produced on day 13 with 70 rpm again providing the 
best conditions for culture with significantly higher viable cell counts than those 
on all the other conditions studied. In addition, static cultures on Ti7 produced 
significantly higher viable cell counts when compared to 150rpm (**p<0.01). The 
differences in viable cell counts on Synthemax are only clear on day 13 with large 
error bars contributing to the inability to draw statistically valid conclusions. This 
was partly down to processing issues including Synthemax lost during media 
changes and during the viability assay procedure. With Synthemax highly 
influenced by pipetting action, extraction of media from the well was challenging 
without interacting with the microcarriers. While measures were in place to 
minimize undesired removal of Synthemax, these processes had inherent losses 
which led to large error bars, especially when larger viable cell numbers existed. 
Nevertheless, day 13 viable cell count values show that both static and 70rpm 
conditions provided more favourable conditions for cell culture when compared 
to both 100rpm and 150rpm. 
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Figure 3.3 Standard curve of hBM-MSC’s cell growth plotted as absorbance (nm) versus 
number of viable cells using a CCK-8 proliferation assay. Readings were taken after complete 
attachment of cells for (A) 70rpm (B) 100rpm and (C) 150rpm. Absorbance based on a wavelength 
of 450nm. Error bars represents + SD (n=3) 
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Figure 3.4 Proliferation of hBM-MSC cultured on (A) Ti5, (B) Ti7 microspheres and (C) 
Synthemax in ultra-low attachment well microplates under static and dynamic conditions. 
Readings were taken on days 0, 1, 3, 5, 7, 9 and 13. Error bars represents + SD (n=3). 
Significance values denoted by *=p<0.05, **=p<0.01 and ***=p<0.001.  
(Ti7) 
(Ti5) 
(Syn) 
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When comparing the effect of culture substrate on cell proliferation (Fig 3.5), it 
was observed that across the different conditions studied there was no 
substantial difference between Synthemax microcarriers and the Ti-PGMs. Under 
static conditions Synthemax did perform significantly better than both the Ti-
PGMs after day 9 (*p<0.05) showing that the material response to Synthemax is 
superior to Ti-PGMs. The remaining three dynamic conditions indicated no 
distinct difference in ability to support hBM-MSC proliferation suggesting that 
under stimulation similar yields can be achieved on Ti-PGMs as Synthemax. High 
agitation rates, regardless of substrate type are detrimental to cell growth. The 
cells cultured on Synthemax under 150rpm conditions however did show 
significantly higher cell numbers on day 7 (*p<0.05), however the larger error bars 
indicating potential sampling error. A progressive shift can be seen from static 
culture through to 150rpm, illustrated by Figure 3.5A and B showing that a 
majority of cell proliferation occurs towards the latter days with lower viable cell 
counts between day 1 and 5, while cell agitation under 100rpm conditions (Fig 
3.5C) the step rise in cell number isn’t as pronounced with a flatter growth curve. 
The change is even more visible under 150rpm agitation where the largest 
average increase in cell number occurs on day 3. Cell yield values in Table 3.1 
further corroborate this idea that as agitation intensifies there is a shift to when 
maximum cell yields are achieved and provide an insight to the impact each 
agitation had upon the levels of cell yields achieved by the different culture 
materials. It is evident from Table 3.1 that 70rpm generates the best cellular yield 
across the Ti-PGMs, with fold increase of 2.70 and 2.42 for Ti5 and Ti7 
respectively. On the other hand, cell growth performance on Synthemax was 
optimal under static conditions. These yields were achieved between days 9 and 
13 with the largest percentage increase in viable cell numbers occurring between 
days 5 and 7 for each material’s respective optimal condition.  
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Figure 3.5 Proliferation of hBM-MSC cultured under (A) 0rpm, (B) 70rpm, (C) 100rpm and 
(D) 150rpm conditions. Readings taken on days 0, 1, 3, 5, 7, 9 and 13 of cells cultured on the 
two TiO2 compositions and Synthemax in ultra-low attachment well microplates. Error bars 
represents + SD (n=3).  * = p<0.05 
 
 
 
Table 3.1. Fold increase values of cultured hBM-MSCs indicating the 
maximum cells yield achieved over the course of the experiment under the 
different conditions and materials used. The time point (in days) at which 
the maximum yield was achieved is indicated within the parentheses. 
 
Material  Condition (Day) 
 
0rpm 
 
70rpm 100rpm 150rpm 
Ti5 1.8(9) 2.7 (13) 1.9 (13) 1.6 (3) 
Ti7 1.8 (9) 2.4 (13) 1.5 (13) 1.6 (3) 
Synthemax 3.0 (13) 2.9 (13) 2.0 (7) 2.0 (9) 
 
 
 
(150rpm) 
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Figure 3.6 Comparison of static controls used when studying hBM-MSC proliferation on 
Ti5 over 13 days where Exp 1, 2 and 3 denote three different static runs which were used 
as controls carried out in parallel with the dynamic studies (70pm, 100rpm and 150rpm). 
Exp 1- Static control for 70rpm, Exp 2- Static control for 100rpm study and Exp-3 Static control 
for 150rpm study. Error bars represents + SD (n=3).  
 
 
As was seen in Chapter 2, a static control plate using Ti-PGMs was present in all 
three dynamic conditions studied, to determine comparability and batch 
consistency across the independent experiments. The only difference visible 
between the runs would be the attachment seen on day 1 between the different 
runs (Figure 3.6). This potentially owes to the variability in seeding efficiency 
during the first 4 hours. 
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3.3.2.2 Macroscopic evaluation of hBM-MSC – Ti-PGM clustering 
The effects of agitation were captured visually using phase contrast microscopy 
(Figure 3.7). The interaction between Ti-PGMs and hBM-MSCs was captured 
over time under specifc agitation speeds. As Figure 3.8 suggests, the Ti-PGMs 
on day 1 formed an even monolayer when all plates were kept under static 
conditions. On day 3 clusters begin to form in all conditions, with size and number 
of clusters varying from condition to condition. The clustering observed on day 3 
under static and 70rpm conditions showed fewer clusters that were more densely 
packed while at 100 and 150rpm conditions the clusters were spread around the 
well. When the culture period extends to day 7, few differences in cluster number 
and size were observed, with large macrounits visible under all conditions. The 
remaining number of Ti-PGMs not incorporated into these structures also 
remained similar. However, detailed information about the behaviour within the 
core of the structures could not be fully concluded. The only observable difference 
on day 7 was that within the unused Ti-PGMs smaller clusters still seemed to be 
forming under static and 70rpm conditions, while for the 100 and 150rpm 
conditions the remaining Ti-PGMs seemed to remain in the periphery of the well. 
Clear differences are highlighted on day 13 between 150rpm and the other culture 
speeds. The fastest agitation speed of the group showed considerably lower 
levels of cluster formation compared to the three other speeds, with a large 
quantity of Ti-PGMs remaining within the well. The structure that had formed on 
day 7 seems to break down during the days leading up to day 13 into two 
distinguishable macrostructures. As for the other three speeds, there are minimal 
observable differences between them, with all three conditions illustrating 
clusters which have incorporated a majority of the available Ti-PGM’s to form one 
large Ti-PGM-cell structure. 
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Figure 3.7 Formation of Ti-PGM-cell clusters under different agitation rates. Phase contrast 
images of an individual ultra-low attachment microwell illustrating hBM-MSCs cultured on Ti5 over 
a 13-day period using the same well from day 3 onwards. Red markings highlight areas of 
clustering. Images were taken under 2x magnification. 
 
 
In comparison, Figure 3.8 shows the development of Synthemax clusters over 
the course of 13 days. In contrast to hBM-MSC cultured on day 1 on Ti-PGMs, 
Synthemax microcarriers seem to have improved attachment with clusters 
forming relatively early. Based on the darker areas indicating more densely 
packed clustering, it can be observed that on day 3 static conditions allowed 
improved cluster development compared to the dynamic conditions. As the 
culture progresses to day 7 the clustering under each condition progresses 
slowly, with minimal differences noted between days 3 and 7. However on day  
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Figure 3.8 Formation of Synthemax-cell clusters under different agitation rates. Phase 
contrast images of an individual ultra-low attachment microwell illustrating hBM-MSCs cultured 
on Synthemax over a 13-day period using the same well from day 3 onwards. Red markings 
highlight areas of clustering. Images were taken under 2x magnification. 
 
 
 
13, as was noted with the Ti-PGM’s, 150rpm conditions were notably less 
effective at maintaining the clusters formed towards this latter time point. The 
three other agitiation speeds produced clusters which maintained their structures 
from day 7 through to day 13, and static conditions showed visibily favourable 
conditions in aiding the ability of bringing together the remaining microcarriers. 
The interesting thing to note here is the correlation between these images and 
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the cell proliferation assays. While the phase contrast images of 0rpm and 
150rpm corroborate well with the cell proliferation graphs, 70rpm and 100rpm 
agree to a lesser degree with the images of 70rpm not conclusively validating the 
agitation speeds ability to yield high viable cell numbers. One potential 
explanation for this discrepancy is the inability to visualize all the Sythemax 
microcarriers or clusters formed in the well. This is due to density of the 
microcarriers and the liquid surface tension of the microwell. Both of these factors 
coupled together meant cell clusters became buoyant preventing them from 
being imaged clearly, as they would be out of focus. 
 
 
3.3.2.3 Matrix deposition by hBM-MSCs on Ti-PGMs 
Analysis of matrix deposition by hBM-MSCs cultured on Ti5 and Ti7 microspheres 
under static and dynamic conditions in ultra-low attachment plates was 
undertaken at 7 and 13 days (Figures 3.9 and 3.10). Fibronectin expression 
surrounding the cells cultured on the Ti-PGMs was visibly higher around both 
materials when cultured for 13 days under 70rpm conditions (Figure 3.9). The 
cells cultured on Ti5 under static conditions for 13 days generated extremely 
mature ECM compared to Ti7 under the same conditions. While cells cultured on 
Ti5 showed more fibronectin expression on day 7 compared to Ti7, its expression 
on day 13 except for cells cultured under static conditions, showed no clear 
differences between Ti5 and Ti7. There was limited expression of fibronectin 
under 150rpm conditions on both day 7 and 13.  Compared to fibronectin, type-I 
collagen expression under the different conditions was distinctly lower. When 
comparing their immunofluorescent profiles (Figures 3.9 and 3.10) a trend is 
evident in their respective protein expressions, whereby the cells cultured on day 
13 expressed more type-I collagen than on day 7, and furthermore 150rpm overall 
showed lower expression that the other conditions. There were no observable 
differences in type-I collagen expression between the two types of Ti-PGMs 
studied. Cells cultured under the higher agitation rates showed stretched, fibrous 
structures while the expression of ECM under static conditions seemed more rigid 
and mature. It should be noted that Synthemax microcarriers’ images have not 
been used due to the following reasons; firstly, processing caused degradation 
of the Synthemax-cell clusters through pipetting action required for the multiple 
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washing and staining steps, the remaining microcarriers were kept for staining 
however their tendencies to float in solution hindered proper focussing of 
Synthemax. 
 
 
 
 
Figure 3.9 Fibronectin expression by hBM-MSCs cultured on Ti-PGMs in ultra-low 
attachment 96-well microplates at a range of agitation rates on days 7 and 13 post culture 
using confocal laser scanning microscopy. Images were acquired and converted into Z-stack 
images which were rendered to produce a maximum intensity projection of cross-sections up to 
150µm. Images taken at 10x magnification where scale bar is 100µm.  
Ti5 
150rpm 
100rpm 
0rpm 
Day 7 Day 13 
70rpm 
Ti7 
Day 7 Day 13 
100µm 
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Figure 3.10 Type-I collagen expression by hBM-MSCs cultured on Ti-PGMs in ultra-low 
attachment 96-well microplates at a range of agitation rates on days 7 and 13 post culture 
using confocal laser scanning microscopy. Images were acquired and converted into Z-stack 
images which were rendered to produce a maximum intensity projection of cross-sections up to 
150µm. Images taken at 10x magnification where scale bar is 100µm. 
 
 
 
 
 
 
 
 
 
150rpm 
100rpm 
70rpm 
Ti5 
0rpm 
Day 7 Day 13 
Ti7 
Day 7 Day 13 
100µm 
 121 
 
3.3.3 The effect of an altered biophysical environment on cell/microsphere 
interaction 
3.3.3.1 Cell proliferation of hBM-MSC cells cultured in conditioned media 
Cell proliferation was examined to determine if hBM-MSCs had improved growth 
profiles when cultured in conditioned media. The absorbance values generated 
from the CCK-8 assay identified the different levels of proliferation when hBM-
MSC cultured in various types of conditioned media (TiO2-conditioned, 
Osteogenic differentiation and DMEM) over a 7 day period when grown on TCP 
is represented in Figure 3.11. It was observed that for all the different culture 
media tested, cell number increased over time, from day 1 to 7 (***p<0.001). From 
day 1 to day 3 cell number increased across all media types (***p<0.001), 
however there were significant increases in cell proliferation in both 2mg/ml TiO2-
conditioned media (*p<0.05) and ostoegenic differentiation media (***p>0.001) 
when compared to the DMEM control. TiO2-conditioned media at a concetration 
of 2g/l showed significantly higher cell viability than media containing a 20mg/ml 
concentration.  By day 5 greater numbers of cells were found in 2mg/ml TiO2-
conditioned media than 20mg/ml TiO2-conditioned media, osteogenic 
differentiation media (**p<0.01) and DMEM (***p<0.001). By the end of culture 
on day 7 both 2g/l and 10g/l TiO2-conditioned media resulted in increased cell 
number, compared with the DMEM control (***p<0.001). Compared to the hBM-
MSC population in DMEM, 2mg/ml and 10mg/ml TiO2-conditioned media were 
49.4% and 27.1% higher respectively.  
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Figure 3.11 Optical densities readings of hBM-MSCs proliferated in different conditioned 
medias. hBM-MSCs were cultured in conditioned media in Nunclon™ flat bottomed tissue culture 
96-well microplates (Thermo Fisher Scientific, UK) and CCK-8 assay readings were taken at time 
points 1, 3, 5 and 7. Ti-conditioned media, commercially available osteogenic media (Lonza, UK) 
and commercially available DMEM (Gibco®, Life Technologies Ltd., Paisley, UK) were the studied 
conditioned media types. Error bars represent +SD and n=3 biological repeats. *=p<0.05, 
**=p<0.01 and ***=p<0.001. Note that the differences shown in the bar chart, while not visibily 
clear to be statistically significant are determined using specific models based on prerquistes of 
normality and variance. Box-and-whisker plots in Figure A.4 of the Appendix provide a more 
accurate representation of the differences observed between the different media types. 
 
 
3.3.3.2 Extracellular matrix protein immunofluorescent expression 
The expression of type-I collagen from hBM-MSC cells which have been cultured 
for 7 days in various types of media (TiO2-conditioned media, osteogenic 
differentiation media and DMEM) on Nunclon tissue culture 96-well microplates 
is shown in Figures 3.12. Images taken of the cells cultured in the TiO2-
conditioned media showed similar type-I collagen expression to standard DMEM 
after 7 days of culture. Osteogenic differentiation media on the other hand 
showed higher levels of type-I collagen expression when compared to the control 
and other media types. 
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The expression of extracellular structural protein osteopontin and osteoblast 
secreting protein osteocalcin are illustrated in Figures 3.13 and 3.14 respectively. 
Osteopontin expression was negligible on day 7 of culture across most of the 
conditions studied. One of the only conditions to show upregulation of osteopontin 
expression compared to the DMEM control was that of the hBM-MSCs cultured 
under osteogenic differentiation media. Limited expression was observed with the 
late differentiation marker osteocalcin across all media types.  
 
 
 
Figure 3.12 Type-1 collagen expression by hBM-MSCs cultured in Nunclon™ flat bottomed 
tissue culture 96-well microplates (Thermo Fisher Scientific, UK) after 7 days of culture in 
Ti-conditioned media, commercially available osteogenic differentiation media (Lonza, UK) 
and DMEM (Gibco®, Life Technologies Ltd., Paisley, UK). Images take at 20x magnification 
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Figure 3.13 Osteopontin expression by hBM-MSCs cultured in Nunclon™ flat bottomed 
tissue culture 96-well microplates (Thermo Fisher Scientific, UK) after 7 days of culture in 
Ti-conditioned media, commercially available osteogenic differentiation media (Lonza, UK) 
and DMEM (Gibco®, Life Technologies Ltd., Paisley, UK). Images take at 20x magnification 
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Figure 3.14 Osteocalcin expression by hBM-MSCs cultured in Nunclon™ flat bottomed 
tissue culture 96-well microplates (Thermo Fisher Scientific, UK) after 7 days of culture in 
Ti-conditioned media, commercially available osteogenic differentiation media (Lonza, UK) 
and DMEM (Gibco®, Life Technologies Ltd., Paisley, UK). Images take at 20x magnification 
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3.4 Discussion 
The main objective of this chapter was to determine whether Ti-PGMs can 
support hBM-MSCs responses that are critical for cell expansion and osteogenic 
differentiation. Having found in Chapter 2 that Ti-PGMs can support osteoblastic 
MG63 cell proliferation, we sought to follow up that study with an analysis of 
MSCs, which are a more clinically relevant cell type for tissue engineering. While 
the agitation speeds chosen in Chapter 2 were directly based on Froude mixing 
patterns (Weheliye et al., 2013), the speeds chosen for the hBM-MSC cell line 
were established using the results obtained from the previous chapter as a 
reference point but also following the rationale that the optimal agitation rate 
determined for MG63 cells could be excessive for MSCs in light of previous 
studies carried out on MSCs in shaken vessels (Oh et al., 2009, Deutsch and 
Guldberg, 2010, Siddiquee and Sha, 2013). While limited research has been 
carried out on shaken culture of MSCs, especially on microspheres, an estimate 
of the required agitation rate used in this chapter could only be gauged from 
previous studies by identifying the vessel dimensions, volume of liquid used, and 
the orbital diameter of the shaken platforms used in these studies. By using these 
parameters to identify the mixing patterns created in each respective study, 
suitable speeds could be determined to carry out the experiments in this chapter. 
Most of the agitation rates used in these studies corresponded to a Froude 
number that was a magnitude lower than that associated with the speeds 
calculated from Frc in Chapter 2. Consequently, new agitation speeds were 
determined based around these Froude values to study the impact of dynamic 
culture conditions on hBM-MSC proliferation. These were 75rpm, 100rpm and 
150rpm.  
 
First and foremost, it was necessary to ensure that the hBM-MSCs maintained 
the required functional characteristics of MSCs such as multi-potency and ability 
to differentiate along adipogenic, chondrogenic and osteogenic lineages. 
According to the International Society for Cellular Therapy (ISCT) the minimal 
criteria required to define human MSCs is their ability to adhere to plastic 
surfaces, under standard culture conditions, the ability to express key surface 
markers (CD73, CD90 and CD105) and be void of expression of other specific 
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markers (including CD34, CD45, CD11b) and finally differentiate to osteoblasts, 
adipocytes and chondroblasts in vitro (Dominici et al., 2006). The hBM-MSCs 
used in this research were cultured to an upper passage limit of P6; therefore, it 
was important to ensure that the cells maintained their differential capacity. As 
cells become subjected to increased numbers of passages, the probability that 
their genes involved in cell cycle, DNA replication and DNA repair are significantly 
down-regulated increases (Wagner et al., 2010, Oliveira et al., 2014). Therefore, 
as aforementioned the cells used were not used past their sixth passage. Having 
carried out the differentiation of the hBM-MSCs it was clear to see that the cell 
line used had its intrinsic property to differentiate into adipocytes, chondrocytes 
and more importantly osteoblasts (Fig 3.1). Furthermore, the highest passages 
of cells used also retained their pluripotency, confirmed through flow cytometry. 
 
It was important to consider how best to determine the quantity of Synthemax 
microcarriers used for this study. As the Synthemax microcarriers are larger in 
dimension (125-212µm) compared to the Ti-PGMs there was no practical way to 
generate a monolayer and ensure that equivalent surface areas for cell 
attachment was available. It was decided that using a quantity of microcarriers 
and Ti-PGMS that had the same cross-sectional areas was a compromise 
between the Ti-PGMs having a larger total surface area and the Synthemax 
occupying a large volume of the well. In future, it is recommended that a more 
suitable microcarrier is chosen with dimensions similar to the Ti-PGMs studied. 
Comparing the performance of Ti-PGMs and Synthemax in terms of cell 
proliferation, a clear trend wasn’t evident and each material performed differently 
under different conditions. Under static conditions Synthemax performed 
significantly better than the Ti-PGMs (Fig 3.5). However, under dynamic 
conditions there were no clear differences on average between the culture-
substrates studied. The observed differences seen under static conditions may 
arise from the density differences between Synthemax and the Ti-PGMs. As the 
density of Synthemax (1.026 g/cm3) is lower than that of Ti-PGMs (2.65-2.67 
g/cm3), the higher agitation may have a greater impact on Synthemax mobility 
compared to Ti-PGMs which could become detrimental to cell attachment and 
growth. As the highest agitation rate studied with the hBM-MSCs was half the NC, 
the turbulent mixing zone wouldn’t have reached the base of the vessel, where 
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the hBM-MSCs attached to the Ti-PGMs remained throughout culture. This 
effectively harboured the hBM-MSCs cultured on Ti-PGMs away from a high 
shear zone. However, this stagnation of the Ti-PGMs can become detrimental, 
because if the heavy Ti-PGMs resist the flow of fluid, surface shear on the Ti-
PGMs will increase. The effects of static/low agitation culture conditions would be 
favourable for Synthemax culture as cells would be able to proliferate on the 
protein coated surface undisturbed. The suppliers recommended protocol for 
culture of MSC’s on Synthemax microcarriers suggests agitation speeds of 30-
40rpm; however, this is when used with a spinner flask. It can be expected that 
the performance of the microcarriers reduce as shaken agitation speed increases 
from static conditions to agitation higher than 50rpm. Fold expansion was 
determined (Table 3.1) and revealed that Ti-PGMs performed better under low 
agitation rates, with maximum cell numbers on both Ti-PGMs being achieved at 
70rpm conditions.  
  
However, when agitation was increased past this point the effects of fluid flow 
became limiting with lower cells yield achieved. The difference in concentration 
of TiO2 within the Ti-PGMs had limited effect on proliferation under each 
condition. The Ti-PGMs matched Synthemax proliferation under agitated 
conditions, providing clear evidence to suggest that the Ti-PGMs can efficiently 
support hBM-MSC proliferation under dynamic conditions. Mild agitation had a 
positive effect on hBM-MSC proliferation when cultured on Ti-PGMs; however, 
this was not the case for Synthemax which could achieve better cell growth from 
the outset. The use of agitation to enhance proliferation of BM-MSCs has been 
well documented. Conflicting reports have been made in studies examining the 
impact of fluid flow on cell proliferation. In the studies which have reported 
improved MSC proliferation, the cells were exposed to oscillatory fluid flow of 1Hz 
and a shear stress of 10 dyn/cm2 for 2 hours, with proliferation assessed after 24 
hours (Li et al., 2004). The effects of oscillatory fluid flow also increased mRNA 
levels of both osteopontin and osteocalcin. Studies have shown that human 
alveolar bone marrow-derived mesenchymal stem cells subjected to long periods 
of high agitation had reduced cell proliferation compared to when cultured for 
shorter periods, however the speeds only created laminar shear stresses, 
suggesting that light agitation is required to improve proliferation (Lim et al., 
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2014). However, other studies exist reporting a lack of cell growth when shear 
stresses of 1.6-2.7 dyn/cm2 were applied, considerably lower than those applied 
in the study carried out by Lim et al (Kreke and Goldstein, 2004, Kreke et al., 
2005). The loss of cell viability upon administration of fluid flow has been 
hypothesized to be down to the loss of a non-osteogenic subset of MSCs unable 
to adapt or lacking the inherent qualities to respond with the appropriate 
mechanotransduction tools (Kreke et al., 2005). 
 
Cell-microsphere clustering can be used as an indicator that cells are interacting 
and forming bridges across to adjacent microspheres, resulting in the formation 
of complex 3D structures. Therefore, cultures were imaged to determine whether 
clusters formed and to what extent. The phase contrast microscopy images 
support the cell proliferation assay findings, where the cell cultured in 150rpm 
conditions on both Ti-PGMs and Synthemax exhibited limited clustering by day 
13 when compared to the other conditions studied. While clusters were formed 
under static, 70 and 100rpm conditions when hBM-MSCs were cultured on Ti-
PGMs, substantial clustering was only observed in wells containing Synthemax 
under static conditions. The change in fluid dynamics upon increasing agitation 
could affect the clustering formed on both materials. Moreover, as Synthemax 
has a lower density and is buoyant, there is a greater distribution of microcarriers 
throughout the whole culture volume, reducing the collision events that can lead 
to bridging and clustering. This differs from the clusters formed with Ti-PGMs 
which remain at the bottom of the well. As described by Weheliye et al., upon 
agitating a cylindrical vessel in an orbital manner, two distinct zones form, an 
upper zone where toroidal vortices enable effective mixing, and a stagnant region 
towards the base of the well (Weheliye et al., 2013). Therefore, the impact of 
increasing agitation would have a larger effect on particulates in suspension, in 
this case Synthemax, rather than microspheres at the base of the vessel, such 
as Ti-PGMs.  
 
ECM proteins type-I collagen and fibronectin are important for cell responses 
including induction of osteogenic differentiation and have been shown to regulate 
MSC behaviour when coupled with the ECM rich reservoir of endogenous and 
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exogenous growth factors (Bi et al., 2005, Schwab et al., 2013). Osteogenic 
differentiation is highly dependent on the external microenvironment, and the 
presence of key ECM proteins can influence the process (Salasznyk et al., 2004). 
A plethora of research has been published on ECM-mediated osteogenic 
differentiation of MSCs cultured on biomaterials (Bierbaum et al., 2012, Penolazzi 
et al., 2012, Polo-Corrales et al., 2014, Noh et al., 2016), including bioactive 
glasses (Harvestine et al., 2016). Studies have shown that the presence of type-
I collagen and fibronectin during culture induces osteogenic differentiation 
(Moursi et al., 1997, Salasznyk et al., 2004, Cool and Nurcombe, 2005, Donzelli 
et al., 2007, Schneider et al., 2010), therefore the relative decrease in type-I 
collagen  and fibronectin expression at 150rpm compared to the other agitation 
rates studied indicates that high agitation can negatively influence osteogenic 
differentiation. The influence of fibronectin is predominantly via its capacity to 
promote cellular adhesion and it has been shown to promote MSC attachment 
(Hidalgo-Bastida and Cartmell, 2010). However, type I collagen  is more 
abundantly secreted by differentiating osteoblasts, therefore is more commonly 
used as a marker of early stage osteogenic differentiation (Salasznyk et al., 
2004). However, the timing of type-I collagen upregulation is very specific as 
studies have shown that immature osteoprogenitor cells do not express type-I 
collagen, whereas it is upregulated by mature osteoprogenitor cells (Huang et al., 
2007). This is evident on both Ti-PGMs with visibly increased type I collagen 
expression on day 13 under static 70 and 100rpm conditions.  
 
The effect of increased TiO2 concentration on ECM synthesis was negligible and 
this may result from improved stability, hence reduced rate of degradation 
associated with glasses doped with high quantities of TiO2. While Abou Neel et 
al., showed that increasing TiO2 content from 3 mol% to 5 mol% in phosphate 
glasses led to up-regulated type I collagen   expression, it was concluded that 
concentrations beyond 5 mol% did not produce any significant changes in 
degradation and therefore would show no increase in TiO2 dissolution (Abou Neel 
et al., 2007). There are, however, conflicting reports of the effect of agitation upon 
type-I collagen   expression of hBM-MSCs. While some studies concluded 
subjecting the cells to agitation resulted in increased expression (Augst et al., 
2008) some studies have shown that increased exposure to fluid flow and shear 
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have reduced type-I collagen expression (Grellier et al., 2009). Clearly the rate of 
agitation is an important factor and there may be a critical threshold after which 
fluid flow no longer positively stimulates, but instead negatively impacts on cell 
outputs. 
 
The degradation of Ti-PGMs in vitro causes release of Ca2+ and inorganic 
phosphate ions which can affect surrounding cells. Calcium and phosphate ions 
exist in basal DMEM media at a concentration of 1.8mM and 0.09mM 
respectively, as the ion plays an essential role in maintaining growth and function 
of the cells. However, the concentration of Ca2+ present during the process of 
bone remodelling by the action of osteoclasts is significantly higher at 40mM, a 
local concentration increase that has proven important in regulating osteoblast 
proliferation and differentiation. Therefore cells responsible for bone formation 
should be able to withstand these conditions (Silver et al., 1988). The 
differentiation process of bone-forming cells is highly regulated by Ca2+, 
influencing transcription factors via Ca2+ signal transducers (Parrington and Tunn, 
2014).  Liu et al., concluded that the ionic concentrations of Ca2+ and inorganic 
phosphate found in medium were optimal for MSC cell growth with deviations 
from these quantities resulting in no change or inducing cell apoptosis dependent 
on the ionic species altered (Liu et al., 2009). The hBM-MSCs cultured in 2mg/ml 
TiO2-conditioned media showed improved cell proliferation over 7 days of culture; 
however, this was not coupled with improved differentiation. However, cells 
cultured in higher concentrations of TiO2-conditioned media had reduced cell 
growth over the 7-day period. The short period of time used during to culture cells 
in conditioned media limits their ability to produce the key differentiation markers 
studied, with both OPN and OCN regularly expressed after only 14 days. 
Research carried out by McCullen et al., supported these findings, showing that 
human adipose-derived stem cells proliferated better when cultured in media 
containing slightly increased levels of calcium. However, when these levels 
increased further, proliferation was inhibited (McCullen et al., 2010). Other 
studies have reported that MSCs achieve accelerated growth in culture medium 
containing reduced calcium (Lin et al., 2005), while research also claims that 
higher concentrations promote osteogenic differentiation (Nakamura et al., 2010). 
The significant improvement in growth observed from cells cultured in 2mg/ml 
 132 
 
TiO2-conditioned media compared to DMEM suggests that the products of Ti-
PGMs could promote further proliferation during early cell culture, however longer 
culture is required to establish if the dissolution ions could potentially enhance 
mineralization and osteogenic differentiation. Furthermore, identification of the 
actual concentrations of calcium and phosphate ions in solution should be 
quantified to identify the optimal conditions for proliferation and differentiation of 
hBM-MSCs. 
The work in this chapter forms the basis of exploring larger scale culture vessels 
and the application of Ti-PGMs in the proceeding chapter. Having studied the 
effects of agitation speeds on proliferation and differentiation of hBM-MSCs at 
microwell scale, efforts were made to understand whether these cell 
characteristics can be mimicked at a larger more clinically relevant scale, more 
specifically a 125ml Erlenmeyer flask. 
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Chapter 4 .   Scale-up of hBM-MSC culture in 
125ml Erlenmeyer shake flasks using Ti-PGMs 
 
 
4.1 Introduction 
Having established that hBM-MSCs can be expanded on Ti-PGMs in microscale 
culture systems, the next goal was to determine whether hBM-MSC culture can 
be scaled up to produce clinically relevant quantities of engineered bone-like 
material. 
 
To this end, Chapter 4 focuses on bringing together the knowledge gained 
regarding the use of Ti-PGMs for cell culture from previous chapters and applying 
it to clinical scale manufacturing of tissue engineered microunits of bone.  
 
The process bottlenecks identified in previous chapters with cell culture on Ti-
PGMs such as their inability to be suspended were addressed in this chapter. 
Having determined in the previous chapters that specific Ti compositions (Ti5/ 
Ti7) did not induce significant differences in hBM-MSC growth characteristics nor 
show differences in ECM protein expression, only one Ti-PGM composition was 
carried forward in these scale-up studies. With Ti5 being advantageous in terms 
of reduced amounts of TiO2, which therefore reduces raw material costs, and 
limited differences in degradation rate in Ti-PGMs containing in excess of 5 mol% 
TiO2 (Abou Neel et al., 2007), it was considered acceptable to move forward with 
the Ti5 composition. The ability to support hBM-MSC function under scaled up 
dynamic conditions was compared to that of Synthemax at different agitation 
speeds. Cell characteristics including proliferation, protein and gene expression 
were assessed.  
 
Previous work by Olmos and colleagues devised a model to determine the critical 
agitation speed necessary for suspension of microcarriers in orbitally shaken 
Erlenmeyer flasks (Olmos et al., 2015). The model corroborated with 
observations by Weheliye et al., where similar flow patterns were observed in 
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cylindrical vessels (Weheliye et al., 2013). The Olmos model differed slightly, by 
taking into consideration the dimensions of the particles (dp) and the relative 
density of the material (ρ*), highlighted in equation 4.1. Here, Frs indicates the 
suspended Froude number and the constant A depends on the geometry of the 
vessel used (A=0.12 for an Erlenmeyer flask).  
 
 
𝐹𝑟𝑠 =
2(𝜋𝑁 𝑠)
2𝑑𝑖
𝑔
= 𝐴 ∙ (
𝑑𝑜
𝑑
)
−0.25
∙ (
ℎ𝑙
𝑑
)
0.49
∙ (𝜌∗) ∙ (
𝑑𝑝
𝑑
)
−0.07
      (4.1) 
 
 
The model however was only validated using a specific range of values for each 
of the parameters and the relative density of the Ti-PGMs is greater than the 
upper limit of the particles used to develop this model. 
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4.2 Materials & Methods 
4.2.1 Preparation of human bone marrow derived mesenchymal stem cells 
Human bone marrow derived MSCs sourced from in-house stocks were cultured 
as mentioned earlier in section 3.2.1. Cells were cultured using the same media 
and seeding density. 
 
 
4.2.2 Cell culture on Ti-PGMs and Corning® Synthemax in a 125ml 
Erlenmeyer flask under static and dynamic conditions 
Large scale culture of hBM-MSCs was carried out in Corning® 125ml 
Polycarbonate Erlenmeyer flasks (Corning, UK). A pre-calculated quantity of Ti-
PGMs (0.5g ± 0.05g) and low concentration Synthemax® II (Corning, UK) (0.37g 
± 0.037g) were added to separate dry culture dishes (Nunclon, UK), covered and 
sterilized for 90 minutes using a high intensity Blak-Ray B-100SP lamp (UVP, 
Cambridge, UK). Fresh DMEM containing FBS (10%) and antibody-antimycotic 
solution (1%) (Gibco®, Life Technologies Ltd., Paisley, UK) were added to each 
culture dish enabling transfer of the two different microspheres into their 
respective Erlenmeyer flask. The 2ml solution of media and microspheres were 
transferred from the culture dishes using a 1000µl Gilson pipette into their 
respective 125ml Erlenmeyer flask. The culture dishes were rinsed with a further 
2ml of media to ensure any residual microspheres had been transferred. Once 
all the material had been transferred to their respective flasks, an additional 35ml 
of media was added to bring the total volume within the flask to 39ml. After hBM-
MSCs were harvested using the protocol described in section 2.2.3 a cell 
suspension of 1x106 cells/ml was created. From the resulting solution 1ml was 
transferred to each flask bringing the total volume to 40ml. The flasks were then 
incubated at 37°C in an atmosphere of 5% CO2 for 24 hours under static 
condition. The reason the full working volume was not added to the flask was due 
to the poor seeding efficiency attributed to the increased fluid height. After 24 
hours, an additional 40ml of fresh media was added to each of the flasks, which 
were then placed in their corresponding conditions.  
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The dynamic conditions calculated were determined by the mixing model 
developed to establish particle suspension speeds (Ns) in cylindrical vessels 
including Erlenmeyer flasks (Olmos et al., 2015). Using this model, a Ns speed of 
320rpm (Frs=0.58) was calculated, however results from Chapter 3 indicated that 
using an agitation higher than (Nc assumed to be like Ns at the time of study) 
inhibited proliferation potentially through excessive shear forces and therefore it 
was assumed the same effect would be created at large scale with similar mixing 
dynamics created. Therefore, the upper agitation limit to be studied was 
determined as 160rpm. The other speed studied in this chapter were related to 
the conditions studied at microwell scale including 40rpm and 80rpm 
(0.25Ns=0.5NC) to fully understand the effect of the scaling law on microsphere 
cell culture. While 40rpm agitation at large-scale did not directly correlate to a 
speed studied at microwell scale, it was studied to further understand the 
optimum agitation rate. As higher agitation rates at small-scale were detrimental 
to cell proliferation, it was assumed that the optimal speed may exist between 
static conditions and 0.5NC, and hence 40rpm (0.25NC) was chosen. The 
preparation of the Erlenmeyer flasks for dynamic culture was the same as the 
static flasks, however after the first 24 hours the flasks were kept in their 
respective conditions. After this period, the flasks were transferred into an 
incubator and placed on a KS260 control orbital shaker (IKA, Germany) and kept 
at 37°C and 5% CO2. Media changes were carried out on days 1, 4, 7, 10, 14, 17 
and 21 where only 40ml of the total 80ml volume was removed,  
 
 
4.2.3 Metabolite analysis 
Offline glucose and lactate analysis was carried out using a Bioprofile FLEX 
Analyser (Nova Biomedical, UK) on days 1, 4, 7, 10, 14, 17 and 21. At each 
specified time points, 2ml samples were aspirated from each flask in triplicates 
ensuring no microspheres were removed in the process, with each sample kept 
on ice to minimise metabolic activity and sample degradation. Media changes 
occurred after sample isolation with fresh media compensating for the removed 
sample volume. 
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4.2.4 Confocal laser scanning microscopy 
Immunofluorescent staining of the tissue engineered constructs formed in the 
125ml Erlenmeyer flasks was carried out using the same protocol as that 
described in section 3.2.3.5. Taking into consideration the previous imaging 
issues when imaging cells cultured on Synthemax, optically enhanced 
Sensoplate™ 24-well glass bottom microplates (Grenier Bio-One Ltd, UK) were 
used to ensure image resolution was not lost and high-quality images could be 
obtained. Samples were isolated on day 21 using a sterilised FisherBrand™ 
Stainless Steel spooned spatula (Thermo Fisher Scientific, UK) and transferred 
to a microplate containing 1x PBS. Samples were fixed and stained to 
fluorescently label extracellular matrix proteins fibronectin (Mouse monoclonal, 
ab6328, Abcam, Cambridge, UK) and type-1 collagen (Rabbit polyclonal, 
ab34710, Abcam, Cambridge, UK) and bone specific extracellular matrix proteins 
osteopontin (OPN) (Mouse monoclonal, ab69498, Abcam, Cambridge, UK) and 
osteocalcin (OCN) (Rabbit polyclonal, ab10911, Millipore, UK) as described in 
3.2.3.5. 
 
4.2.5 Scanning electron microscopy 
Clustered samples were fixed in Nunclon™ flat bottomed tissue culture 24-well 
microplates (Thermo Fisher Scientific, UK) using 3% glutaraldehyde (Sigma-
Aldrich, UK) to fix the specimen, and were stored in solution at 4˚C until required 
for SEM preparation. The glutaraldehyde fixative was replaced with a graded 
series of the following alcohols to dehydrate each sample: 70% EtOH for 10 
minutes, 90% EtOH for 10 minutes and 100% EtOH for 10 minutes (3 times). The 
final 100% EtOH step was followed by adding hexamethyldisilazane (HMDS; 
TAAB Laboratories, UK) and leaving for 1–2 minutes to carry out critical point 
drying, after which the HMDS was removed and the samples extracted and dried 
on blotting paper. The samples were then spread on carbon adhesive discs fixed 
to aluminium SEM specimen stubs, with any loose residual material blown off 
using a compressed air duster spray. The adhered specimens were then sputter-
coated with gold/palladium by a Polaron E5100 coating system (Polaron CVT, 
UK). The coated samples were observed using a scanning electron microscope 
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(JSM 5410LV, JEOL, Japan) under different magnifications, operating at a 10kV 
voltage. 
 
 
4.2.6 Quantitative polymerase chain reaction (qPCR)  
Various cell/microsphere clusters were isolated from each flask and transferred 
to Nunclon™ flat bottomed tissue culture 24-well microplates (Thermo Fisher 
Scientific, UK). The cells were harvested from their culture substrate using 0.5ml 
0.25% trypsin-ethylenediaminetetraacetic acid (EDTA) solution for 5 min at 37oC. 
The trypsin was then inhibited by adding 1ml of fresh DMEM, with the resultant 
mix of cells, media and microspheres passed through a sterile Falcon® Cell 
Strainer (Corning, UK) with 40µm pores to separate the cells from the 
microspheres. The cell suspension was then transferred to a 2ml Eppendorf and 
centrifuged at 300g for 5 minutes.  
 
The process of isolating RNA for cDNA synthesis started with the lysis of the cell 
pellet using RLT buffer (Qiagen, Germany). The resulting lysate was 
homogenized using a QIAshredder spin column, which was centrifuged at 
10,000rpm for 2 minutes. The total RNA was isolated from the homogenized cells 
using the RNeasy MicroKit (Qiagen, Germany) according to the manufacturer’s 
instructions, with 14µl of RNase-free water used to elute the isolated RNA. The 
RNA concentration was established using the NanoDrop 1000 (Thermo Fisher 
Scientific, UK). Genomic DNA elimination was carried out using the Quantitect 
Reverse Transcription Kit (Qiagen, Germany) to ensure no DNA was present in 
the RNA template solution. The RNA template was then annealed with the cDNA 
components of the kit, and the reverse transcription reaction was carried out for 
each RNA sample for 15 minutes at 42ºC and then 3 minutes at 95ºC to inactivate 
the reverse transcriptase enzyme.  
 
The cDNA synthesised from each sample was amplified by the CFX connect 
Real-time PCR Detection System (Bio-Rad) using Quantitect SYBR RT-PCR Kit 
(Qiagen). The presence of nucleotides specific to the hBM-MSC cell line and their 
transcription rate were quantified by the amplified SYBR signal after 35-40 
thermal cycles. The total process volume was 25µl containing 5µl of cDNA, 2.5µl 
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of Primer Assay and 12.5µl of Quantitect SYBR Mastermix. Using CFX Manager 
3.0 software relative expression studies were carried out against the expression 
of rRNA encoding housekeeping gene β-actin (. The cDNA was targeted for 
sequences of COL1A1 (QT00037793, Qiagen), RUNX2 (QT00020517, Qiagen) 
and SPP1. 
 
 
4.2.7 Statistical analysis 
All statistical analysis was carried out using IBM SPSS Statistics version 22. 
Analysis was carried out using the techniques described in 2.2.10. 
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4.3 Results 
4.3.1 Expansion of hBM-MSC in scaled up culture vessels 
The first experiment assessed the effect of static and dynamic culture conditions 
in 125mL Erlenmeyer culture flasks. The agitation speeds chosen for this part of 
the research focuses on the same relationship between the dimensionless 
Froude number and rate of agitation that was studied in the previous chapters. 
The underlying difference between the speeds chosen for the current scale and 
those studied previously was the different models chosen to determine the 
Froude number for each vessel type. As the correlation between the Froude 
number and agitation speed remain the same across both model, the mixing 
patterns studied could be mapped effectively from microplates to shake flask. As 
illustrated in Figure 4.1, the relationship between the agitation speed studied and 
the Nc speed is similar at both scales.  
 
  
Figure 4.1 Correlation between Froude number and rate of agitation. An XY scatter plot was 
used to scale agitation rates from (A) 96-well microplates to (B) 125 ml Erlenmeyer shake flasks. 
The figure highlights the speeds chosen in relation to highest agitation rate used (300rpm) at 
microwell scale and how the mixing dynamics have been mimicked at shake flask scale where a 
NS of 320rpm was calculated. 
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Figure 4.2 Progressive changes in Ti-PGMs monolayer with increasing agitation rate. 
Increased orbital agitation leads to the complete suspension of Ti-PGMs (additionally doped with 
a minimal amount of Co2+ to visualize microspheres) in a 125 mL Corning® Erlenmeyer flask 
containing distilled water. Operating conditions are VL=80 mL, do=1.0cm, and agitation rate: N=0 
rpm, 80rpm, 160rpm, 220rpm, 280rpm and 320rpm. Complete suspension was observed for 
Ns=320 rpm 
 
 
Visualizing the effect of increasing agitation on suspension of Ti-PGMs, provided 
an initial observation to understand how well the Froude number could aid 
dynamic cell culture on the microspheres. Using a clamp firmly fixed to the orbital 
plate shaker enabled the movement pattern of Ti-PGMs to be followed as 
agitation speed progressively increased. It can be seen from Figure 4.2 that as 
agitation increases from 0 to 160rpm the stagnant layer of microspheres slowly 
concentrates together in the centre of the flask. The microspheres concentrate 
further until suspension of the Ti-PGMs is achieved at approximately 320rpm as 
predicted by the model developed by Olmos et al. (Olmos et al., 2015) 
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Figure 4.3 Cellular/microsphere structures formed in 125ml Erlenmeyer shake flask after 
21 days of culture. Different clusters formed when hBM-MSCs are cultured on Ti-PGMs under 
(A) 0rpm (B) 40rpm and on Synthemax under (C) 0rpm conditions. (D) Size of the Ti-PGM/cell 
structures formed with the largest cluster measured at 6mm in length. Image was taken at 2x 
magnification. Scale bar is 2000µm. 
 
 
 
 
 
D 
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4.3.2 Metabolite analysis 
Metabolic profiling was undertaken to determine whether agitation speed affects 
the metabolic kinetics of the cells. The metabolic profiles in Figure 4.4 show the 
rates of glucose consumption and lactate production under each condition and 
material investigated. Cells cultured on Ti-PGMs consumed glucose at a greater 
rate when cultured at 160rpm for 21 days (Fig 4.4A), with significant increases 
observed between days 4 to 14 when compared to 0rpm (**p<0.01) and 40rpm 
(*p<0.05), while a significant increase was observed on day 10 compared to 
80rpm (** p<0.01). The lactate production profile of Ti-PGMs (Fig 4.4B) showed 
that the cells produced the same amount of lactate over the first 4 days of culture. 
Between days 4 and 17 variability in lactate production rate could be observed 
between the different conditions. However, the largest difference was seen 
between day 17 and 21 where cells cultured on 160rpm showed a significant 
decrease in lactate production compared to the other conditions. This reduction 
in lactate occurred in parallel to an increase in media glucose concentration. 
Limited differences were observed in the glucose consumption profile of 
Synthemax (Figure 4.4C). However, the lactate profile showed that under 160rpm 
conditions lactate production was significantly lower than the other conditions 
studied (*p<0.05).  
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 Figure 4.4 hBM-MSCs metabolic profiles when cultured on different substrates under 
different agitation rates. Line graphs show glucose consumption (A, C) and lactate production 
(B, D) when cultured on Ti-PGMs (A & B) and Syn (C&D) at days 0, 1, 4, 7, 10, 14, 17 and 21 
under ● - 0rpm ■ - 40rpm ▲- 80rpm and x – 160rpm condition. Values represent mean ± SD 
(n=3). Significance values denoted by *=p<0.05 indicate significant differences between 160rpm 
and both 0 and 40rpm while **=p<0.01 indicates significant differences between 160rpm and all 
other conditions. 
 
 
When comparing the metabolic profiles of Synthemax to those produced by Ti-
PGMs, there were significant differences in glucose consumption across most of 
the agitation speeds studied. When hBM-MSCs were cultured under 0rpm and 
40rpm conditions (Fig 4.5A & B), reduced glucose consumption was observed by 
cells growing on Ti-PGMs compared to Synthemax over the 21 days (*p<0.05). 
These differences were significant at both speeds between day 14 to 21 
(**p<0.01). Cells grown at 80rpm however showed no significant differences 
during the 21-day culture period, however the trend observed at lower agitation 
speeds was not seen at 160rpm, where Ti-PGMs promoted increased glucose 
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consumption when compared to Synthemax from day 10 onwards (**p<0.01). As 
expected higher lactose production was associated to conditions that favoured 
higher glucose consumption illustrated through Figure 4.5 & 4.6. 
 
 
Figure 4.5 Glucose consumption of hBM-MSCs cultured on Ti-PGMs and Synthemax. Line 
graphs showing glucose levels at days 0, 1, 4, 7, 10, 14, 17 and 21 under (A) 0rpm, (B) 40rpm, 
(C) 80rpm, and (D) 160rpm condition. Values represent mean ± SD (n=3). Significance values 
denoted by * = p<0.05, ** =p <0.01 and *** = p< 0.001.  
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Figure 4.6 Lactate production of hBM-MSCs cultured on Ti-PGM sand Synthemax. Line 
graphs comparing lactate levels at days 0, 1, 4, 7, 10, 14, 17 and 21 under (A) 0rpm, (B) 40rpm, 
(C) 80rpm, and (D) 160rpm condition. Values represent mean ± SD (n=3). Significance values 
denoted by * = p<0.05, ** =p <0.01 and *** = p< 0.001.  
 
 
To understand the effect each condition had as the culture progressed, rates of 
glucose consumption and lactate production per hour were determined over the 
21 days illustrated by Figure 4.7. Rates of both glucose consumption and lactate 
production increased over the first 4 days. Distinct differences can be seen 
between the glucose consumption rates of cells cultured on Ti-PGMs and 
Synthemax under 160rpm conditions, where on Ti-PGMs the higher speeds 
induced improved glucose uptake per hour until day 14 after which point the rates 
were by matched the remaining conditions. However, cells cultured on 
Synthemax showed lower glucose consumption rates after day 4 reducing to near 
zero levels by day 21. Lactate production rates were similar across all conditions 
studied when hBM-MSCs were cultured on Ti-PGMs however, Synthemax 
showed rates that fluctuated over time with 160rpm conditions showing lower 
production rates over the 21 days. 
 147 
 
 
 
Figure 4.7 Glucose consumption and lactate production rates per hour of hBM-MSCs 
during culture. Line graphs compare the metabolic rates of hBM-MSCs cultured on Ti-PGMs (A 
& B) and Synthemax (C & D) at days 0, 1, 4, 7, 10, 14, 17 and 21 under 0rpm, 40rpm, 80rpm and 
160rpm condition.  
 
 
4.3.3 Cell interactions with Ti-PGMs and Synthemax cultured in 125ml 
Erlenmeyer flasks 
Details of the interaction between hBM-MSCs and microspheres when cultured 
using both Ti-PGMs and Synthemax in Erlenmeyer shake flask cultures was 
assessed using SEM, which enabled high resolution images to be acquired. The 
images in both Figures 4.8 and 4.9 were taken 21 days post seeding. From both 
figures differences in cell interactions and tissue morphology can be observed. 
Initially, the stark differences in average size of the different types of culture 
substrate can be noticed with Synthemax occupying a larger volume as expected. 
Furthermore, the mode in which the hBM-MSCs use the substrates as a tool for 
growth and support differs with changes in agitation. While the cells grown on 
Synthemax tend to bind strongly with the surface of the carriers and wrap around 
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the particle when subjected to high agitation, the hBM-MSCs grown on the Ti-
PGMs use the material as support tool to grow and network with other cells to 
form ECM. The networking ability of the cells grown on Synthemax under high 
agitation is limited when compared to the cells grown on the substrate under static 
conditions.  
 
 
 
Figure 4.8 hBM-MSCs cultured on both Ti-PGMs (left column) and Synthemax (right 
column) after 21 days of culture under 0rpm, 40rpm and 160rpm conditions in 125ml 
Erlenmeyer shake flasks. Scanning electron microscopy images showing differences in 
microsphere size and morphology of cells cultured under different conditions. Images were taken 
at various magnifications  
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Figure 4.9 hBM-MSCs cultured on both Ti-PGMs (left column) and Synthemax (right 
column) after 21 days of culture under 0rpm and 160rpm conditions in 125ml Erlenmeyer 
shake flasks. Scanning electron microscopy images showing differences in thickness of tissue 
formed under static and high agitation conditions. Images were taken at various magnification 
and scale bars indicates 50µm and 100µm.  
 
 
4.3.4 Matrix deposition by hBM-MSCs on Ti-PGMs cultured at large scale 
Next, we assessed ECM production and deposition on the microcarriers. After 
labelling cell-microsphere structures with antibodies against type-I collagen and 
fibronectin, we then performed confocal microscopy to visualise the deposits. The 
images in Figure 4.10 and 4.11 show the cells attached to Ti-PGMs and 
Synthemax on days 14 and 21, illustrating fibronectin and type-I collagen 
production. For cells cultured on Ti-PGMs under static conditions, fibronectin and 
type-I collagen expression was lower than when cultured under both 40rpm and 
80rpm on day 14. However, when cultured at 160rpm, expression of both ECM 
markers was lower than both the other dynamic speeds. By day 21, fibronectin 
expression was the same under all conditions studied, and relatively higher than 
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the expression observed on day 14. However, type-I collagen expression by 
hBM-MSCs cultured under static conditions was considerably lower than those 
cultured under dynamic conditions.  
 
When comparing the expression of ECM markers by cells cultured on Synthemax 
versus Ti-PGMs, higher expression was observed on Synthemax under static 
and 40rpm culture conditions compared to the higher agitation speeds. The 
expression of both fibronectin and type-I collagen was lower for cells cultured 
under 80rpm and 160rpm on both day 14 and 21. The images illustrate that 
densely packed ECM fibres are generated under static and 40rpm conditions 
when cells were cultured on Synthemax, while the cells cultured on Ti-PGMs 
were less dense and more branched in nature. The morphology of cells cultured 
on Ti-PGMs remained the same when cultured under all conditions, as illustrated 
by the fibronectin staining. This was not apparent for cells cultured on Synthemax, 
which showed a looser, stretched out structure when under high agitation 
conditions. The cell morphology and ECM structure are further highlighted in 
Figures 4.12 & 4.13 which provide a detailed image of the cells cultured on Ti-
PGMs and Synthemax respectively under static conditions. The Hoechst staining 
suggests that cells tend to proliferate to a greater extent on the Synthemax 
surface under static conditions compared to Ti-PGM.  
 
When looking at the homogeneity of ECM protein expression across the whole 
structure (Figure 4.14), there is an even distribution across both clustered 
structures A and B. The quantity of ECM present in both clusters cannot be 
assumed to be the same due to the difference in microsphere quantity within the 
cluster, hence different volumes in both clusters, coupled with the images limited 
to 150µm in cluster depth. The characteristics of the cells surrounding the 
constructs show no distinguishable differences in density or distribution of ECM 
produced.  
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Figure 4.10  Fibronectin and type-1 collagen expression by hBM-MSCs cultured on Ti-
PGMs at days 14 and 21 of culture. Confocal laser scanning microscopy Z-stack images were 
rendered to produce maximum intensity projection of cross-sections up to 150µm. Staining 
pattern highlights fibronectin (green) and type-1 collagen (red) expressed in the extracellular 
matrix. Images taken at 10x magnification where scale bar is 100µm.  
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Figure 4.11 Fibronectin and type-1 collagen expression by hBM-MSCs cultured on 
Synthemax at days 14 and 21 of culture. Confocal laser scanning microscopy images of were 
acquired and converted into Z-stack images which were rendered to produce a maximum intensity 
projection of cross-sections up to 150µm. Staining pattern highlights fibronectin (green) and type-
1 collagen (red) expressed in the extracellular matrix. Images taken at 10x magnification where 
scale bar is 100µm.  
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Figure 4.12 hBM-MSCs cultured on Ti-PGMs at day 21 of static culture in a 125ml 
Erlenmeyer flask. Confocal laser scanning microscopy images were acquired and converted into 
Z-stack images which were rendered to produce a maximum intensity projection of cross-sections 
up to 150µm. Staining pattern highlights fibronectin (green) and type-1 collagen (red) expressed 
in the extracellular matrix. Nuclear staining was carried out using Hoechst 33342 (blue). Images 
taken at 20x magnification where scale bar is 100µm.  
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Figure 4.13 hBM-MSCs cultured on Corning® Synthemax at day 21 of culture when 
cultured under static conditions. Confocal laser scanning microscopy images were acquired 
and converted into Z-stack images which were rendered to produce a maximum intensity 
projection of cross-sections up to 150µm. Staining pattern highlights fibronectin (green) and type-
1 collagen (red) expressed in the extracellular matrix. Nuclear staining was carried out using 
Hoechst 33342. Images taken at 20x magnification.  
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Figure 4.14  hBM-MSCs cultured on (A) TI-PGMS and (B) Corning® Synthemax at day 21 of 
static culture. Confocal laser scanning microscopy Z-stack images were rendered to produce a 
maximum intensity projection of cross-sections up to 150µm. Staining pattern highlights 
fibronectin (green) and type-1 collagen (red) expressed in the extracellular matrix. Bright field 
images (far-right) show the distribution of microcarriers in the cluster. Nuclear staining was carried 
out using Hoechst 33342. Images were taken at 5x magnification.  
 
 
Next, key markers of differentiation were studied. Cells were cultured on 
microspheres and immunolabelling with antibodies against osteopontin and 
osteocalcin was undertaken (Figure 4.15 & 4.16). hBM-MSCs cultured on Ti-
PGMs were found to deposit osteopontin after 14 days. The staining intensity was 
decreased at 21 days for all agitation speeds studied, indicating that the marker 
reached peak expression and then declined. On the other hand, osteocalcin was 
upregulated from 14 days to 21 days, under agitation culture.  
 
Expression of osteopontin and osteocalcin from hBM-MSCs were compared 
between static and dynamic conditions. Both expression markers when hBM-
MSCs were cultured on Ti-PGMs under dynamic conditions, were higher than 
that achieved under static conditions except for 80rpm conditions which showed 
lower levels of expression of osteopontin on day 14 and 21 of culture. In contrast, 
hBM-MSCs cultured on Synthemax showed lower expression of osteocalcin at 
day 21 across all conditions when compared to Ti-PGM, however showed similar 
osteopontin expression on both days with marginally higher expression achieved 
(A) 
(B) 
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on day 21 under 160rpm compared to Ti-PGM. Both markers showed marginally 
higher expression on day 21 of Synthemax culture at 160rpm when compared to 
the other speeds studied. 
 
 
Figure 4.15 hBM-MSCs cultured to Ti-PGMs at day 21 of static culture. Confocal laser 
scanning microscopy Z-stack images were rendered to produce maximum intensity projection of 
cross-sections up to 150µm. Staining pattern highlights osteopontin (green) and osteocalcin (red) 
found in the extracellular matrix. Images taken at 10x magnification where scale bar is 100µm.  
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Figure 4.16  hBM-MSCs cultured on Synthemax at day 21 of static culture. Confocal laser 
scanning microscopy Z-stack images were rendered to produce maximum intensity projection of 
cross-sections up to 150µm. Staining pattern highlights osteopontin (green) and osteocalcin (red) 
found in the extracellular matrix. Images taken at 10x magnification where scale bar is 100µm.  
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4.3.5 hBM-MSC osteogenic gene expression  
Gene expression was assessed to understand the effect the different culture 
substrates and agitation conditions had on osteogenic differentiation. Cells 
isolated on day 21 from each condition were processed to quantify levels of 
osteogenic specific genes (COL1A1, RUNX2 and SPP1) expressed by the cells. 
The level of gene expression for each sample was normalized against expression 
of the housekeeping gene β-actin, and that product was then normalized relative 
to Synthemax cultured under static conditions. For COL1A1, significant 
differences in expression between the different speeds studied for both 
substrates were only observed under 40rpm conditions were up-regulation of 
COL1A1 was observed on Ti-PGMs compared to Synthemax (**p<0.01). 
 
Figure 4.17 Relative quantification of gene expression of (A) COL1A1 (B) RUNX2 and (C) 
SPP1 in hBM-MSCs seeded on Ti-PGMs and Synthemax after 21 days in culture. 
Significance values denoted by * = p<0.05, ** =p <0.01 and *** = p< 0.001 indicate highly 
significant gene expression compared to Synthemax. Error bars represent the mean value 
considered for three replicate specimens (±SD). 
 
 159 
 
There was no significant difference in RUNX2 expression (Fig 4.17(B) between 
the different conditions or substrates studied over the 21-day period, even though 
there was a non-significant tendency in favour of Ti at each time point. On the 
contrary, there were significant differences observed in SPP1 expression 
between the different materials studied. When hBM-MSCs were cultured under 
static conditions, Ti-PGMs showed up-regulated SPP1 expression compared to 
Synthemax (**p<0.01). However, under 160rpm conditions the inverse was 
observed where Synthemax supported higher SPP1 expression (*p<0.05). The 
difference observed at 160rpm resulted from the relative increase in SPP1 
expression by hBM-MSCs cultured on Synthemax compared to the other three 
speeds studied with significant upregulation in comparison to 0, 40 (***p<0.001) 
and 80rpm (**p<0.01). 
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4.4 Discussion 
The focus of this chapter was effectively scale up hBM-MSC culture to improve 
overall production of bone-like material. The interactions between hBM-MSCs 
and Ti-PGMs or Synthemax in a 125ml Erlenmeyer flask (reflecting scale up for 
production of clinical quantities of autologous material), were investigated to 
understand cell behaviour when scaling up a two-phase culture system with 
orbital mixing. This chapter consolidates work carried out at small scale using 
both MG63 and hBM-MSCs to understand the impact of fluid flow and explored 
further the application of Ti-PGMs in guiding osteogenic differentiation of 
immature hBM-MSCs. The research carried out will aid future efforts in 
understanding mixing regimes and help develop strategies to develop tissue 
engineered bone using bioactive glass for clinical bone defects. 
 
Research has been undertaken to understand how expansion of stem cells can 
be improved using microcarriers in shaken flask culture systems by determining 
the agitation speeds necessary to suspend the culture material therefore 
improving homogenous cell expansion. Initial work carried out by Weheliye et al., 
(2013) focused on looking at the mixing patterns achieved in 
microwells/cylindrical vessels (Weheliye et al., 2013). Subsequent work by Olmos 
et al., (2015) focused on creating a model to determine the critical agitation speed 
of microcarriers in various Erlenmeyer flasks using parameters that were closely 
associated to the initial model developed by Weheliye et al (Olmos et al., 2015). 
While the first iteration focused on understanding the in-phase to out-of-phase 
transition of the contents in a cylindrical vessel, the second iteration developed 
by Olmos et al., incorporated factors contributed by a second phase, the 
microspheres. When determining the Nc using Weheliye’s model where relative 
density of the Ti-PGMs is not considered and is applicable only to cylindrical 
vessels, an agitation speed of 160rpm was calculated. The images illustrating the 
progressive suspension of Ti-PGMs when agitated in a 125ml Erlenmeyer flask 
(Figure 4.2) show that at 160rpm the Ti-PGMs begin to be pulled to the centre of 
the flask base, indicating the transition from in-phase flow to out-of-phase flow. 
However, the microspheres glide across the base of the flask, remaining relatively 
static. This phenomenon was observed also by Pieralisi et al., (2016), who 
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showed, using GE Cytodex 3 microcarriers, these microcarriers being pushed 
from the periphery towards the centre of the reactor base at the point of flow 
transition (Pieralisi et al., 2016). However, the microcarriers were subsequently 
suspended into the bulk flow. The density dependent model calculated that the 
Ns speed required to suspend the Ti-PGMs was 320rpm, which correlates with 
the images in Figure 4.2. The density of the Ti-PGMs, while exceeding the limits 
of the model developed by Olmos et al., correlates well with the expected mixing 
patterns. Based on these two models, between the NC speed calculated using 
Weheliye’s model (160rpm) and the Ns determined using Olmos’ model (320rpm), 
a mixing system change occurs between the two speeds which needs to be 
studied further. 
 
As aforementioned, small scale studies carried out in Chapter 3 showed that 
hBM-MSCs cultured at 0.5NC induced lower levels of cell proliferation and 
therefore it was used as the upper limit agitation in this study. Metabolite analysis 
from extracted media samples was undertaken to make an inference of relative 
growth occurring under each condition studied. The specific rate of both glucose 
consumption and lactate production could not be determined due to the inability 
to quantify viable cell number at each time point. The high density of Ti-PGMs 
coupled with the different cluster sizes formed by Synthemax and Ti-PGM, 
generated variability in the sampling process. Cell growth was therefore inferred 
using the metabolite data to determine non-specific rates of glucose consumption 
and lactate production. The accumulation of Ti-PGMs to the centre of the flask 
induced by 160rpm agitation promoted better cell metabolism and growth 
possibly due to the proximity of the microspheres. This allowed the cells to 
proliferate better, helped by the ability to easily bridge between microspheres, 
which formed a scaffold-like structure, utilising the available surface area more 
effectively. The high agitation conditions were however detrimental to hBM-MSCs 
cultured on Synthemax, whose metabolic rates were reduced. This varying effect 
induced by a high agitation rate is further corroborated by the YLac/Glc ratio with Ti-
PGMs under 160rpm conditions. The ratio of 0.896 was the lowest ratio amongst 
all conditions studied using Ti-PGM, while Synthemax generated a ratio of 1.209, 
the highest for its material. The optimal regime for Synthemax culture was under 
static conditions with a ratio of 0.886 with progressively higher ratios as agitation 
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increased (40rpm=1.006, 80rpm=1.104). Metabolite ratios of Ti-PGMs followed 
the same trend until 160rpm with an increase in ratio value as agitation increased 
(0rpm=0.985, 40rpm=0.995, 80rpm=1.14).  
 
The growth patterns witnessed at a larger scale differed depending on the culture 
substrate examined. The patterns were mimicked closely when considering 
Synthemax due to the similarities of its Ns and Nc, and due to the limited impact, 
the density of the microcarriers had on their ability to be suspended. However, 
Ti-PGMs exhibited different effects at the two scales studied. This fundamentally 
owes to the difference in the models developed by Weheliye et al., and Olmos et 
al. The small-scale studies carried out in this research focused on the transition 
of in-phase mixing to out-of-phase mixing with the assumption that when NC was 
administered the microspheres would achieve suspension (NCr~Ns). At the time 
of the small-scale studies no model existed for the mixing of two-phase systems, 
therefore Ns could not be determined. The transition model was limited to 
cylindrical vessels and could not be applied confidently to Erlenmeyer flasks. 
Therefore, the speeds studied at the different scales were determined using the 
transition model rather than the suspension model. Nevertheless, considering the 
magnitude of the Ns relative to NC (Table 4.1), mixing dynamics of dense 
microspheres at different scales are better compared by NC values calculated 
using the transition model rather than the suspension model due to the high 
agitations required. The values provided in Table 4.1 should be considered as 
estimates for two reasons. Firstly, the model developed by Weheliye et al., was 
used here to determine the Nc in Erlenmeyer flasks where transition from in-
phase to out-of-phase occurs, even though the model has only been validated 
with cylindrical vessels. Additionally, the relative error stated with the suspension 
model in regards to cylindrical vessel is 10.2% (Olmos et al., 2015). 
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Table 4.1 Critical (NC) and suspension (Ns) agitation speeds based on 
models developed by Weheliye et al., (Weheliye) and Olmos et al., (Olmos).  
 
Scale 96-well microplate Erlenmeyer flask (125ml) 
Model Weheliye  Olmos  Weheliye  Olmos  
Parameter NC Ns NC  Ns 
Orbital Speed (rpm) 340 787 160 320 
 
 
Inducing osteogenic differentiation through fluid flow has been studied 
extensively using parallel plate flow technology, and orbital cultures have shown 
to provide the same effects in a less homogenous manner (Kreke et al., 2005, 
Huang et al., 2010). Models have been developed by different research groups 
aiming to understand the effects of fluid flow on mammalian cell cultures. 
However, no clear agreement has been reached in the literature available 
(Thomas et al., 2011, Lim et al., 2014, Nienow et al., 2014, Velasco et al., 2016). 
Many of these studies have examined the effects of shear in a global nature within 
a vessel, where cell properties such as product titre were related to flow patterns 
and shear stress. These techniques provide limited understanding of local shear 
stresses which becomes crucial when considering microcarrier culture where 
vector and magnitude of shear stresses impact stem cell fate (Sargent et al., 
2010). Although research has been carried out on understanding the effect of 
orbital mixing on two-phase culture systems, no work has been carried out to 
understand the effects these different mixing regimes have on cell growth and 
phenotypic behaviour when attached to microspheres. The effect of fluid flow on 
hBM-MSCs ability to be differentiated to an osteogenic phenotype when cultured 
on Ti-PGMs can be better understood by examining the expression of osteogenic 
markers OPN (SPP1) and OCN. OPN is a phosphoprotein that is associated with 
mineralization of ECM synthesized by bone forming cells (Butler, 1989) and OCN 
is a calcium binding protein (Aubin et al., 1995). Expression of OPN was observed 
in day 14 of hBM-MSC culture on both Ti-PGMs and Synthemax, however was 
down-regulated on day 21. This was expected due to OPN being an early marker 
of osteogenic differentiation (Zohar et al., 1998, Köllmer et al., 2013, Granéli et 
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al., 2014). When hBM-MSCs were cultured on Ti-PGMs, osteogenic 
differentiation was induced after 21 days under dynamic conditions, highlighted 
by a marked increase in type-I collagen and OCN expression compared to static 
culture. hBM-MSCs cultured on Synthemax in the presence of fluid flow however, 
did not show increased type-1 collagen or fibronectin expression when agitation 
speed increases, potentially due to the levels of shear becoming detrimental to 
cell maturation. However, increased expression of OPN and OCN was observed 
when hBM-MSCs were cultured on Synthemax for 21 days at 160rpm compared 
to the other conditions potentially indicating that high agitation levels can be 
osteoinductive. This effect was also confirmed by qPCR data showing a 
progressive increase in OPN expression as cells were exposed to higher agitation 
for 21 days. The increase in OPN expression in response to fluid flow has been 
well documented (You et al., 2001, Kreke et al., 2005, Sharp et al., 2009, Yourek 
et al., 2010) with evidence to show that OPN is more shear-responsive than other 
osteogenic markers such as bone morphogenetic protein 2 (BMP-2). As hBM-
MSC proliferation was limited on Synthemax at 160rpm, the total number of cells 
possessing osteogenic properties would be low in number, however high in 
percentage. Orbital mixing at 160rpm influences the mixing dynamics of 
Synthemax greater than Ti-PGMs due to their density differences, hence this 
would explain the significant difference in OPN expression. Increased levels of 
OPN and OCN expression by BM-MSCs when low magnitudes of shear stress 
were applied have been documented in research carried out in studies showing 
that fluid flow could be used as a tool for isolating osteogenically sub-populations 
through mechanotransduction (Kreke et al., 2005). 
While the upregulation of OPN on Synthemax can be attributed to the effects of 
fluid flow as opposed to the osteoinductive properties of the polystyrene material, 
it can’t be concluded that the effect of flow is the sole factor in inducing osteogenic 
differentiation on Ti-PGMs. The ability of the materials to induce an osteogenic 
response can be better understood by examining phenotypic properties under 
low flow conditions where cell numbers are relatively similar. When looking at the 
osteogenic differentiation of hBM-MSCs cultured under lower agitation speeds, 
Ti-PGMs have overall significantly greater osteoinductive properties than 
Synthemax with higher gene expression of both COL1A1 and OPN documented. 
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This increased expression of OPN under static culture was previously observed 
when hMSCs were cultured on Ti5 compared to silica glass microspheres 
(Lakhkar et al., 2015a). The reason behind the enhanced osteogenic response 
was due to the release of various phosphate species from the glass structure; 
however, the exact mechanism still needs to be studied to understand the 
pathways involved in improved osteogenic differentiation. The confocal images 
on day 21 under static conditions indicate that Synthemax expresses larger 
amounts of COL1A1 compared to Ti-PGM, however due to its weak staining this 
could be down to auto-fluorescence or ineffective washing steps of the dense 
ECM. A clear positive control was not used when conducting the PCR 
experiments therefore it would be necessary to compare genetic expression of 
cells cultured in osteogenic media cultured on Synthemax.  
 
The attachment of the cells is an area that hasn’t been fully addressed thus far in 
this research and based upon the SEM images, shows a potential avenue for 
development. The differing levels of cell adhesion after 21 days of culture on Ti-
PGMs and Synthemax indicates that surface modifications are required to 
optimize the performance of Ti-PGMs as a platform for cell attachment and rapid 
proliferation. It is unknown whether processing steps when fixing and imaging the 
samples disturbed cells and cell-secreted ECM from the microspheres. However, 
the Synthemax underwent the same process and cells remained adhered to the 
microcarrier surface. The use of protein coatings as a biofunctionalization tool, 
mainly biomimetic ECM, has been studied on different material surfaces 
(Chrzanowski et al., 2012, Shin et al., 2012, Truong et al., 2012, Pérez et al., 
2013, Kang et al.). However, limited work exists on phosphate glasses. Fusion 
protein fibronectin-osteocalcin (FN-OCN) has been identified as potential dual-
purpose protein by enhancing cell attachment (FN) and inducing osteogenic 
differentiation through OCN simultaneously, which is reported to have a high 
affinity for hydroxyapatite (HA) (Lee et al., 2013). The formation of a biologically 
active HA layer has classically been deemed as a requirement of biomaterials 
when present in a physiological environment, due to its compositional similarity 
to apatite found in bone and its bone-bonding qualities (Kokubo et al., 2004). 
However, the use of such fusion proteins or biofunctionalization coatings that 
depend on a HA coating will be redundant due to the lack of HA formation on Ti-
 166 
 
doped phosphate glasses when in physiological fluid (Abou Neel et al., 2007). 
The presence of adhesion proteins in FBS also provides additional factors to 
promote adhesion which need to be taken into consideration (Hayman et al., 
1985). While developments of various coatings could improve the attachment of 
MSCs to the Ti-PGMs surface, further work is needed to understand the affinity 
of the surface to these coatings. 
 
In summary, scale up of hBM-MSCs was examined using Ti-PGMs under static 
and dynamic conditions. The microspheres have shown their ability to support 
limited cell proliferation but provide strong guidance for differentiation when used 
at large scale. The effect of fluid flow to enhance osteogenic differentiation was 
also observed. However, better understanding of spatial shear stress is needed 
inside a shaken vessel. While the sizes of macrostructures produced in this part 
of the study are magnitudes smaller than those needed to treat a majority of 
critical size defects, the motivation to continue scaling up now exist having 
confirmed that scale up can be achieved. The constructs created in this study are 
of suitable sides to treat critical size maxillo/craniofacial defects in animal models 
such as mouse and rats (Poser et al., 2014). In order to create quantities of 
materials suitable to treat the upper limit of human maxillo/craniofacial defects 
further scale up is required. Other modes of increasing the size of the overall 
construct should be explored, such as running multiple 125ml cultures in parallel, 
consequently bringing the structures formed into a larger vessel, similar to a seed 
train or using larger vessel sizes within the constraints of the Olmos model 
(maximum limit of 1L Erlenmeyer flask). However, further tissue characterization 
would be needed, and additional risk is introduced by creating an open system. 
The Froude number was used to effectively scale microwell processes (Chapter 
3) to cultures in Erlenmeyer flasks, providing a greater understanding of the use 
of biomaterials in clinically relevant culture processes. Furthermore, the model 
developed by Olmos et al., has been used outside ranges permitted, validating 
its use for biomaterials with high densities. It is important to further understand 
whether the constructs produced in this study can be used individually or 
combined with additional macrounits to meet clinical needs. 
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Chapter 5 .   Qualitative analysis of in vitro 
osteoclast resorption of Ti-PGMs and effect of 
modified surfaces on hBM-MSC behaviour  
 
 
5.1 Introduction 
A majority of the work carried out with Titanium-doped phosphate glass has 
focused on its ability to aid cell proliferation by recognising its biodegradability 
and slow release of ions (Abou Neel et al., 2008). However, no demonstration of 
its reactivity to other bone remodelling cells such as osteoclasts has been 
performed. The scope of this chapter is to examine the activity of bone resorbing 
cells cultured on Titanium-doped phosphate glass. 
 
Where osteoblasts form bone, osteoclasts resorb it. Osteoclasts are formed 
through the fusion of hematopoietic precursors resulting in multi-nucleated cells 
(Teitelbaum and Ross, 2003). Their adhesion to bone tissue is controlled by the 
interaction of integrins such as vitronectin receptor αVβ3 (VNR) along with bone 
tissue ECM, which stimulates adhesion and migration (Duong and Rodan, 2001). 
However, there is no evidence to indicate the molecular components of Titanium-
doped phosphate glass induce osteoclast attachment. The osteoclastogenesis 
process is fully elucidated, with formation of sealing zones and a ruffled 
membrane (Vaananen et al., 2000) both indicative markers of osteoclast 
resorption activity. Lysosomal enzymes are released from the ruffled membrane 
into the resorption site during the resorption process, while the sealing zone is 
essential for attachment and to initiate bone resorption (Xia et al., 1999, 
Nakayama et al., 2011). Within this resorptive environment, osteoclasts function 
by the acidification and release of bone degrading enzymes such as cathepsin K, 
tartrate resistant acid phosphatase (TRAP) and matrix metallopeptidase 9 (Blair 
et al., 1986, Teitelbaum et al., 1997, Boyle et al., 2003, Teitelbaum, 2007). The 
migratory action of osteoclasts during the resorption process is induced by 
cellular processes called filopodia and lamellipodia (Mattila and Lappalainen, 
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2008). The migration of these cells coupled with the resorption action forms 
resorption trails. In vitro differentiation of monocytes to osteoclasts occurs on 
synthetic surfaces like TCP and glasses. However, the formation of sealing zones 
is not documented (Saltel et al., 2004) implying that osteoclast activity and cell 
morphology is inhibited by different substrates. As the bone matrix represents the 
natural environment of osteoclasts, Titanium-doped phosphate glasses may limit 
osteoclastogenesis, with poor formation of inorganic hydroxyapatite (Abou Neel 
et al., 2007) and organic components such as type-I collagen only formed when 
culturing bone forming cells.  
 
With no current agreement for quantitatively comparing different osteoclastic 
resorption models and low efficacy in mimicking osteoclast action in vitro, it is 
very difficult to understand the true resorption of biomaterials by osteoclasts. 
Common cell lines such as RAW 264.7 are widely used to understand 
osteoclastogenesis in vitro, however primary cells are a better tool to understand 
the whole osteoclastogenic process. Osteoclasts of various species have been 
used including mouse (Benghuzzi et al., 1999, Leeuwenburgh et al., 2001), rat 
(Zheng et al., 1998, Monchau et al., 2002) and human (Schilling et al., 2004), on 
biomaterials such as calcium phosphate, hydroxyapatite, tricalcium phosphate 
and aluminium calcium phosphorous oxide, which could be resorbed by 
osteoclasts. However, coated silica glass showed resistance to resorption (Taylor 
et al., 2002). There is currently no existing literature published identifying the 
resorption of TiO2 doped phosphate glass by osteoclasts. 
 
This chapter assessed the process of osteoclastogenesis specifically on 
Titanium-doped phosphate glass discs (Ti-PGD), examining monocyte cell 
differentiation when cultured on the biomaterial and the resorption activity of 
osteoclasts formed. Undifferentiated cells were used rather than pre-
differentiated cells, as the mechanism of osteoclastogenesis in vivo commences 
with monocytes forming into osteoclasts on the surface of the resorbed material. 
The choice to use discs was made after initially culturing the cells on Ti-PGMs, 
however having stained the cells it was clear the curvature limited the efficiency 
of image capture. In addition to assessing the differentiation potential and 
resorbability of the material, the effect of RANKL concentration was assessed as 
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it is known to stimulate osteoclastogenesis and improve resorption. Finally, as it 
was hypothesized that osteoclast resorption would affect the surface of the Ti-
PGMs/Ti-PGDs by increasing surface roughness through the production of pits 
and migration trails, the consequent bone remodelling process on this surface 
was examined by culturing hBM-MSCs on acid etched Ti-PGDs to understand if 
cells could proliferate after the action of osteoclasts. 
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5.2 Materials and Method 
5.2.1 Preparation of Ti-PGD 
Phosphate glass containing 5 mol% TiO2 was prepared using the same protocol 
described in section 2.2.1. However, the cooling steps were different as the 
melted crystal was then poured into 15mm (for use in 24-well microplates) rod-
shaped moulds, which had been pre-heated at 420˚C to promote homogenous 
cooling within the mould during the cooling process. The material was kept under 
420˚C for 2 hours before cooling at room temperature. The rods were 
consequently cut with a microtome diamond blade cutter (Leica SP1699, UK) 
where the 15mm diameter rods were cut into 2mm thick disks. The different 
cooling procedures used in manufacturing both the rods and microspheres, may 
potentially alter the material properties and surface chemistry, therefore further 
characterization is required. Furthermore, MAPP gas flaming of the rods was not 
carried out as the surface upon which the cells were seeded on would not be in 
direct contact with flame prior to the rod being sliced. Care was taken when 
producing the glass rods as the viscosity of the melted glass coupled with the 
rapid cooling makes pouring the molten solution into the mould very difficult. In 
the case where large quantities of material remained within the crucible a further 
reheating process was used to bring the material into its molten phase to 
minimize material wastage. 
 
 
5.2.2 Isolation of mouse monocytes from mice and osteoclast 
differentiation 
A standard protocol was used to carry out initial studies (Orriss and Arnett, 2012). 
Mice (7-11 weeks MF-1 Female) were sacrificed by cervical dislocation at day 0 
and collected from UCL Biological Services. They were dissected using sterile 
surgical tools to isolate the mouse femur and tibia for monocyte extraction. 
Boneheads were removed by using dissection scissors after which a G-25 
PrecisionGlide needle and 10ml disposable syringe (both from BD Biosciences 
Europe, UK) were used to flush the bone marrow with flushing buffer (1x PBS 
and 2% fetal bovine serum). The resulting suspension was pelleted in S1 media 
(Table 5.1), seeded into T-75 flasks and incubated overnight at 37°C/5% CO2 
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post-centrifugation. Suspended mouse bone marrow derived monocytes were 
then collected and counted after 24 hours, while the attached cell populations 
were discarded. The isolated cells were resuspended in S2 media (Table 5.1) in 
preparation for cell seeding.  
 
 
Table 5.1 Different media types used during the monocyte isolation and 
osteoclast differentiation processes 
 
S1 Media 
Media components % of total volume 
Minimal essential medium (MEM) (Gibco, UK) ~88 
Fetal bovine serum (FBS) (Gibco, UK) 10 
Antibiotic-antimycotic solution (Gibco, UK) 1 
100ug/ml Wyeth M-CSF (416-ML, R&D Systems, UK) 0.0001 
 
S2 Media 
Media components % of total volume 
Minimal essential medium (MEM) ~88 
Fetal bovine serum (FBS)  10 
Antibiotic-antimycotic solution  1 
100ug/ml Wyeth M-CSF 0.0001 
20ug/ml RANKL (462-TEC, R&D Systems, UK) 0.00015 
 
 
Upon seeding the required numbers of monocytes, S2 cultures were left for 7 
days during which half S2 media was changed every 2 days. After day 7, acidified 
media was used to induce the resorption process. As the optimal conditions were 
achieved at pH 7, adjustments were made by the addition of small quantities of 
12.5M hydrochloric acid (HCL) into 100ml of S2 media, until the right pH was 
reached, identified using a pH probe. Monocytes were incubated with acidified 
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S2 media for 48 hours after which qualitative analysis was carried out using 
different techniques. 
 
 
5.2.3 Seeding density study for monocyte cell culture on Ti-PGD 
Monocyte seeding density experiments were carried out to understand the levels 
of cells numbers needed to effectively form osteoclasts when monocytes were 
seeded on Ti-PGDs. Four different cell concentrations (2.5x105, 5x105, 1x106 and 
2.5x106 cells/cm2) were studied on Ti-PGDs placed in ultra-low attachment 24-
well microplates The Ti-PGDs were sterilized using a high intensity UV lamp for 
90 minutes before seeding, after which the cells were maintained in the media 
regimes and durations stated in section 5.2.2. 
 
 
5.2.3.1 Tartrate-resistant acid phosphatase staining (TRAP) 
Cells underwent a staining process for tartrate-resistant acid phosphatase 
(TRAP) to understand the osteoclastogenesis and resorption activity on Ti-PGDs. 
A Leukocyte Acid Phosphatase Kit (387-A, Sigma, UK) was used for staining 
according to the supplier’s protocol. Initially samples were fixed with 4% PFA for 
15 minutes and consequently washed twice with 1x PBS. The cells were then 
washed and probed for TRAP ((1:1:1:2:4:22.5) Fast Garnet GBC Base Solution: 
Sodium Nitrite Solution: Napthol AS-BI Phosphate Solution: Tartrate Solution: 
Acetate Solution: Deionized H2O)) for 1 hour in the dark at 37˚C. Counter-staining 
was achieved using Haematoxylin solution Gill No.3 and after incubation for 2 
minutes the cells were washed with deionized H2O several times to remove 
residual staining solution. The TRAP positive cells were visualized under a light 
microscope at 20x magnification.  
 
 
5.2.3.2 Immunofluorescent staining 
To evaluate the morphology, differentiation and multi-nuclearity, PFA-fixed 
samples of monocytes grown on Ti-PGDs were stained for Cathepsin K (Rabbit 
polyclonal, AB19027, Abcam) F-actin (Alexa Fluor® 488 Phalloidin, A12379, 
ThermoFisher Scientific, UK) and nuclear acids (Hoechst 33342, ThermoFisher, 
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UK). Samples were incubated for 60 minutes with each primary antibody and 
subsequently for 15 minutes in the dark to complete nuclear staining. After 
washing with PBS cells were incubated in a secondary antibody solution (Goat 
Anti-Rabbit Alexa-Fluor® 594 A-11012, ThermoFisher), 
 
 
5.2.3.3 Scanning electron microscopy imaging (SEM) 
Osteoclast morphology and resorption activity was assessed using SEM with 
samples prepared using the same technique as described in section 4.2.5. 
 
 
5.2.4 Effect of RANKL concentration on osteoclastogenesis  
Having studied osteoclastogenesis on Ti-PGDs using culture protocols used for 
osteoclastogenesis on bone-like substances such as dentine, experiments were 
carried out to understand the effect of increased concentrations of RANKL (Bio-
techne, UK), a protein key in the differentiation of monocytes, osteoclast 
formation and resorption. The study involved using the protocol described in 
section 5.2.2 and a seeding density of 2.5x106 cells/cm2 with 3 different 
concentrations of RANKL. S2 media and acidified S2 media were supplemented 
with 0, 3 and 30 ng/ml of RANKL to map the optimal RANKL concentration for 
osteoclastogenesis on Ti-PGDs. 
 
 
5.2.4.1 Scanning electron microscopy imaging 
Osteoclast morphology and resorption activity was assessed using SEM with 
samples prepared using the same technique as described in section 4.2.5. 
 
 
5.2.5 hBM-MSCs culture on acid-etched Ti-PGDs 
The effect of surface porosity on the ability of hBM-MSCs to proliferate was 
analysed by acid-etching the surface of the Ti-PGDs and assessing their ability 
to support cell growth. This method aimed to mimic the acidic environment 
produced during which active osteoclasts resorb the bone surface. By using an 
acidic solution which created the same pH allowed the Ti-PGDs to be subjected 
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to the same environment. The mechanism of resorption and development of 
resorption pits varies significantly between natural osteoclast activity and the 
method used here, however this study should provide an understanding of how 
well hBM-MSCs can repopulate highly etched surface. Phosphoric acid (85% 
H3PO4, Sigma-Aldrich, UK) was used to form a 30% H3PO4 solution (diluted in 
distilled H2O) which was stored in a glass bottle at room temperature. Individual 
wells of ultra-low attachment 24-well microplates were filled with individual 15mm 
Ti-PGDs which were sterilized using a high-intensity UV lamp. The 30% H3PO4 
was added in quantities of 500µL to wells containing Ti-PGDs and were kept 
incubated at 37°C in an atmosphere of 5% CO2 for 15 minutes and 24 hours. The 
acid-etched Ti-PGDs were washed with DMEM (10% FBS, 1% AA) to ensure all 
acid had been removed from the wells. This was aided by the colour change of 
the media when in the presence of acid from a red to a yellow colour. Once the 
media maintained its red appearance, 2x104 hBM-MSCs were seeded into each 
well and were incubated at 37°C in an atmosphere of 5% CO2. Cells culture was 
carried out for 3 days after which samples were fixed for analysis. 
 
 
5.2.5.1 Scanning electron microscopy imaging 
Proliferation of hBM-MSCs was qualitatively assessed using SEM with samples 
prepared using the same technique as described in section 4.2.5. 
 
 
5.2.6 hBM-MSC culture on acid-etched Ti-PGMs 
The effect of porosity was further explored on Ti-PGMs to understand how cells 
proliferated on the microsphere versions of the discs. Ti-PGMs were acid-etched 
prior to hBM-MSC culture, by treatment for 15 minutes with 30% H3PO4 solution. 
After removing the solution and washing out the remaining acid with DMEM 
media, 5x103 cells were seeded into the wells and were incubated at 37°C in an 
atmosphere of 5% CO2. Untreated Ti-PGMs and Synthemax were chosen as 
suitable controls to understand the effect porosity had on cellular growth. Cell 
proliferation was determined on days 1, 4, and 7 using a CCK-8 kit with media 
changes carried out every 48 hours. 
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5.3 Results 
5.3.1 Mouse bone marrow-derived monocyte culture and differentiation on 
Ti-PGDs 
The tartrate-resistant acid phosphatase (TRAP) staining of the cells visualized by 
the dark bodies on the crystalline Ti-PGD surface showed that as cell seeding 
density increased, the proximity of adjacent monocytes increased, therefore 
encouraging fusion to form multi-nucleated cells. Minimal numbers of cells were 
visibly stained in cultures with the lowest seeding density with the frequency of 
stained cells increasing with increasing cell density. However, from the TRAP 
images (Fig 5.1) it is unclear whether the aggregates formed are functional 
osteoclasts or cells closely packed together. Further, giant osteoclasts cannot be 
identified after 9 days of culture on Ti-PGDs. Furthermore, the crystalline 
structure of the Ti-PGDs prevented accurate identification of multi-nucleated 
bodies, as light would refract while travelling through the material. No visible 
resorption trails can be identified on the surface with a lack of TRAP staining 
present around the larger bodies formed.  
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Figure 5.1 TRAP-staining showing monocyte distribution and osteoclast formation using 
different seeding densities. The different densities used were A- 2.5x105 cells/cm2 B-5 x105 
cells/cm2 C- 1x106 cells/cm2 and D- 2.5x106 cells/cm2. The red arrows indicate areas of possible 
osteoclastogenesis. Images were taken at 20x magnification with the scale bars representing 
200µm. 
Next, confocal microscopy was used to visualize cathepsin K expression, one of 
the enzymes responsible in bone degradation. Cathepsin K enzyme expression 
was prominent in monocytes cultured on Ti-PGDs, with many areas populated 
with high numbers of cells showing higher expression than individual cells. The 
lack of resorption trails is further validated through the immunofluorescent 
imaging, with no faint cathepsin K staining visible around a multi-nucleated 
osteoclast. Faint cathepsin K staining is used as an indication that an active 
osteoclast is migrating across the material surface. Furthermore, no F-actin 
cytoskeleton ring was visible even at high cell densities, which highlights the lack 
of sealing zone formation at this stage of culture. Hoechst staining allowed 
visualising the cell nucleus; however, it was not evident from immunofluorescent 
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imaging whether multi-nucleated osteoclasts existed with clusters of cell visible 
without a distinguishable actin ring. 
 
 
 
 
Figure 5.2 Cathepsin K expression from mouse monocytes cultured on Ti-PGDs. The 
immunofluorescent image illustrates expression of bone degrading enzyme cathepsin K (red) 
when 2.5x106 cells/cm2 were seeded on Ti-PGDs. Staining of F-actin (green) and nuclear stain 
(blue) Hoechst 33342 were carried out to highlight actin ring formation and multi-nuclearity 
respectively. Scale bar indicates 400µm with images taken at 5x magnification. 
 
 
Cathepsin K activity in Figure 5.2 indicates that enzymes involved in the 
resorption process are produced, however SEM was used to confirm that the 
materials could be degraded by the enzyme. When examining the SEM images 
(Figure 5.3) the ability of osteoclasts to resorb the Ti-PGDs is observed with clear 
pits formed under the active cell. Inactive monocytes showed no material 
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resorption indicating an earlier phase of osteoclastogenesis. The acidification 
action of the pre-osteoclasts allowed the material directly in contact with the cells 
to be resorbed; however, little migration occurs to allow further lateral axis 
resorption. From Figure 5.4 the resorption activity of pre-osteoclasts is validated 
with a potential resorption occurring in a perpendicular manner to the surface of 
the Ti-PGDs indicated by the deep cavity produced. Also illustrated by Figure 
5.4A are the differences between activated osteoclast precursors and inactive 
precursors. While the cell in the cavity shows no visible attachment to the Ti-PGD 
surface (inactive), the cell adjacent to it on the right (denoted by the red arrow) 
shows cell processes used to bind to the surface (active). 
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Figure 5.3 Monocyte culture and differentiation into pre-osteoclasts on the Ti-PGDs. SEM 
images of individual monocytes are illustrated in image A after 9 days of culture, while image B 
shows potential pre-osteoclasts and the lateral resorption. A hollow evacuated area can be seen 
under the cell with a similar shape to that of the cell. The degraded edge of the Ti-PGDs can be 
seen detached from the cell. Images were taken at various magnifications. 
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Figure 5.4 Pre-osteoclast resorption activity of the Ti-PGDs. The SEM images shows the 
differences between cellular material, the Ti-PGD surface and the resorption pit. The evacuated 
area can be seen under the cell with differing surface morphology to the Ti-PGD. Image B focuses 
on a section of image A to highlight the differences in textures of the modified surface. The arrows 
in image A indicate active (with cell processes) and inactive cells (without cell processes) adjacent 
to each other. Images were taken at various magnifications. 
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5.3.2 Effect of RANKL concentration on osteoclastogenesis  
Next, the effect of different concentrations of RANKL was assessed, to determine 
whether there is a dose-effect on osteoclastogenesis. Assessing the morphology 
of the cells cultured under the three different conditions helps to evaluate the 
efficacy of the osteoclastogenesis process on the Ti-PGDs at different RANKL 
concentrations. As RANKL concentration increased, there was a tendency for the 
cells to locate closer to each other on the Ti-PGDs. Cells cultured under the 
highest RANKL concentration produced flatter, pancake-like inactive osteoclasts 
which had larger diameters than those visible under standard RANKL 
concentration (3ng/ml). As was visible in earlier experiments, cell processes 
(filopodia) were not visible at all concentrations studied, limiting cell migration.  
 
 
 
Figure 5.5 Mouse bone-marrow derived monocytes cultured on Ti-PGD for 9 days at 
different concentrations of RANKL. The different concentrations are highlighted by (A) 0 ng/ml 
(B) 3ng/ml and (C) 30ng/ml, with images taken at different magnifications. Scale bars represent 
20µm intervals. 
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5.3.3 Evaluation of acid-etched Ti-PGDs to support hBM-MSC culture 
To assess the effect of Ti-PGD surface modification on consequent bone 
formation, modified Ti-PGDs were produced using acid etching techniques and 
then examined the interaction of hBM-MSCs with the altered surface. From 
Figure 5.6 clear differences were seen between the surfaces of the Ti-PGDs acid-
etched for different treatment times. When comparing the Ti-PGDs surface-
treated for 15 minutes compared to the control group, a more contoured surface 
can be witnessed in both the light and scanning electron microscopy images. 
However, Ti-PGDs acid treated for 24 hours showed the most significant 
difference when compared the control group with the surface showing deep 
networking valleys across the surface of the structure. There was no distinct trend 
to the location of the valleys; however, this could be due to the heterogeneous 
distribution of ions in the glass disc during the melting and quenching process of 
the glass. 
 
The application of Ti-PGDs were further assessed by seeding hBM-MSCs on the 
modified structures to understand whether effective cell interactions could occur 
on modified surfaces caused by acid treatment that is akin to the osteoclast-
mediated acid degradation that occurs in vivo. From Figure 5.7, which illustrates 
the morphology of cells grown on Ti-PGDs that have been acid treated for 24 
hours, it can be deduced that hBM-MSCs can interact well with the modified 
surface, highlighted by the thick layered sheet of cells above the valleys. 
Interestingly, images taken at higher resolution uncovered the formation of 
horizontal valleys through which cell processes were found to be passing, 
highlighting the ability of the hBM-MSCs to network through a degrading 
structure. 
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Figure 5.6 Effects of different incubation periods in 35% H3PO4 on the surface of Ti-PGDs. 
Images A-C were acquired using light microscopy technology while the images D-F were acquired 
using SEM. The different periods of time studied were: A/D- Untreated control, B/E- 15 minutes, 
and C/F- 24 hours. Scale bars for the light microscopy images indicate 400µm with images taken 
at 5x magnification. SEM images were taken at various magnification. 
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Figure 5.7 hBM-MSCs cultured on Ti-PGDs acid treated for 24 hours. The SEM images 
highlight the networks formed by hBM-MSCs within the channels created by the acid etching 
process of the Ti-PGDs, after 3 days of culture. The white arrow highlights a cell process passing 
through a horizontal valley. Images were taken at 1000x magnification with scale bars indicating 
20µm. 
A 
 
A 
B 
 
B 
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5.3.4 Cell proliferation of hBM-MSCs on acid-etched Ti-PGMS 
The CCK-8 proliferation assay values were used to understand the effect acid 
etching had on cell attachment and proliferation over the course of 7 days, 
presented in Figure 5.8. Examining the cell viability based on the absorbance 
values, it can be seen that Synthemax showed improved cell attachment and 
growth over the first 24 hours when compared to both the control Ti-PGM group 
and the acid etched Ti-PGMs.  On day 4 of culture, Synthemax maintained their 
enhanced proliferative ability however cell cultures on untreated Ti5 
microspheres showed increased viability from day 1 to 4. By day 7 hBM-MSCs 
cultured on acid etched Ti5 microspheres showed significantly lower cell 
absorbance values than untreated Ti5 microspheres (***p<0.001). 
 
 
 
Figure 5.8 Proliferation of hBM-MSCs on untreated Ti5 and acid-etched Ti5 microspheres 
compared to Synthemax. CCK-8 assay readings were taken at time points day 1, 4 and 7 Error 
bars represent +SD (n=3). **=p <0.01. 
 
The differences in surface topography can be observed through the SEM images 
presented in Figure 5.9. Images A and B illustrate the porous  layer created due 
to the effects of the H3PO4. The pores generated do not extend through the 
microsphere to form a network, however generates a rough surface for cell 
attachment. The pores are visibly heterogenous in character such as depth and 
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width, and are located in an irregular manner across the surface. Figure 5.9C and 
D examine the surface properties of Synthemax which shows a rough surface 
due to the protein surface coating administered to the polystyrene microcarriers, 
which aids surface attachment. The raw untreated microcarriers (Fig 5.9E) show 
a smoother surface with limited changes in surface topogrpahy when compared 
to the Synthemax surface (Fig 5.9C). 
 
 
 
 
Fig 5.9 Scanning electron microscopy images showing the surface topography of Ti-PGMs 
incubated in H3PO4. Samples were acid-treated for 15 minutes (A, B), Synthemax microcarriers 
(C, D) and untreated titanium phosphate microspheres (E). Images were taken at different 
magnifications.  
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5.4 Discussion 
This chapter of the research aimed to determine whether titanium-doped 
phosphate glass is capable of being resorbed by osteoclasts. Initially, the 
capacity of the material to support osteoclastogenesis was assessed, followed by 
the resorptive capability of the developed osteoclasts. The initial experiments 
focused on understanding what seeding density of monocytes is required to 
initiate osteoclastogenesis. Various seeding densities have been suggested in 
the literature, from 5x104 cells/cm2  (Wittrant et al., 2008) up to 2.5x106 cells/cm2 
(Orriss and Arnett, 2012). Having studied a range of different densities on the Ti-
PGDs it was evident that higher densities were required to promote effective 
osteoclast formation, illustrated by TRAP staining. One reason for the low 
numbers of giant osteoclasts formed may be due to a lack of inorganic 
components in the material. The material’s relative bio-inert nature when 
compared to physiological bone (due to a lack of bone specific proteins such as 
collagen and other proteins, factors paramount in the activity of osteoclast) limits 
the ability of osteoclast progenitors to bind effectively to the surface, fuse 
together, and consequently migrate and resorb the Ti-PGDs.  
 
Vitronectin and osteopontin act as ligands, by binding to integrins found on the 
cell membrane such as vitronectin receptors αVβ3 (VNR) (Chambers and Fuller, 
2011), therefore osteoclasts have limited affinity to biomaterials without these 
present. The lack of these regulatory proteins for attachment, will concurrently 
lead to the absence of a resorption trail. Therefore, future work could assess 
potential approaches to functionalisation of the materials via coatings using a 
range of bioactive molecules.  
 
While giant active osteoclasts are more effective at resorbing bone-like materials 
compared to smaller active osteoclasts due to the surface area they occupy, there 
is no conclusive evidence directly correlating material type with its ability to induce 
the formation of large osteoclasts. In fact, giant, inactive (non-resorbing) 
osteoclasts have been cultured on tissue culture plastic, a material incapable of 
being resorbed by active osteoclasts (Orriss and Arnett, 2012), hence cell size 
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shouldn’t be solely used to assess the biomaterials ability to generate functional 
osteoclasts.  
 
The use of cathepsin K enzyme secretion as a molecular marker of osteoclast 
activity is also under dispute, with authors of studies concluding that cathepsin K 
expression is independent of substrate, where no difference in expression is 
observed between monocyte cells cultured on plastic, bone particles or in 
suspension (Rieman et al., 2001). While surface properties have been shown to 
have no effect on cathepsin K expression, it was necessary to understand 
whether cells grown on Ti-PGDs could synthesis enzymes necessary for 
remodelling and resorption of the biomaterials. The immunofluorescent images 
indicated that cells were capable of secreting cathepsin K, and high cathepsin K 
expression was associated with areas of high cell clustering, suggesting that the 
osteoclastogenesis process was initiated. The lack of a positive control for this 
study owes to the Ti-PGDs thickness being magnitudes higher than the dentine 
discs obtained, therefore future work should look at having a suitable control that 
to compare resorption rates of the materials. Future studies should look to either 
create thinner Ti-PGDs or find a suitable resorbable substance to compare Ti-
PGDs to. While cathepsin K expression presents uncertainty as a key marker of 
active osteoclasts, the role of F-actin is undisputed. F-actin ring formation occurs 
during the resorption process carried out by osteoclasts, and the actin rings 
create sealing zones between the cells and the bone-like material (Jurdic et al., 
2006, Teitelbaum, 2007). The formation of this sealing zone is identified as the 
point at which resorption is initiated (Chambers and Fuller, 2011). The ability to 
identify actin ring formation is an indicator of an active osteoclast, confirmed by 
osteoclasts cultured on tissue culture plastic, which are unable to form actin rings 
or are limited to forming podosome dots (actin ring precursors) (Wilson et al., 
2009, Kleinhans et al., 2015), and are therefore considered inactive. The 
osteoclasts formed on the surface of the Ti-PGDs showed no distinct actin ring 
formation even in areas showing the presence of high cathepsin K expression 
and pits. The lack of visible actin ring may be due to the culture period being too 
short to support the formation of the necessary structures specifically on the Ti-
PGDs. 
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Interestingly, the osteoclasts which exhibited resorptive activity maintained no 
sealing zone commonly seen with resorbing osteoclasts. Instead they resided 
within the resorbed pit with no cellular processes, which suggests either the 
osteoclasts were resorbing in a downwards fashion into the material, or the 
environment surrounding the osteoclasts inhibited any further osteoclast function. 
From the SEM images, evidence is provided to illustrate that resorption of the 
biomaterial can be achieved, however the lack of resorption trails suggests the 
cells are unable to migrate on the material. This owes to the limitation of the 
material; as aforementioned, it doesn’t provide support for monocyte cell 
attachment and its metallic dopant (Ti4+) potentially inhibits osteoclastogenesis. 
Future work could assess the application of surface coatings e.g. collagen to the 
material as a means of enhancing monocyte attachment and osteoclastogenesis. 
 
It is well documented that metallic oxides of different valences alter the activity of 
osteoclastogenesis. While doping specific biomaterials can enhance stability of 
the structure and promote osteoblastic formation, the effects of these ions on 
osteoclastogenesis and osteoclastic resorption are generally detrimental. When 
looking at bivalent cations such as Mg2+, Sr2+ and Zn2+ evidence exists that these 
ions inhibit or at least slow down differentiation of precursor monocytes into 
mature osteoclasts (Hadley et al., 2010, Janning et al., 2010, Tat et al., 2011, 
Yamaguchi and Weitzmann, 2011, Roy and Bose, 2012, Bose et al., 2013, 
Ostrowski et al., 2015). Other research has concluded that elevated levels of 
extracellular inorganic phosphate (Pi) ions may be responsible for reduced 
osteoclast activity and potential osteoclast apoptosis, however understanding of 
the mechanism involved has not been fully elucidated (Yates et al., 1991, 
Hayashibara et al., 2007).  
 
Stimulation of the osteoclast progenitor surface receptor RANK by RANKL is a 
significant cue for osteoclast maturation (Lacey et al., 1998). Therefore, to 
improve osteoclast activity it was deemed appropriate to increase RANKL 
concentration and determine whether enhanced resorption could be achieved. 
While there was no change in resorptive activity between the different RANKL 
concentrations studied (0, 3, 30 ng/ml), the structure and sizes of cells formed 
varied a great degree. Whether this is achieved during the initial stages of cell 
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culture by monocytes aggregating in suspension, or at the stage of attachment 
where RANKL induces cells to migrate to one another, evidence exists to show 
that osteoclastogenesis is affected by RANKL concentration.  
 
While the challenge to develop a perfectly resorbable biomaterial still exists, there 
lies a question of whether bone-forming cells will repopulate and fill the resorption 
pits created. The idea envisaged is that the ideal material would trigger 
coordinated osteoblastic formation and osteoclastic resorption. The geometric 
structure of a biomaterial can be a cue for cell adhesion and consequently 
proliferation (Dalby et al., 2014). Improvements in biomaterial microarchitecture 
need to be achieved to enhance these tissue regeneration responses. It has been 
documented that pore size in tissue engineered substrates greatly influences 
mechanical properties (Jones et al., 2009). While small pores could restrict cell 
infiltration into a structure and revascularization, large pores can reduce structural 
stability (Jones et al., 2009). It has been documented that scaffolds with larger 
uniform pore sizes resulted in better functional bone regeneration (Guda et al., 
2014). The level of porosity also plays an important role in tissue regeneration, 
as differing scaffold porosities influence both cell proliferation and osteogenic 
differentiation. Work carried out by Horst et al., showed that increased surface 
porosity accelerated cell proliferation in vitro (Horst et al., 2014). While other 
studies have shown that increased surface porosity supresses early cell 
proliferation (Wall et al., 2009). However, there is no universally accepted pore 
size dimension known to induce osteogenic differentiation (Bohner et al., 2011). 
 
Limited work to our knowledge, has been carried out on understanding the effect 
of porosity on MSC proliferation on micro-spherical phosphate glass particles. 
Therefore, understanding whether the effects observed in this study are 
representative to those witnessed in the broader tissue engineering community 
can’t be confirmed. However, when comparing the pore sizes created through 
acid-etching of the Ti-PGMs compared to the sizes shown to promote better cell 
proliferation, the smaller sizes could be a potential reason for the lower cell 
proliferation after 7 days compared to the untreated surface. Cell type may also 
play a role in the effect of pore size and porosity on cell proliferation. With the 
average size of MSCs significantly larger than osteoblastic cells, care needs to 
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be taken in determining the architecture of the microspheres for culture and 
differentiation.  
 
It can be concluded that Ti-PGMs subjected to a short period of acid-etching have 
reduced proliferative capacity when compared to control Ti-PGMs and 
Synthemax. Wall et al., showed that MSCs don’t like to reside on acid-etched Ti-
discs while Harle et al., showed that osteoblasts preferred to, indicating the two 
cell types that are born of the same precursor respond differently (Harle et al., 
2006, Wall et al., 2009). This suggests further work is required to understand how 
well MSCs can repopulate a degrading structure. Additionally, the effect of 
porosity may have an impact on the fluidization of the microspheres during large 
scale cell culture. Extended periods of acid exposure will inevitably reduce the 
overall density of the microspheres, making them more buoyant and increasing 
the likelihood that they could be brought into suspension. However, a careful 
balance is necessary to ensure that the additional porosity doesn’t inhibit cell 
attachment.  
 
Overall, this chapter showed that some key responses associated with osteoclast 
formation are evident on phosphate glass microcarriers. However, the absence 
of critical parameter, F-actin ring formation, means that further work is needed to 
determine whether osteoclastogenesis can truly take place on these materials 
and hence promote resorption. Acid etching, to mimic the acid resorption that 
takes place in vivo did not yield positive results for MSC proliferation, even though 
a dense carpet of cells was identified at the surface. 
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Chapter 6 .   Summary: General conclusion and 
future work 
 
 
6.1 Research objectives and conclusions 
The present research was undertaken with the hypothesis that that spheroidized 
phosphate glass microspheres can support critical cell responses that will 
ultimately enable scalable production of bone-like tissue microunits. The overall 
goal was to demonstrate the potential of Titanium-doped phosphate glass to 
support production of bone-like tissue in a manner that is transferable to scalable 
bioreactor-based cell culture. To achieve this goal, the following aims were 
defined: 
 
1) Assess the biocompatibility of the material with the following differentiated 
and primary cell types: 
a) Osteosarcoma cell line (MG63) 
b) Human bone marrow-derived mesenchymal stem cells (hBM-
MSCs) 
2) Determine the effects of fluid flow forces induced by dynamic culture on    
cell/engineered tissue quality. 
3) Establish whether scale-up of cell culture can be achieved to create 
increased quantities of engineered bone-like material. 
 
The following section summarises the key findings identified in the studies carried 
out and identifies direction for future work to address the various challenges 
encountered throughout the research. 
 
The first objective was to determine whether Ti-PGMs could support MG63 and 
hBM-MSC culture. Initially, three different glass compositions were developed 
containing 0, 5 and 7 mol% quantities of TiO2. However, during the study the 0 
mol% composition degraded within 3 days when in solution. Therefore, only the 
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5 and 7 mol% compositions were taken forward and extensively studied with both 
cell types.  
 
One major limitation of the study which should be considered when drawing 
conclusions from the results is the lack of material characterization carried out in 
this study. Prior characterization of this material has been carried out within the 
laboratory on the stochiometric compositions studied ((Lakhkar et al., 2012a). 
However, as the experiments carried out in this study used a different batch of 
material from the aforementioned study and additionally multiple batches were 
used in this research it is important to clarify that the lack of control in regard to 
the characterization of the material could potentially play a role in the cell 
behaviour. 
 
Initial cell culture studies using MG63 cells indicated that the material was 
biocompatible and able to support cell growth. No difference was observed 
between the two compositions studied in terms of cell growth, indicating that both 
were structurally suitable for cell growth and support. Over the 13 days of culture 
2.64- and 2.65-fold increases were achieved by Ti5 and Ti7 respectively. 
However, this was lower than proliferation on commercially available tissue 
culture plastic, which increased viable cells by 4.59-fold. The studies served as a 
starting point into understanding whether bone forming cells could be cultured on 
the materials. In comparison with commercially available surface-treated 
polystyrene microcarriers, Synthemax, which are classified as an entity optimized 
for MSC attachment, Ti-PGMs exhibited similarity in their ability to support hBM-
MSC proliferation across most of the conditions studied. The fold increase values 
supported the hypothesis that Ti-PGMs could effectively support hBM-MSC 
proliferation and essentially provided the foundation to explore how microscale 
cultures could be translated to 125ml shaken cultures. Light microscopy revealed 
that both cell types when cultured on Ti-PGMs could form networks between 
microspheres and consequently create clustered macrostructures.  
 
Unlike the MG63 cells that were studied in Chapter Two, hBM-MSCs are 
influenced by their local environment more than MG63 by forces such as fluid 
flow, a characteristic that can be used to aid cell differentiation. The studies using 
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hBM-MSCs not only focused on the proliferation of immature stem cells but also 
on understanding the influence of Ti-PGM on their osteogenic differentiation. 
During cell culture, attachment protein fibronectin and early bone differentiation 
marker type-1 collagen were both up-regulated after 13 days of culture. Further 
studies examined whether soluble factors released from the substrates can 
induce an osteogenic response, using conditioned media from 5 mol% powders. 
The results indicated that the dissolution components of the material didn’t have 
as prominent an effect as commercially available osteogenic media. However, 
they did support cell proliferation at low concentrations.  
 
Having studied the responses of MG63 and hBM-MSCs on different compositions 
of Ti-PGM’s at small scale, a choice was taken to narrow down the compositions 
to be studied at large scale to one Ti-PGM type. As earlier results showed limited 
differences activity of MG63 cells on the different Ti-PGMs, yet for hBM-MSCs 
Ti5 produced higher cell yields, large-scale studies were carried out using only 
Ti5. 
 
The second objective of this research was to establish whether dynamic culture 
could improve cell activity on Ti-PGMs due to the associated action of mixing. 
The Froude number, a scalable dimensionless number dependent on vessel 
geometry, fluid height and orbital diameter (Weheliye et al., 2013) was used to 
determine the agitation rates chosen for studies of both MG63 and hBM-MSC 
responses. MG63 cell growth in microplates orbitally shaken at speeds calculated 
to achieve optimal mixing showed no enhanced response compared to static 
culture conditions. However, the cell-microsphere structures that formed varied 
greatly with high speeds creating small clusters, but static and intermediate 
agitation rates creating larger clusters. The high agitation rates also forced the 
cells to metabolise in an ineffective manner, generating more lactate per unit of 
glucose consumed compared to the other conditions. The effect of dynamic 
culture on hBM-MSCs is generally well understood, with evidence clearly 
showing that fluid flow can positively influence hBM-MSC differentiation (Reich et 
al., 1990, Bancroft et al., 2002, Kreke and Goldstein, 2004, Kreke et al., 2005).  
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Moderate agitation was stimulatory to and enhanced proliferation of hBM-MSC 
on Ti-PGMs compared to static culture, whereas higher agitation speeds were 
detrimental to hBM-MSC growth, when compared to static conditions and 
moderate agitation rates. Regarding cluster formation, similar observations were 
seen for MG63 cells, with higher agitation rates leading to small clusters. It is 
concluded that moderate agitation rates are beneficial when using Ti-PGMs due 
to the mixing patterns created. At high agitation rates cell growth is limited, 
therefore complete mixing within a reactor vessel shouldn’t be used for cell 
culture using the conditions chosen (media and microcarrier type) unless carried 
out in a shear-controlled manner. 
 
The final objective of this research was to explore the opportunity to use the 
knowledge gained from small scale to translate to large scale, using the different 
Froude models to predict the agitation speeds required. Having explored the use 
of different bioreactors (perfusion and magnetic-wheel bioreactor) and their 
compatibility in aiding the use of Ti-PGMs as a platform for large scale culture, 
shaken culture was chosen as it best mapped to the mixing mode used in small 
scale studies and therefore extrapolation of observations across the two scales 
should be more achievable. 
 
The assessment of each of the reactor types considered will be discussed briefly 
towards the end of this section. Using a model developed by Olmos et al., (Olmos 
et al., 2015) to understand mixing systems at large scale under shaken culture 
taking into account parameters studied by Weheliye et al., (Weheliye et al., 2013), 
agitation speeds could be determined for large-scale culture which would map to 
the mixing systems used in small-scale studies. Large-scale culture of hBM-
MSCs in 125ml Erlenmeyer flasks showed the same trends that were witnessed 
at small scale. Cell proliferation on Synthemax decreased when orbital agitation 
was increased, while culture on Ti5 was better under static and moderate 
agitation conditions. Interestingly, when extremely high agitation rates were used 
at large scale the Ti-PGMs would concentrate into the centre of the vessel, in an 
area which cells proliferated and secreted ECM, indicating that the effects of fluid 
flow shear were low in the centre of the vortex created. The major highlight of the 
research was the Ti-PGMs ability to match, and under higher agitation conditions 
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exceed Synthemax’s ability to support cell proliferation. The large-scale use of 
Ti-PGMs validated previous studies carried out at small scale using the material 
of its ability to provide cues for osteogenic differentiation. With limited work 
existing on the use of shaken platforms and bioactive materials to support the 
formation of tissue engineered macrostructures at a clinically relevant scale, 
further work is required in the field to characterize the materials created at the 
studied scale and to understand whether the Olmos model used in this study can 
be validated for Ti-PGMs at larger vessel sizes. 
 
Additionally, this research explored how well the substrate could be reabsorbed 
by cells responsible for bone remodelling in vivo. Using mouse bone marrow 
derived monocytes; the Ti-PGDs were assessed for their ability to support 
osteoclastogenesis. Overall, the formation of functional osteoclasts was not 
evident through visual analysis, attributable to the lack of attachment proteins 
available in Ti-PGDs. While limited attachment of what were deemed as pre-
osteoclast cells was observed, many cells showed their resorptive capacity of Ti-
PGDs. Further work is necessary to understand whether the substrate can be 
altered to improve osteoclast attachment and migration, therefore improving 
osteoclast migration and hence substrate resorption. The resorption activity was 
also mimicked through acid etching of Ti-PGMs and MSC proliferation was 
assessed. The acid-etching studies also provided an understanding of how well 
bone-forming cells could function on a porous structure, an eventuality from 
structural degradation. 
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6.2 Future Work 
The mode of using Ti-PGMs to produce tissue engineered constructs of bone in 
order to treat critical size defects cannot be determined until further 
characterization of the tissues formed, as well as the feasibility of further scale up 
have been established. This research has provided an insight to the potential 
uses of Ti-PGMs within a dynamic environment; however, work in the future 
should look to determine specific operating ranges to exploit the impact of 
dynamic culture conditions and fluid flow shear stresses. By narrowing down 
specific agitation windows to optimize proliferative and differentiation conditions, 
a single closed vessel has the potential to eliminate other modes of cell expansion 
and reduce the costs of expensive differentiation media required to generate 
bone tissue in vitro. 
 
One key area to focus on highlighted by limited resorption is the incorporation of 
active biological ingredients such as attachment proteins into the structure or 
through surface coatings. As discussed in Chapter 4, the use of protein coatings 
as a biofunctionalization tool has been studied extensively; however, the benefits 
of the applied coating would be limited to the outer surface of the material. Sol-
gel synthesis presents a useful alternative to the melt-quench method used in this 
research to produce glass. Formation through the hydrolysis and dehydration of 
inorganic salts and metal hydroxides, permits sol-gel glasses to be processed at 
low temperatures therefore allowing proteins to be incorporated into the glass 
structures (Arcos and Vallet-Regí, 2010). The loading of osteogenic compounds 
within Ti-PGMs could allow it to act as a drug delivery system by the 
supplementation of osteo-regenerative agents to the injured site. 
 
While the material showed promise as a biomaterial, its density creates a 
challenge for use in microsphere format in scaling up cell culture. There was 
some evidence from the acid-etching studies that it is possible to etch pores into 
the material and could be explored further as a means of reducing density and 
increasing buoyancy of the material. Successful transition of shaken culture from 
microscale to large-scale was achieved, through proven cell proliferation and 
improved osteogenic differentiation compared to commercially used 
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microcarriers, however the use of Ti-PGMs in different bioreactor types showed 
the limitations that need to be addressed, including its ability to be suspended to 
create a homogeneous cell culture environment. Techniques such as thermally 
induced phase separation (TIPS), used with other biomaterials such as PLGA, 
could aid the production of highly porous structures, increasing the overall 
buoyancy on the Ti-PGMs. However, in vitro characterization will need to be 
carried out to ensure any newly formulated microsphere can provide the same 
physical and structural properties of its predecessor (Parmar et al., 2015). 
 
Besides single-use shaken bioreactors, other disposable bioreactors were 
considered, including PBS Biotech’s novel MagDrive bioreactor which employs a 
low shear, pneumatic mixing system with high oxygen transfer rates. The PBS 
0.1 MAG was used to determine how well Ti-PGMs could be cultured in a stirred 
vessel with a relatively low shear environment. Initial work studied three different 
agitation speeds (0, 25, and 50 rpm) using both Ti-PGMs and Synthemax. While 
both substrate types could be cultured and monitored through metabolite 
analysis, the process of extracting cell-microsphere material post-culture created 
problems, more so for the Ti-PGM’s due to accessibility. The positioning of the 
vertical wheel prevented the extraction of the dense Ti-PGMs which were situated 
under the wheel, with any alternative intervention breaking the structures formed 
(Figure 6.2). However, the Synthemax microcarriers were used effectively with 
the PBS 0.1MAG bioreactor with both dynamic conditions improving cell 
proliferation with significantly higher (*p<0.05) rates of glucose consumption at 
day 10 compared to static culture in the same vessel. 
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Figure 6.1 Glucose consumption and lactate production of hBM-MSCs cultured on 
Synthemax using a PBS 0.1MAG bioreactor. The magnetically driven air wheel bioreactor was 
run at 0, 25 and 50 rpm with samples of media taken on days 1, 4, 7, 10, 13 and 16. *=p<0.05. 
Error bars indicate ±SD. 
 
Figure 6.2 PBS 1.0 MAG Bioreactor containing Ti-PGMs under static (A) and 50rpm (B) 
conditions. The image illustrates the Ti-PGMs (1g) circled in blue remaining static at the base of 
the reactor when the highest speed was administered. Furthermore, the location of the magnetic 
drive prevents extraction of the material in an effective manner. The arrow indicates the direction 
of wheel rotation. 
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The use of perfusion bioreactors is a heavily researched area that offers 
interesting possibilities for the development for small-sized bone tissue that can 
be used to combat bone loss caused by injuries, congenital deformities or disease 
(Yeatts and Fisher, 2011). Basic perfusion bioreactor systems generally comprise 
a substrate material (either a scaffold or microparticles) placed along with cells 
inside a chamber. Cell culture medium flows through the chamber in a closed 
loop via tubes passing through a peristaltic pump that controls the medium 
perfusion rate. Perfusion bioreactor systems allow a laminar flow of medium and 
mass transport of nutrients and oxygen throughout the entire volume of the 
construct and are therefore able to overcome the diffusional limitations 
associated with other bioreactor types (e.g. rotating wall bioreactors). By varying 
the perfusion rate using the peristaltic pump, the fluid shear stresses exerted on 
the tissue can be optimised to provide the environment for optimal growth of 
small-sized bone tissue.  
 
An in-house designed perfusion device (Fig 6.3) was used to understand the 
effectiveness of a perfusion bioreactor to be used with the Ti-PGMs. The idea 
was to create a homogenous expanded bed microsphere system to improve 
seeding and expansion of the hBM-MSCs, and consequently study the effects of 
different flow rates on cell proliferation and osteogenic differentiation. However, 
having calculated the Galileo fluidization parameter to determine the flowrate 
required to overcome the terminal falling velocity, the force required to maintain 
the Ti-PGMs in suspension exceeded the value of the pump that had been used 
(Richardson et al., 2002a, Richardson et al., 2002b). This limited studies to be 
carried out in packed bed mode, which had their inherent disadvantages such as 
concentrations gradients at low perfusion rates, and limited cell attachment at 
high flow rates. Although preliminary work on using perfusion bioreactors with Ti-
PGMs has been carried out in the author’s present laboratory, it is expected that 
the selection of an appropriately sized perfusion chamber and optimisation of the 
seeding and culturing protocol, together with on-going developments in 
microsphere surface functionalization and specialised stem cell medium 
production, will in the long term lead to the realisation of the main objective of the 
research, which is to develop viable bone tissue in vitro for use in bone 
replacement therapies.  
 201 
 
 
 
Figure 6.3 Different perfusion devices used to study the effects of fluidization of Ti-PGMs 
(A - doped with 5 mol% Co2+ and B – Ti5). The Faculty of Engineering and Design Group at the 
University of Bath tested the Ti-PGMs in their in-house developed perfusion device (A), while an 
in-house perfusion reactor (B) developed within the UCL Biochemical Engineering Regenerative 
Medicine lab was used to compare different perfusion reactor dimension on fluidization of the 
microspheres. The perfusion devices was connected to a Watson Marlow 205U (Wolflabs, UK) 
peristaltic pump where various flow rates were administered from 0 to 20 ml/min. Under maximum 
flowrate conditions, the Ti-PGMs would momentarily fluidize however would settle immediately.  
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Chapter 7 .   Bioprocess validation 
considerations of biomaterials used in cell 
therapy manufacturing 
 
 
One of the major challenges facing commercialization of cell therapies is the 
ability to translate protocols from the lab bench to closed, controlled bioreactors 
to deliver a consistent quality product in a reproducible fashion. This is a 
necessary step to meet scale up requirements to treat large numbers of patients. 
Furthermore, maintaining critical product attributes such as biologic identify and 
function requires great control, hence validation of the processes needs to meet 
regulatory standards. 
 
The ultimate goal of the work carried out in this thesis would be to create a 
controlled system which could deliver personalized units of tissue engineered 
bone for defects of different sizes using microspheres and cells assembled into 
personalised geometries using custom-made moulds. The strategy to develop 
customised material will need to be explored further by understanding whether 
cell expansion and differentiation can be achieved in a sequential process within 
a mould effectively.  
 
The application of tissue engineering to treat bone defects requires a balance 
between technical feasibility of the cell culture process and the economic drivers 
to minimize cost and maximize value. From the materials perspective, the 
material properties need to be adequate to provide the cells with an appropriate 
biophysical environment to deliver a product fit for purpose. While the science 
and engineering around developing a biomaterial play a crucial part in its 
success, knowledge of relevant regulations, standards and the required 
validation assessments are essential. 
 
Regulatory guidance for biomaterials and medical product development focuses 
primarily on safety and efficacy. The US Food and Drug Administration (FDA) 
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and the Medicines and Healthcare Products Regulatory Agency (MHRA) aims to 
evaluate the risks associated with the medical entity regarding its proposed use, 
with biocompatibility being an area within the safety category that must be shown. 
The biomaterial’s intended use correlates directly to the types of tests that need 
to be performed.  
 
The International Organization for Standards (ISO) have developed specific 
areas of ISO 10993 which clarifies the necessity to understand ‘the potential 
biological risk arising from the use of medical devices’. The guidelines understand 
that biological hazards are ‘wide and complex’ and that adverse interactions 
caused by certain material may not be a problem when interacting with other 
materials. Furthermore, it highlights the required biological tests that are required 
to evaluate the material, where commonly used materials, known as reference 
materials provide the basis for comparison and benchmarking for novel 
biomaterials. Additionally, the ability of a biomaterial to be sterilized significantly 
impacts on the ease with which to create a safe product that can be 
commercialised. With this research focusing on cell-based therapies, sterile 
processing environments need to be established to minimise the risk of disease 
transmission via pathogens to acceptable levels. Therefore, fully characterising 
biocompatibility and having a simple sterilization procedure, while ensuring 
performance criteria are met during product development, will ease the regulation 
process.  
 
The ability of a biomaterial to carry out what it claims to do needs to be 
demonstrated, hence the correct type of tests need to be chosen to evaluate 
performance characteristics. Many of the tests that can be used to evaluate 
biomaterials, including phosphate glasses, have been identified by organizations 
like the American Society for Testing and Materials (ASTM) and ISO. Further 
tests to demonstrate efficacy and safety could include animal testing. Having 
implanted the cell-microcarrier clusters in to the chosen animal model 
(mouse/rat), appropriate tests should be chosen based on species and specific 
outcome measures such as local tissue regeneration and reactive immune 
responses. Testing on areas in an animal that correlate directly to the target area 
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for treatment in a human is important as the different anatomy and physiology to 
humans can be challenging.  
 
While good manufacturing practice (GMP) addresses the manufacturing aspect 
of product development, it is important to consider the cell therapy lifecycle. 
Therefore, GMP should consider premarketing activities such as design and 
development, manufacturing, process validation and quality control, whilst also 
considering post-marketing activities. If the Advanced Therapy Medicinal Product 
(ATMP) is then granted approval, the product is available on the market and is 
continuously regulated by the FDA. 
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Appendix 
A.1 Geometrical characteristics and calculated Frc and Nc (using minimum 
and maximum operating conditions) using 96-well microplates. 
Variable Value Unit 
Well Inner Diameter di 6.4 x 10-3 m 
 
Orbital Diameter do 1 x 10-2 m 
 
Liquid Volume (min) Vmin 1.5 x 10-7 m3 
 
Liquid Volume (max) Vmax 1.6 x 10-7 m3 
 
Critical Froude Number (min) Frcmin 0.65  
 
Critical Froude Number (max) Frcmax 0.70  
 
Critical Speed (min) Ncmin 340 min-1 
 
Critical Speed (max) Ncmax 350 min-1 
 
 
 
A.2 Geometrical characteristics and calculated Frc and Nc (using minimum 
and maximum operating conditions) using an 125ml Erlenmeyer flask. 
Variable Value Unit 
Flask Inner Diameter di 6.6 x 10-2 m 
 
Orbital Diameter do 1.0 x 10-2 m 
 
Non-Dimensional Fluid Height hL/di 0.51  
 
Orbital to Flask Diameter Ratio do/d 0.15  
 
Flask Maximum Working Volume VL 8 x10-5 m3 
 
Relative Density ρ* 2.6  
 
Particle to Vessel Diameter Ratio dp/d 1.29 x 10-3  
 
Suspension Froude Frs 0.58  
 
Suspension speed Ns 320 min-1 
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A.3 Geometrical/Physical characteristics and calculated Ga and flowrate 
to achieve Ti-PGM suspension 
Variable Value Unit 
Particle Diameter di 6.6 x 10-2 m 
 
Relative Density ρ* 2.6  
 
Voidage corresponding to Minimum 
Fluidising Velocity 
emf 0.4  
 
 
Galileo Number Ga 12.06  
 
Reynolds Number at the Minimum 
Fluidising Velocity 
Remf 0.02 x10-2  
 
 
Volumetric Flowrate at the Minimum 
Fluidising Velocity 
Qmf 7 x 10-8 m3/s 
 
 
 
 
 
A.4 Box-and-whisker plots required for bar charts presented in Chapter 3 
 
(a) 
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(b) 
 
(c) 
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(d) 
 
Figure A.1. Box-and-whisker plots representing the results of a CCK-8 assay to quantify 
hBM-MSC proliferation, cultured in different types of conditioned media (Ti-conditioned 
media (2 mg/ml,10mg/ml and 20mg/ml), DMEM and osteogenic media in Nunclon™ flat 
bottomed tissue culture 96-well microplates on days a) 1, b) 3 c) 5 and 7. Note that circles 
indicate outliers (values more than the interquartile range) while asterisks indicate extreme 
outliers (values more than three times the interquartile range). 
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